
<html lang="en"     class="pb-page"  data-request-id="f04b6349-52e5-440f-b34c-3d510d8e0bd1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2021.64.issue-3;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01774;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor" /></meta><meta name="dc.Creator" content="Vanessa  Hoguet" /></meta><meta name="dc.Creator" content="Manuel  Lasalle" /></meta><meta name="dc.Creator" content="Mathieu  Maingot" /></meta><meta name="dc.Creator" content="Geoffroy  Dequirez" /></meta><meta name="dc.Creator" content="Rajaa  Boulahjar" /></meta><meta name="dc.Creator" content="Florence  Leroux" /></meta><meta name="dc.Creator" content="Catherine  Piveteau" /></meta><meta name="dc.Creator" content="Adrien  Herledan" /></meta><meta name="dc.Creator" content="Alexandre  Biela" /></meta><meta name="dc.Creator" content="Julie  Dumont" /></meta><meta name="dc.Creator" content="Oscar  Chávez-Talavera" /></meta><meta name="dc.Creator" content="Loïc  Belloy" /></meta><meta name="dc.Creator" content="Isabelle  Duplan" /></meta><meta name="dc.Creator" content="Nathalie  Hennuyer" /></meta><meta name="dc.Creator" content="Laura  Butruille" /></meta><meta name="dc.Creator" content="Sophie  Lestavel" /></meta><meta name="dc.Creator" content="Emmanuel  Sevin" /></meta><meta name="dc.Creator" content="Maxime  Culot" /></meta><meta name="dc.Creator" content="Fabien  Gosselet" /></meta><meta name="dc.Creator" content="Bart  Staels" /></meta><meta name="dc.Creator" content="Benoit  Deprez" /></meta><meta name="dc.Creator" content="Anne  Tailleux" /></meta><meta name="dc.Creator" content="Julie  Charton" /></meta><meta name="dc.Description" content="PEGylation of therapeutic agents is known to improve the pharmacokinetic behavior of macromolecular drugs and nanoparticles. In this work, we performed the conjugation of polyethylene glycols (220–..." /></meta><meta name="Description" content="PEGylation of therapeutic agents is known to improve the pharmacokinetic behavior of macromolecular drugs and nanoparticles. In this work, we performed the conjugation of polyethylene glycols (220–..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 20, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01774" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01774" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01774" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01774" /></link>
        
    
    

<title>Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01774" /></meta><meta property="og:title" content="Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0015.jpeg" /></meta><meta property="og:description" content="PEGylation of therapeutic agents is known to improve the pharmacokinetic behavior of macromolecular drugs and nanoparticles. In this work, we performed the conjugation of polyethylene glycols (220–5000 Da) to a series of non-steroidal small agonists of the bile acids receptor TGR5. A suitable anchoring position on the agonist was identified to retain full agonistic potency with the conjugates. We describe herein an extensive structure–properties relationships study allowing us to finely describe the non-linear effects of the PEG length on the physicochemical as well as the in vitro and in vivo pharmacokinetic properties of these compounds. When appending a PEG of suitable length to the TGR5 pharmacophore, we were able to identify either systemic or gut lumen-restricted TGR5 agonists." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01774"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01774">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01774&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01774&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01774&amp;href=/doi/10.1021/acs.jmedchem.0c01774" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1593-1610</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01768" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01809" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Vanessa Hoguet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vanessa Hoguet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vanessa++Hoguet">Vanessa Hoguet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuel Lasalle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuel Lasalle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuel++Lasalle">Manuel Lasalle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mathieu Maingot</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mathieu Maingot</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mathieu++Maingot">Mathieu Maingot</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Geoffroy Dequirez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Geoffroy Dequirez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Geoffroy++Dequirez">Geoffroy Dequirez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rajaa Boulahjar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajaa Boulahjar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajaa++Boulahjar">Rajaa Boulahjar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Florence Leroux</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Florence Leroux</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Leroux">Florence Leroux</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Catherine Piveteau</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Catherine Piveteau</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Piveteau">Catherine Piveteau</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adrien Herledan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adrien Herledan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adrien++Herledan">Adrien Herledan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexandre Biela</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexandre Biela</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre++Biela">Alexandre Biela</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julie Dumont</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julie Dumont</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Dumont">Julie Dumont</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Oscar Chávez-Talavera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Oscar Chávez-Talavera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Oscar++Ch%C3%A1vez-Talavera">Oscar Chávez-Talavera</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Loïc Belloy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Loïc Belloy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lo%C3%AFc++Belloy">Loïc Belloy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isabelle Duplan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabelle Duplan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Duplan">Isabelle Duplan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nathalie Hennuyer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nathalie Hennuyer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nathalie++Hennuyer">Nathalie Hennuyer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Butruille</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Butruille</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Butruille">Laura Butruille</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sophie Lestavel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sophie Lestavel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sophie++Lestavel">Sophie Lestavel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emmanuel Sevin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emmanuel Sevin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emmanuel++Sevin">Emmanuel Sevin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maxime Culot</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maxime Culot</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maxime++Culot">Maxime Culot</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7452-0867" title="Orcid link">http://orcid.org/0000-0001-7452-0867</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fabien Gosselet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabien Gosselet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabien++Gosselet">Fabien Gosselet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bart Staels</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bart Staels</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bart++Staels">Bart Staels</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benoit Deprez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benoit Deprez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#1577707b7a7c613b71706567706f55607b7c6338797c7979703b7367"><span class="__cf_email__" data-cfemail="98fafdf6f7f1ecb6fcfde8eafde2d8edf6f1eeb5f4f1f4f4fdb6feea">[email protected]</span></a>. Phone: +33 (0)320 964 924.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benoit++Deprez">Benoit Deprez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne Tailleux</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne Tailleux</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Tailleux">Anne Tailleux</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Julie Charton</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julie Charton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#c2a8b7aeaba7eca1aaa3b0b6adac82b7acabb4efaeabaeaea7eca4b0"><span class="__cf_email__" data-cfemail="d1bba4bdb8b4ffb2b9b0a3a5bebf91a4bfb8a7fcbdb8bdbdb4ffb7a3">[email protected]</span></a>. Phone: +33 (0)320 964 928.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Charton">Julie Charton</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6895-276X" title="Orcid link">http://orcid.org/0000-0001-6895-276X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01774&amp;href=/doi/10.1021%2Facs.jmedchem.0c01774" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1593–1610</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 20, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 October 2020</li><li><span class="item_label"><b>Published</b> online</span>20 January 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01774" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01774</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1593%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVanessa%2BHoguet%252C%2BManuel%2BLasalle%252C%2BMathieu%2BMaingot%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D3%26contentID%3Dacs.jmedchem.0c01774%26title%3DBeyond%2Bthe%2BRule%2Bof%2B5%253A%2BImpact%2Bof%2BPEGylation%2Bwith%2BVarious%2BPolymer%2BSizes%2Bon%2BPharmacokinetic%2BProperties%252C%2BStructure%25E2%2580%2593Properties%2BRelationships%2Bof%2BmPEGylated%2BSmall%2BAgonists%2Bof%2BTGR5%2BReceptor%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1610%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01774"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1308</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01774" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vanessa&quot;,&quot;last_name&quot;:&quot;Hoguet&quot;},{&quot;first_name&quot;:&quot;Manuel&quot;,&quot;last_name&quot;:&quot;Lasalle&quot;},{&quot;first_name&quot;:&quot;Mathieu&quot;,&quot;last_name&quot;:&quot;Maingot&quot;},{&quot;first_name&quot;:&quot;Geoffroy&quot;,&quot;last_name&quot;:&quot;Dequirez&quot;},{&quot;first_name&quot;:&quot;Rajaa&quot;,&quot;last_name&quot;:&quot;Boulahjar&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Leroux&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Piveteau&quot;},{&quot;first_name&quot;:&quot;Adrien&quot;,&quot;last_name&quot;:&quot;Herledan&quot;},{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;Biela&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Dumont&quot;},{&quot;first_name&quot;:&quot;Oscar&quot;,&quot;last_name&quot;:&quot;Chávez-Talavera&quot;},{&quot;first_name&quot;:&quot;Loïc&quot;,&quot;last_name&quot;:&quot;Belloy&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Duplan&quot;},{&quot;first_name&quot;:&quot;Nathalie&quot;,&quot;last_name&quot;:&quot;Hennuyer&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Butruille&quot;},{&quot;first_name&quot;:&quot;Sophie&quot;,&quot;last_name&quot;:&quot;Lestavel&quot;},{&quot;first_name&quot;:&quot;Emmanuel&quot;,&quot;last_name&quot;:&quot;Sevin&quot;},{&quot;first_name&quot;:&quot;Maxime&quot;,&quot;last_name&quot;:&quot;Culot&quot;},{&quot;first_name&quot;:&quot;Fabien&quot;,&quot;last_name&quot;:&quot;Gosselet&quot;},{&quot;first_name&quot;:&quot;Bart&quot;,&quot;last_name&quot;:&quot;Staels&quot;},{&quot;first_name&quot;:&quot;Benoit&quot;,&quot;last_name&quot;:&quot;Deprez&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Tailleux&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Charton&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;1593-1610&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01774&quot;},&quot;abstract&quot;:&quot;PEGylation of therapeutic agents is known to improve the pharmacokinetic behavior of macromolecular drugs and nanoparticles. In this work, we performed the conjugation of polyethylene glycols (220–5000 Da) to a series of non-steroidal small agonists of the bile acids receptor TGR5. A suitable anchoring position on the agonist was identified to retain full agonistic potency with the conjugates. We describe herein an extensive structure–properties relationships study allowing us to finely describe the non-linear effects of the PEG length on the physicochemical as well as the in vitro and in vivo pharmacokinetic properties of these compounds. When appending a PEG of suitable length to the TGR5 pharmacophore, we were able to identify either systemic or gut lumen-restricted TGR5 agonists.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01774&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01774" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01774&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01774" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01774&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01774" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01774&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01774&amp;href=/doi/10.1021/acs.jmedchem.0c01774" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01774" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01774" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01774%26sid%3Dliteratum%253Aachs%26pmid%3D33470812%26genre%3Darticle%26aulast%3DHoguet%26date%3D2021%26atitle%3DBeyond%2Bthe%2BRule%2Bof%2B5%253A%2BImpact%2Bof%2BPEGylation%2Bwith%2BVarious%2BPolymer%2BSizes%2Bon%2BPharmacokinetic%2BProperties%252C%2BStructure%25E2%2580%2593Properties%2BRelationships%2Bof%2BmPEGylated%2BSmall%2BAgonists%2Bof%2BTGR5%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D3%26spage%3D1593%26epage%3D1610%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/jmcmar.2021.64.issue-3/20210211/jmcmar.2021.64.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">PEGylation of therapeutic agents is known to improve the pharmacokinetic behavior of macromolecular drugs and nanoparticles. In this work, we performed the conjugation of polyethylene glycols (220–5000 Da) to a series of non-steroidal small agonists of the bile acids receptor TGR5. A suitable anchoring position on the agonist was identified to retain full agonistic potency with the conjugates. We describe herein an extensive structure–properties relationships study allowing us to finely describe the non-linear effects of the PEG length on the physicochemical as well as the <i>in vitro</i> and <i>in vivo</i> pharmacokinetic properties of these compounds. When appending a PEG of suitable length to the TGR5 pharmacophore, we were able to identify either systemic or gut lumen-restricted TGR5 agonists.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Pegylation in Drug Discovery</h3><div class="NLM_p">Polyethylene glycol (PEG) polymers are composed of linear or branched repeating units of ethylene glycol. PEG is biocompatible, highly soluble, and FDA-approved for human use. Although there is increasing awareness of allergic reactions to PEGs, which must be kept in mind when designing new PEGylated compounds, PEGs are usually safe and widely used in foods, cosmetics, and drugs. Conjugation of polyethylene glycol to therapeutic agents is a commonly explored strategy to modulate the pharmacokinetic properties of drugs and thereby to improve their therapeutic effect. Initially, this strategy was mainly used for macromolecular drugs such as proteins, enzymes, nanoparticles, oligonucleotides, or antibodies and led to the commercialization of several drugs since 1990.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1−7)</a> Most of these drugs, as well as those in development are macromolecules modified with large PEG (5–40 kDa). Nevertheless, PEGylation of small “drug-like” molecular agents is an emerging strategy to improve or enable novel therapeutics.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a></div><div class="NLM_p">Literature is rich in pharmacokinetics (PK) studies for large biomolecules coupled to large PEG (5–40 kDa).<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> However, the impact of PEGylation of small molecules with chains <5000 Da on PK properties remains largerly unknown. In addition, in the case of small molecules, PEGylation is more likely to mask a large proportion of the pharmacophore and leads to drastic loss of affinity due to steric hindrance than in the case of proteins and nucleic acids. Thus, accurate knowledge of structure–activity relationships of the parent compound and size and architecture of the PEG are crucial to address the challenge of the optimized balance between PD and PK.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">We will present here detailed <i>in vitro</i> and <i>in vivo</i> nonlinear structure–properties relationships in a series of TGR5 (Takeda G protein-coupled receptor 5) agonists aminothioimidazoles PEGylated with linear methoxy PEG (mPEG) of various lengths (220–5000 Da).</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> PEGylation of TGR5 Agonists</h3><div class="NLM_p">TGR5 (also known as GPBAR-1, GPR131, and M-BAR) is a G protein-coupled receptor responsive to bile acids identified in 2002.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> TGR5 activation has been shown to trigger the secretion of intestinal glucagon-like peptide-1 (GLP-1) by colonic L cell<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and enhanced energy expenditure.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It has recently become an attractive target for the treatment of type 2 diabetes and its metabolic complications. <i>In vivo</i>, to exert their GLP-1 secretagogue action and provide the expected antidiabetic effect, TGR5 agonists do not need to reach the systemic circulation. Indeed, they can stimulate GLP-1 secretion by activation of TGR5 expressed on the enteroendocrine L cells of the intestinal epithelium. Unwanted side effects triggered by activation of TGR5 in gallbladder, heart, and skin were reported by investigators working with systemic TGR5 agonists in preclinical models.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> Consequently, the lowest possible, subpharmacological, systemic exposure is desirable.</div><div class="NLM_p">Our team has previously described a new class of potent 5-amino-2-thio-imidazole TGR5 agonists.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In this previous work, to limit systemic exposure after oral administration, our TGR5 agonists were designed as chimeric compounds composed of a TGR5 pharmacophore linked to an ionic kinetophore.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The kinetophore concept, introduced in 2006, refers to a highly polar and/or large chemical moiety tethered to a pharmacologically active compound, meant to prevent absorption through the intestinal epithelium.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Amongst the possible “large and highly polar” kinetophore moieties, we decided to use, in this work, mPEG of various lengths as a single coupling chemistry can be used to produce structures of very different sizes and because we assumed that the large negative contribution of the PEG to logD could easily reduce intestinal absorption.</div><div class="NLM_p">One of the milestones in the PEGylation strategy was the identification of a “mute” position on the pharmacophore part where linking such bulky and polar groups would not impact interactions with the target. Furthermore, each ethylene glycol in PEG binds to several water molecules (up to three per monomeric unit) leading to a solvated PEGylated structure much larger than a molecule of similar molecular mass.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> During the optimisation of potency of our 5-amino-2-thioimidazoles,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> we produced a detailed SAR and identified a proper position to link the methoxy PEG (mPEG) kinetophore with limited potency loss (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The mPEGs were coupled directly to the parent compound (series 1) or through a benzamide linker to put the kinetophore farther away from the ligand–receptor interface (series 2).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously described TGR5 agonist <b>24</b> and general structure of the PEGylated TGR5 agonists of this work.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">The synthesis of the 5-amino-2-thio-imidazole unconjugated parent compounds <b>1</b> and <b>2</b> was performed following procedures previously described and is presented in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref21 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref24">(21,24)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to <b>1</b> and <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) paraformaldehyde, MeONa, room temp., 16 h, (ii) NaBH<sub>4</sub>, MeOH, reflux, 1–3 h, 77%; (b) (i) Boc-Gly-OH, T3P, DIEA, EtOAc, room temp., 30 min to 48 h, 100%, (ii) TFA(30%)/DCM, room temp., 30 min, 100%; (c) (i) chloroacetyl chloride, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min, (ii) aq. NH<sub>3</sub>, EtOH, 65 °C, 1 h, then HCOOH, 75% (over two steps); (d) 4-fluorophenylisothiocyanate, NEt<sub>3</sub>, EtOH, room temp., 15 min, 76%; (d′) 4-fluoro-3-methoxy-aniline, TCDI, NEt<sub>3</sub>, dioxane, room temp. to 60 °C, overnight, 49%; (e) 2-bromomethyl-1,3-difluorobenzene, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, room temp., 16 h, 91%; (f) T3P, DIEA, EtOAC, 150 °C (μW), 10–40 min, or reflux, 24 h, 33–63%.</p></p></figure><div class="NLM_p">For clarity of presentation, to differentiate easily monodisperse and polydisperse PEGylated conjugates, a P was added to the number of the polydisperse mPEG conjugates. Compounds <b>P3</b> to <b>P6</b> (series 1) were obtained by the same synthetic pathway starting from the thiourea intermediates <b>1d</b> and <b>2d</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). PEGylated <i>S</i>-benzylisothioureas <b>P3a</b>–<b>P6a</b> were obtained by alkylation of <b>1d</b> and <b>2d</b> with mPEG benzyl chloride intermediates (<b>P3ii</b>–<b>P6ii</b>). After cyclization and HPLC purification, compounds <b>P3</b>–<b>P6</b> were obtained as polydisperse mixtures and characterized by LCMS to determine the number of ethylene oxide units (<i>n</i>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to <b>P3</b>–<b>P6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) poly(ethylene glycol) methyl ether tosylate (average Mn = 600, 900, and 2000 g/mol), K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux, overnight, 61–100%; (b) TEA, mesyl chloride, DCM, room temp., overnight, 100%; (c) <b>P3ii</b>–<b>P6ii</b>, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, room temperature, overnight, 17–47%; (d) T3P, DIEA, EtOAC, 150 °C (μW), 10–40 min, or reflux (classical heating), 24 h, 13–27%.</p></p></figure><div class="NLM_p">As for series 2, two synthetic pathways were investigated. In the first route, the mPEG moiety was introduced on a boronic acid intermediate and coupled to the pharmacophore part via a Suzuki reaction to give compounds <b>P8</b> and <b>P10</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). In a more convenient and convergent route, the mPEG part was introduced in the last step of the synthesis by forming an amide bond with commercial polydisperse (mPEG-NH<sub>2</sub>, average Mn = 500, 750, 2000, and 5000 g/mol) or monodisperse PEGylated amines (<i>n</i> = 5, 7, 9, 11, 16, 24, 36) and biphenylcarboxylic acid intermediate <b>7c</b>. This second route afforded for polydisperse compounds <b>P7</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b> and seven monodisperse compounds <b>13</b>–<b>19</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to <b>P8</b> and <b>P10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-bromo-2-(chloromethyl)-1,3-difluoro-benzene, NaI, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, room temp., overnight, 98%; (b) T3P, DIEA, EtOAc, 150 °C (μW), 10 min, 100%; (c) 2-[2-methoxypolyethyleneglycoxy]ethanamine (average Mn = 750 and 2000 g/mol), TEA, DCC, HOBt, DCM, room temp., overnight, 64–66%; (d) <b>P8i</b> or <b>P10i</b>, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, H<sub>2</sub>O/DME/EtOH, 100 °C (μW), 10 min, 43–47%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to <b>P7</b>–<b>P12</b> and <b>13</b>–<b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-carboxyphenylboronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub> or PdCl<sub>2</sub>dppf, H<sub>2</sub>O/DME/EtOH, 100 °C (μW), 10 min, 52%; (b) mPEG-NH<sub>2</sub> (average Mn = 500, 750, 2000, and 5000 g/mol) or mPEGn-NH<sub>2</sub>, TEA, DCC, or DIC, HOBt, DCM, room temp., overnight.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <i>In Vitro</i> Studies</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Biological Activity</h4><div class="NLM_p">The <i>in vitro</i> potencies of the mPEGylated compounds were first compared to their unconjugated counterparts <b>1</b> and <b>2</b>. EC<sub>50</sub>s were measured on both human and murine receptors in a CRE-driven luciferase reporter assay in TGR5-transfected HEK293 cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Activities of Compounds <b>1</b>, <b>2</b>, and <b>P3</b>–<b>P6</b> (Series 1)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0013.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> hTGR5</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> mTGR5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">35 [22–54]</td><td class="colsep0 rowsep0" align="left">0.8 [0.5–1.4]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9–13</td><td class="colsep0 rowsep0" align="left">166 [133–208]</td><td class="colsep0 rowsep0" align="left">18 [13–26]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P4</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">10–22</td><td class="colsep0 rowsep0" align="left">580 [536–628]</td><td class="colsep0 rowsep0" align="left">29 [25–33]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P5</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">34–52</td><td class="colsep0 rowsep0" align="left">1230 [1145–1322]</td><td class="colsep0 rowsep0" align="left">68 [62–75]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">20 [13–30]</td><td class="colsep0 rowsep0" align="left">0.8 [0.2–3.4]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P6</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">14–24</td><td class="colsep0 rowsep0" align="left">330 [306–349]</td><td class="colsep0 rowsep0" align="left">26 [22–30]</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">CRE-driven luciferase reporter assays in TGR5-transfected HEK293 cells. Units are nM for EC50. EC50 values are reported with their 95% confidence intervals in brackets.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Activities of Compounds <b>2</b>, <b>P7</b>, <b>P9</b>, <b>P11</b>, <b>P12</b>, <b>13</b>–<b>19</b> (Series 2)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> hTGR5</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> mTGR5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">polydisperse</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">20 [13–30]</td><td class="colsep0 rowsep0" align="left">0.8 [0.2–3.4]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P7</b></td><td class="colsep0 rowsep0" align="left">4–13</td><td class="colsep0 rowsep0" align="left">60 [48–75]</td><td class="colsep0 rowsep0" align="left">5 [4–6]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P9</b></td><td class="colsep0 rowsep0" align="left">11–25</td><td class="colsep0 rowsep0" align="left">145 [129–163]</td><td class="colsep0 rowsep0" align="left">13 [11–15]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P11</b></td><td class="colsep0 rowsep0" align="left">31–57</td><td class="colsep0 rowsep0" align="left">515 [442–601]</td><td class="colsep0 rowsep0" align="left">25 [21–29]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P12</b></td><td class="colsep0 rowsep0" align="left">100–138</td><td class="colsep0 rowsep0" align="left">1102 [940–1291]</td><td class="colsep0 rowsep0" align="left">63 [59–68]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monodisperse</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">99 [81–122]</td><td class="colsep0 rowsep0" align="left">6 [5–7]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">99 [76–128]</td><td class="colsep0 rowsep0" align="left">10 [9–11]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">122 [106–140]</td><td class="colsep0 rowsep0" align="left">13 [12–14]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">120 [107–135]</td><td class="colsep0 rowsep0" align="left">13 [12–14]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">609 [441–841]</td><td class="colsep0 rowsep0" align="left">30 [26–36]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">735 [523–1032]</td><td class="colsep0 rowsep0" align="left">39 [31–49]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">1527 [1126–2073]</td><td class="colsep0 rowsep0" align="left">50 [35–70]</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">CRE-driven luciferase reporter assays in TGR5-transfected HEK293 cells. Units are nM for EC50. EC50 values are reported with their 95% confidence intervals in brackets.</p></div></div></div><div class="NLM_p">The introduction of a mPEG moiety directly on the difluorophenyl ring (<b>P3</b>–<b>P6</b>) led to a PEG size-dependent decrease in potency on both human and murine receptors. However, potencies remained in the nanomolar range on the murine receptor for all sizes. Potency was slightly better on the human receptor (<b>P6</b><i>versus</i><b>P4</b>) when starting from unconjugated parent compound <b>2</b> (X = OCH<sub>3</sub>).</div><div class="NLM_p last">As expected, the addition of a larger and more rigid spacer (series 2) aiming at reducing the steric interference of the mPEG part on the pharmacophore-target interaction allowed a 2-fold gain of potency on both receptors (<b>P9</b> versus <b>P6</b>). Interestingly, the use of two different synthetic routes gave the target compound with highly similar PEG size distribution (compounds <b>P8</b> (<i>n</i> = 12–24) versus <b>P9</b> (<i>n</i> = 11–25) and <b>P10</b> (<i>n</i> = 33–57) versus <b>P11</b> (<i>n</i> = 31–57)) and the same potencies. It is important to note that, while potency appears to be size-dependent, all conjugates (even the larger PEG conjugate <b>P12</b>, <i>n</i> > 100) retained their full TGR5 agonist efficacy in the <i>in vitro</i> reporter assay.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Physicochemical and <i>In Vitro</i> ADME properties</h4><div class="NLM_p"><i>In vitro</i> ADME studies were then performed to further characterize the profile of the conjugates. Solubility, lipophilicity, metabolic stability, and permeability were measured for both series of polydisperse PEG conjugates (<b>P3</b> and <b>P4</b> and <b>P7</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Physicochemical and ADME Parameters of PEGylated Compounds and Their Parent Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0014.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center"><i>n</i> (PEG unit)</th><th class="colsep0 rowsep0" align="center" char=".">MW (g/mol)</th><th class="colsep0 rowsep0" align="center" char=".">solubility (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">LogD<sub>7.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>int</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">P<sub>app A-B</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">P<sub>app B-A</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">efflux ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">485</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">1287</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P3</b></td><td class="colsep0 rowsep0" align="left">9–13</td><td class="colsep0 rowsep0" align="char" char=".">911–1087</td><td class="colsep0 rowsep0" align="char" char=".">181</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">528</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep1" align="left"><b>P4</b></td><td class="colsep0 rowsep1" align="left">10–22</td><td class="colsep0 rowsep1" align="char" char=".">955–1483</td><td class="colsep0 rowsep1" align="char" char=".">>200</td><td class="colsep0 rowsep1" align="char" char=".">1.5</td><td class="colsep0 rowsep1" align="char" char=".">34</td><td class="colsep0 rowsep1" align="char" char="."><0.2</td><td class="colsep0 rowsep1" align="char" char=".">25</td><td class="colsep0 rowsep1" align="char" char=".">>125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">516</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">3.97</td><td class="colsep0 rowsep0" align="char" char=".">1254</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P7</b></td><td class="colsep0 rowsep0" align="left">4–13</td><td class="colsep0 rowsep0" align="char" char=".">824–1220</td><td class="colsep0 rowsep0" align="char" char=".">151</td><td class="colsep0 rowsep0" align="char" char=".">3.42</td><td class="colsep0 rowsep0" align="char" char=".">524</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">19.5</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P9</b></td><td class="colsep0 rowsep0" align="left">11–25</td><td class="colsep0 rowsep0" align="char" char=".">1132–1748</td><td class="colsep0 rowsep0" align="char" char=".">>200</td><td class="colsep0 rowsep0" align="char" char=".">1.58</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char="."><0.02</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char=".">>455</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P11</b></td><td class="colsep0 rowsep0" align="left">31–57</td><td class="colsep0 rowsep0" align="char" char=".">2012–3156</td><td class="colsep0 rowsep0" align="char" char=".">>200</td><td class="colsep0 rowsep0" align="char" char=".">–1.53</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char="."><0.12</td><td class="colsep0 rowsep0" align="char" char="."><0.03</td><td class="colsep0 rowsep0" align="char" char=".">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>P12</b></td><td class="colsep0 rowsep0" align="left">100–138</td><td class="colsep0 rowsep0" align="char" char=".">5048–6720</td><td class="colsep0 rowsep0" align="char" char=".">>200</td><td class="colsep0 rowsep0" align="char" char=".">–1.58</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Solubility measured in PBS pH 7.4 starting from a 10 mM solution in DMSO of the compound (<a class="ref internalNav" href="#sec4_3_1" aria-label="Method A">Method A</a>).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Cl<sub>int</sub>: intrinsic clearance measured on male mouse microsomes (μL/min/mg proteins).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Permeability on a Caco-2 cell monolayer. “A-B” indicates the transport from the apical side to the basolateral side; “B-A” indicates the transport from the basolateral side to the apical side. Permeability is expressed in 10<sup>–6</sup> cm/s. Permeability classification: low, P<sub>app</sub> < 2 × 10<sup>–6</sup> cm/s; high, P<sub>app</sub> > 20 × 10<sup>–6</sup> cm/s. Compounds recovery >75% in all experiments except for <b>P7</b> in P<sub>app A-B</sub> experiment (54%).</p></div></div></div><div class="NLM_p">As expected, the PEGylation of the small TGR5 agonists substantially alters their physicochemical and ADME properties in a size-dependent manner (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The introduction of a PEG moiety strongly improved solubility in both series 1 and 2 in agreement with the decrease in lipophilicity (LogD7.4). Introduction of the shorter PEG (<b>P3</b> and <b>P7</b>) has a moderate effect on the microsomal stability with a decrease by a factor 2 of the intrinsic clearance compared the parent compounds (<b>1</b> and <b>2</b>). In contrast, the longer PEG confers protection against oxidative metabolism to the conjugate compounds (<b>P4</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b>). The impact of PEGylation (PEG ≤5 kDa) of the TGR5 agonists on intestinal permeability was assessed <i>in vitro</i> in a Caco-2 monolayer permeability assay. As can be seen in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, compounds <b>P3</b> and <b>P7</b> (<i>n</i> ≤ 13) retain a substantial permeability (2 × 10<sup>–6</sup> cm/s < P<sub>app</sub>A-B < 20 × 10<sup>–6</sup> cm/s), whereas conjugates from both series with larger PEG (<b>P4</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b>) are classified as poorly permeable (P<sub>app</sub>A-B < 2 × 10<sup>–6</sup> cm/s). Surprisingly, the very low transepithelial permeability from apical to basal side of <b>P4</b> and <b>P9</b> is not due to a poor membrane crossing ability (P<sub>app</sub>B-A > 2 × 10<sup>–6</sup> cm/s) but to a very high efflux (efflux ratio > 100), showing that they are substrates of efflux pumps despite their high molecular weight. Conjugates of higher size (<b>P11</b> and <b>P12</b>) however are unable to enter the cell neither through passive diffusion nor active transport (P<sub>app</sub>A-B and P<sub>app</sub>B-A < 2 × 10<sup>–6</sup> cm/s).</div><div class="NLM_p">We next refined the structure–properties relationships by measuring <i>in vitro</i> ADME properties for individual compounds in the polydisperse compounds of series 1 (<b>P3</b> and <b>P4</b>) and 2 (<b>P7</b> and <b>P9</b>). The effect of PEG size on oxidative metabolism was investigated more finely (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of the number of PEG units (<i>n</i>) on microsomal stability. (A) Intrinsic clearance Cl<sub>int</sub> (μL/min/mg) for compounds <b>P3</b> and <b>P4</b> (series 1) as a function of size. (B) Intrinsic clearance Cl<sub>int</sub> (μL/min/mg) for compounds <b>P7</b> and <b>P9</b> (series 2) with or without CYP3A4 inhibitor (ketoconazole, 5 μM). (C) Intrinsic clearance Cl<sub>int</sub> (μL/min/mg) for series 1 and 2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In both series, we can see again a clear dependence of the oxidative metabolism on the PEG size (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,C) and the cytochrome 3A4 appeared to be the main isoform in the metabolism of our PEGylated conjugates since the intrinsic clearance was reduced drastically in presence of ketoconazole, a CYP3A4 inhibitor (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><div class="NLM_p">The apical to basolateral permeability decreases with the increase in PEG length. Interestingly enough, the PEG itself, despite its very large size compared to the original ligand and its important contribution to molecular surface, volume, and logD, does not impose a full control on membrane crossing ability and clearance over the properties of the naked ligand. Indeed, significantly different permeabilities are observed between series 1 and 2 for <i>n</i> below 13 PEG units. It is only when <i>n</i> reaches 13 that the permeability becomes very low in both series (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Apparent permeability on Caco-2 cell monolayer P<sub>app A-B</sub> (from the apical side to the basolateral side) for series 1 (gray, compounds <b>P3</b> and <b>P4</b>) and series 2 (black, compounds <b>P7</b> and <b>P9</b>) depending on the number of PEG units (for <i>n</i> ≥ 13 P<sub>app</sub>A-B < 0.2 × 10<sup>–6</sup> cm/s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Solubility, intestinal (Caco-2 cell monolayer), and blood–brain barrier (BBB) permeabilities were also measured for the monodisperse PEGylated analogs <b>13–19</b>. Permeability across brain-like endothelial cells (BLECs) were assessed on an <i>in vitro</i> human BBB model consisting of endothelial cells derived from CD34<sup>+</sup> cells co-cultivated with brain pericytes, thus acquiring a BLEC phenotype in 6 days. Values measured for monodisperse species are in very good agreement with those measured for mixtures. A dramatic increase in the solubility was observed between compounds <b>14</b> (161 μM) and <b>15</b> (>50,000 μM) with only two PEG units difference between both compounds (<i>n</i> = 7 and <i>n</i> = 9, respectively). We confirmed the decrease in the permeability in a PEG length-dependent manner. The BBB permeability (endothelial permeability coefficient (Pe<sub>A-B</sub>)) was very low for all compounds (Pe<sub>A-B</sub> < 1 × 10<sup>–3</sup> cm/min), showing that PEGylation can be used to exclude compounds from certain tissues, such as the central nervous system by impeding crossing of the blood–brain barrier (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>)<named-content content-type="anchor" rid="fig4" type="simple"></named-content>.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Apparent permeability on Caco-2 cell monolayer: A-B (from apical to basolateral) and B-A (from basolateral to apical) for compounds <b>P7</b> and <b>P9</b> depending on the number of PEG units. Permeability is expressed in 10<sup>–6</sup> cm/s.(for <i>n</i> ≥ 13 PappA-B < 0.2 × 10<sup>–6</sup> cm/s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Calculated and Measured ADME Paramaters of Monodisperse PEGylated Analogs</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">apparent permeability on Caco-2 cell monolayer <sup>c</sup></th><th class="rowsep1 colsep0" align="center" char=".">permeability across BLECs<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">MW (g/mol)</th><th class="colsep0 rowsep0" align="center" char=".">solubility<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">ALogP<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PSA (Å<sup>2</sup>)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">P<sub>app A-B</sub></th><th class="colsep0 rowsep0" align="center" char=".">P<sub>app B-A</sub></th><th class="colsep0 rowsep0" align="center" char=".">efflux ratio</th><th class="colsep0 rowsep0" align="center" char=".">Pe <sub>A-B</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">516</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">1354</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">149</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">1133</td><td class="colsep0 rowsep0" align="char" char=".">161</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">168</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">1045</td><td class="colsep0 rowsep0" align="char" char=".">>50,000</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">186</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">32.0</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">957</td><td class="colsep0 rowsep0" align="char" char=".">>50,000</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">205</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">33.3</td><td class="colsep0 rowsep0" align="char" char=".">74.1</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">869</td><td class="colsep0 rowsep0" align="char" char=".">>50,000</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">251</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">15.6</td><td class="colsep0 rowsep0" align="char" char=".">465.5</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">1706</td><td class="colsep0 rowsep0" align="char" char=".">>50,000</td><td class="colsep0 rowsep0" align="char" char=".">4,2</td><td class="colsep0 rowsep0" align="char" char=".">325</td><td class="colsep0 rowsep0" align="char" char=".">≤0.011</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">2235</td><td class="colsep0 rowsep0" align="char" char=".">>50,000</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">435</td><td class="colsep0 rowsep0" align="char" char=".">≤0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Solubility measured in water starting from the powder of the compound (<a class="ref internalNav" href="#sec4_3_2" aria-label="Method B">Method B</a>) except for compound <b>2</b> (<a class="ref internalNav" href="#sec4_3_1" aria-label="Method A">Method A</a>).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Calculated parameter using Pipeline Pilot (Dassault Systems). PSA: polar surface area.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Permeability assessed on a Caco-2 cell monolayer. “A-B” indicates the transport from the apical side to the basolateral side; “B-A” indicates the transport from the basolateral side to the apical side. Apparent permeability (Papp) is expressed in 10<sup>–6</sup> cm/s. Permeability classification: low, Papp < 2 × 10<sup>–6</sup> cm/s; high, Papp > 20 × 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Permeability across BLECs (Pe<sub>A-B</sub>) is expressed in 10<sup>–3</sup> cm/min. Permeability classification: low permeability, Pe < 1 × 10<sup>–3</sup> cm/min. High permeability, Pe > 2 × 10<sup>–3</sup> cm/min.</p></div></div></div><div class="NLM_p">As for compound <b>P9</b> (<i>n</i> = 11–25), a very high efflux ratio (>450) was obtained for compound <b>17</b> (<i>n</i> = 16) in the Caco-2 assay. Caco-2 cells express several efflux transporters such as P-glycoprotein (P-gp, ABCB1), breast cancer resistance protein (BCRP, ABCG2), and members of multidrug resistance-associated protein family (MRPs, ABCCs). To determine if the PEGylated conjugates are substrates or inhibitors of efflux pumps, we loaded Caco-2 cells with specific substrates of these pumps (rhodamine 123 for P-gp/BCRP and CMFDA for MRPs) and investigated effect of these compounds on cellular efflux of these substrates<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Effect of PEGylated analogs on rate of excretion of rhodamine 123. (b) Effect of PEGylated analogs on the rate of excretion of CMFDA. (c) Effect of polyethylene glycol amine (mPEGn-NH<sub>2</sub>) on the rate of excretion of rhodamine 123. Specific inhibitors for P-gp/BCRP (verapamil), MRPx (MK571) were used as positive control. Acetanomiphen and diazepam were used as negative controls. Data were represented as means + s.e.m. (<i>n</i> = 8–15), *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 (ANOVA–Dunnett test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Altogether, these results in Caco-2 cells and BLECs confirmed that PEGylated conjugates do interact with efflux transporters expressed by physiological barrier cells composing intestine or blood–brain barrier. Results of <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> indicate that compound <b>2</b> is an inhibitor of P-gp/BCRP, whereas conjugation with PEG chains alleviates inhibition and increases efflux accordingly. In contrast, compound <b>2</b> does not seem to interact with MRPx (no inhibition, no efflux). Interestingly, coupling with PEG induces inhibition of MRPx at small chain lengths while long chain lengths (<i>n</i> = 16–24) reduce interaction with the pumps as for P-gp and BCRP. Since basolateral to apical (B-A) permeability across Caco-2 could be influenced both by the ability of compounds to permeate cell membrane (passive permeability) and by their active efflux by transporters, this might explain the biphasic effect of the PEG chain length on the transport from basolateral to apical compartment (B to A) observed in Caco-2 cells for polydisperse conjugates (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The decrease in permeability for PEGylated conjugates also observed in a human BBB model expressing these efflux pumps also supports this hypothesis.</div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>In Vivo</i> Studies</h3><div class="NLM_p">Compounds of series 1 and 2 showing similar <i>in vitro</i> ADME properties, we selected compounds of series 2 for <i>in vivo</i> studies because they display higher potencies on both murine and human TGR5 activation. <i>In vivo</i> pharmacokinetic studies were performed to assess the impact of the PEG size on the exposure of some organs and tissues following oral administration by the polydisperse compounds of series 2. First, plasma and liver compound concentrations were measured (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Second, as several TGR5 agonists are described to be highly excreted in bile, we were interested in measuring the concentrations of such large agonists in gallbladder (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). At last, in our research program aiming at targeting distal intestinal TGR5, data on the time course in the gut for the PEGylated conjugates were crucial for the proper design of <i>in vivo</i> pharmacodynamic experiments. Thereby, the concentrations of the conjugates in the different sections of the intestine were measured as a function of time after gavage to define their transit time and gut exposure (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma, liver, and gallbladder exposure in C57Bl6 mice following oral dosing (32 μmol/kg) of compounds <b>P7</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b> (<i>n</i> = 3 mice/time points).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Time course of compounds <b>P7</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b> concentrations in duodenum, jejunum, ileum, and colon of C57Bl6 mice, after a single oral administration (32 μmol/kg), mean ± s.e.m. (<i>n</i> = 3 mice/time points).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our series, plasma and liver exposure reach a moderate maximum for the intermediate size <b>P9</b> and remain very low for the other compounds (<b>P7</b>, <b>P11</b>, and <b>P12</b>).</div><div class="NLM_p">Despite its very low permeability on Caco-2 cells (Papp < 0.02 × 10<sup>–6</sup> cm/s), <b>P9</b> has a higher plasma and liver exposure after oral dosing than compound <b>P7</b>, expected to be more absorbed consistently with its higher permeability (Papp = 4.9 × 10<sup>–6</sup> cm/s). This result could be explained by the better metabolic stability of <b>P9</b> (as observed <i>in vitro</i> on microsomes).</div><div class="NLM_p">As we observed that some of our PEGylated conjugates are highly effluxed and substrates of some intestinal efflux transporters expressed in Caco-2 cells (P-gP), we were interested in exploring the effect of the PEG length on their biliary excretion. As can be seen in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, weak gallbladder exposure was observed for <b>P11</b> and <b>P12</b> while high concentrations of compounds <b>P7</b> and <b>P9</b> were measured.</div><div class="NLM_p">PEG length also drastically impacts gut luminal exposure. In line with its permeability measured <i>in vitro</i> (Caco-2 assay), compound <b>P7</b> displays a very low exposure of the GI tract, that can be the result of an early and strong intestinal absorption compared to longer PEG conjugates. In contrast, high concentrations of <b>P9</b>, <b>P11</b>, and <b>P12</b> were measured in the distal intestine (C > 500 μM) from 4 h after oral administration onward.</div><div class="NLM_p">In all, these <i>in vitro</i> and <i>in vivo</i> PK studies on the different PEG conjugates allowed us to explore and fine-tune the impact of the PEGylation on the ADME profile of these compounds. As expected, we observed that solubility increased and lipophilicity decreased in a PEG length-dependent manner in both series 1 and 2. PEGylation, even with very short PEG, was in this project an efficient strategy to dramatically improve the solubility of the naked pharmacophores (from micromolar range for pharmacophore <b>2</b> to more than 50,000 μM for conjugates from <i>n</i> = 9, <b>15</b>–<b>19</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Interestingly, we observed that short PEGs in both series 1 and 2 (<b>P3</b> and <b>P7</b>, <i>n</i> ≤ 13, Cl<sub>int</sub> around 500 μL/min/mg proteins) have a moderate impact on the microsomal stability (Cl<sub>int</sub> around 1200 μL/min/mg proteins for the naked pharmacophores) while longer PEG efficiently protected the conjugates against oxidative metabolism (Cl<sub>int</sub> < 20 μL/min/mg proteins for <b>P9</b>, <b>P11</b>, and <b>P12</b>). The impact of the spacer (series 1 and 2) on microsomal stability is significant for <i>n</i> < 13, but intrinsic clearance becomes very low for <i>n</i> above 13 units of PEG in both series (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Intestinal permeability and transport are also finely tuned by chosing the right PEG length. The intestinal absorption can be drastically reduced with nine or more PEG units (<b>15</b>–<b>19</b>, P<sub>app</sub>A-B < 2 × 10<sup>–6</sup> cm/s). It is important to remember that compounds <b>15</b>, <b>16</b>, and <b>17</b> (<i>n</i> = 9, 11, 16, respectively) display high permeability from the basolateral to apical side (B-A). Therefore, the low transepithelium permeability is not the result of a poor membrane crossing ability but rather that of their high efflux (efflux ratio = 465 for <b>17</b>). In contrast, <b>18</b> (<i>n</i> = 24) and <b>19</b> (<i>n</i> = 36) are unable to cross the membrane through passive diffusion nor active transport (very low P<sub>app</sub>A-B and P<sub>app</sub>B-A). It is worth nothing that PEGylation of the pharmacophore <b>2</b>, which is a substrate of the efflux pump P-gP/BCRP (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a), even with the longer PEG (<b>19</b>, <i>n</i> = 36, MW = 2235 g/mol), does not preclude the interaction of the conjugate with this transporter nor its ability to be transported. Interestingly, the mPEGn-NH<sub>2</sub> are not P-gP/BCRP substrate (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c) showing that the hydrophobic pharmacophore is required for the interaction with this efflux pump and the PEG moiety alone is not recognized by P-gp or BCRP.</div><div class="NLM_p">The <i>in vivo</i> pharmacokinetic studies have shown that the use of an appropriate length of PEG allows one to balance the solubility, intestinal absorption, and hepatic metabolism to obtain either systemic (<b>P9</b>) or gut-restricted TGR5 agonists (<b>P11</b> and <b>P12</b>).</div><div class="NLM_p last">Through this process, <b>P11</b> (<i>n</i> = 31–57) was identified as a potent agonist (mTGR5 EC<sub>50</sub> = 25 nM) with high intestinal exposure combined to extremely low passive membrane crossing. <b>P11</b> was selected to assess the feasability of apical stimulation of GLP-1 secretion <i>in vivo</i>. As maximal GLP-1 secretion is expected when TGR5 is activated in distal sections of the gut and in line with the pharmacokinetics observed in the intestine for <b>P11</b>, GLP-1 secretion was measured 8 h after oral dosing of <b>P11</b>. Although <b>P11</b> reached a millimolar concentration (>10,000*EC<sub>50</sub>) in the lumen of TGR5 expressing sections of the intestine, it only weakly triggered GLP-1 secretion. It was reported in the literature that functional TGR5 is mostly located on the basolateral side of enteroendocrine L cells and that crossing the intestinal epithelium is required before bile acids or non steroidal TGR5 agonists can trigger a GLP-1 secretory response.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The weak GLP-1 secretion observed with the luminally restricted agonist <b>P11</b>, combined with our previous observation that a gut-targeted but membrane-permeant TGR5 agonist of the same family<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> actually triggers GLP-1 secretion after oral administration, is consistent with a previous work showing that TGR5 agonists trigger the GLP-1 secretory response predominantly by reaching the basolateral side of the L cells embeded in the intestinal epithelium.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many aspects described in this work are relevant for drug research programs focusing on organ-targeted drugs that require an optimization approach different from the classical route. Our study indeed demonstrates that increasing chain length in a series of PEGylated compounds expectedly increases the aqueous solubility of small organic scaffolds and decreases their susceptibility to oxidative metabolism and their passive permeation through cell membranes. Surprisingly, PEGylation does not preclude interactions with efflux pumps, at least for chains smaller than <i>n</i> ≤ 36.</div><div class="NLM_p last">The study of the PK profile of several PEGylated compounds provides a general knowledge and guidelines for the design of topical intestinal compounds that could be transposable to modulators of other intestinal targets. It also could be very useful to design molecules for oral or parenteral routes, with fine-tuned interactions with cell membranes and efflux pumps, thereby controlling organ distribution in general and brain exposure in particular.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>In Vitro</i> TGR5 Assay</h3><div class="NLM_p last">TGR5 activation by compounds and subsequent increase in intracellular cAMP were evaluated using a luciferase reporter gene assay. Human embryonic kidney (HEK) 293 cells were transiently co-transfected with pCMV tag4b-TGR5h (to determine hTGR5 activation) or pCMV AC6-TGR5m (to determine mTGR5 activation) expression plasmids and the pCRE TA-Luciferase reporter plasmid using the JET PEI reagent (Polyplus transfection). Transfected cells were seeded in 96-well plates and incubated overnight with the compounds at increasing concentrations in duplicate. Lithocholic acid (LCA) at 10 μM was used as a positive reference compound. The cAMP-dependent luciferase expression was followed using the BrightGlo reagent according to the manufacturer (Promega) instructions. Luminescence was measured with a Mithras plate reader (Berthold). Data were expressed as the percentage of the 10 μM LCA value, and EC<sub>50</sub> values were calculated using XL fit 5 software or GraphPad Prism 5. Concentration–response curves were fitted by a nonlinear regression analysis to a four-parameter logistic equation.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> LC-MS/MS ADME Methods</h3><div class="NLM_p last">Chromatography was performed using a UPLC system, an Acquity I-Class (Waters). Separation was achieved on a Waters Acquity BEH C18 column (2.1 mm × 50 mm, 1.7 μm). The autosampler and column oven temperatures were 10 and 40 °C, respectively, and the sample injection volume was 1 μL. The mobile phase consisted of 0.1% formic acid in water as solvent A and 0.1% formic acid in acetonitrile as solvent B at a flow rate of 600 μL/min. The gradient was as follows: 0–0.2 min (98%A and 2%B), 2–2.5 min (2%A and 98%B), 2.6 min (98%A and 2%B), 4 min (98%A and 2%B). The gradient step was linear. Mass spectrometry was performed using a Xevo TQD (Waters Corporation) mass spectrometer. The detection of analytes was achieved by electrospray ionization (ESI) in the positive mode with the appropriate MRM transition. For polydisperse PEGylated compounds, LC-MS analyses were performed using several transitions of several of the most abundant species in the mixture. Other mass spectrometer settings were as follows: capillary voltage and cone voltage were optimized for each compound, desolvation temperature 600 °C at a gas flow of 1200 L/h and cone gas flow 50 L/h. The LC-MS/MS instrument was controlled by MassLynx software (Waters).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Solubility Measurements</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Method A</h4><div class="NLM_p last">Ten microliters of a 10 mM solution in DMSO of the compound was diluted either in 490 μL of PBS pH 7.4 or in organic solvent MeOH in a PP tube (<i>n</i> = 3 for PBS, <i>n</i> = 6 for methanol). The tubes were gently shaken for 24 h at room temperature. Then, PBS tubes and three of the six methanol tubes were centrifuged for 5 min at 4000 rpm and filtered over 0.45 μm filters (Millex-LH Millipore). Then, 10 μL of each sample was diluted in 490 μL of MeOH before LC-MS analysis. The solubility is determined by the ratio of mass signal area PBS/organic solvent.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Method B</h4><div class="NLM_p last">Water was added to a known amount of the solid compound to reach the tested concentration. After 24 h of mixing, the solution was centrifuged and the supernatant was diluted in methanol before LC-MS analysis. The compound is quantified against a methanol calibration curve.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> LogD Measurements</h3><div class="NLM_p last">Forty microliters of a 10 mM solution in DMSO of the compound was diluted in 1.960 mL of a 1/1 octanol/PBS at pH 7.4 mixture. The mixture was gently shaken for 2 h at room temperature. Ten microliters of each phase was diluted in 490 μL of MeOH and analyzed by LC-MS/MS. Each compound was tested in triplicate. LogD was determined as the logarithm of the ratio of concentration of product in octanol and PBS, respectively, determined by mass signals.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Microsomal Stability</h3><div class="NLM_p last">Male mouse (CD-1) liver microsomes (BD Gentest) were used. All incubations were performed in duplicate in a shaking water bath at 37 °C. The incubation mixtures contained 1 μM compound with 1% methanol used as a vehicle, mouse liver microsomes (0.3 mg of microsomal protein per mL), 5 mM MgCl<sub>2</sub>, 1 mM NADP, 5 mM glucose 6-phosphate, 0.4 U mL<sup>–1</sup> glucose 6-phosphate dehydrogenase, and 50 mM potassium phosphate buffer (pH 7.4) in a final volume of 0.5 mL. Aliquots were removed at 5, 10, 20, 30, and 40 min after microsome addition, and the reaction was stopped by adding four volumes of ice-cold acetonitrile containing a 200 nM internal standard. The samples were centrifuged for 10 min at 10,000 rpm and, the supernatants were transferred in matrix tubes for LC-MS/MS analysis. Each compound was quantified by converting the corresponding analyte/internal standard peak area ratios to percentage drug remaining, using the initial ratio values in control incubations as 100%. Propranolol, known as a high hepatic clearance drug in rodents, was used as a quality-control compound for the microsomal incubations. <i>In vitro</i> intrinsic clearance (CLint expressed as μl/min/mg) was calculated according to the following formula: CLint = dose/AUC<sub>∞</sub>, where dose is the initial amount of drug in the incubation mixture (1 μM) and AUC<sub>∞</sub> is the area under the concentration versus time curve extrapolated to infinity. The slope of the linear regression from log percentage remaining versus incubation time relationships (−<i>k</i>) was used in the conversion to <i>in vitro t</i><sub>1/2</sub> values by: <i>t</i><sub>1/2</sub> = −ln(2)/<i>k</i>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Caco-2 Permeation Assay</h3><div class="NLM_p">Caco-2 cells (0.4 × 10<sup>5</sup>, ATCC no. HTB-37), at passage 28, were seeded on a 25 cm<sup>2</sup> plastic flask and changed every 2 days with complete medium containing high glucose Dulbecco’s modified Eagle’s medium (DMEM) with <span class="smallcaps smallerCapital">l</span>-glutamine supplemented by 10% of fetal calf/bovine serum, 1% of non-essential amino acids without <span class="smallcaps smallerCapital">l</span>-glutamine. The paracellular barrier characteristics of the Caco-2 cells monolayer were monitored using measurement of the permeability to the non-permeant fluorescent molecule, Lucifer Yellow (LY). Caco-2 cells were trypsinized after 3 days of incubation while they cover 80–90% of the flask and seeded at a density of 5 × 10<sup>5</sup> in 75 cm<sup>2</sup> flasks in complete medium After 5–6 days, Caco-2 cells reach a high cell density (>0.5 × 10<sup>5</sup> cells/cm<sup>2</sup>) and are then passaged into cell HTS 24-well plates with 0.4 μm polycarbonate membrane inserts. Cells were seeded at 200,000 cells/cm<sup>2</sup> and cultivated for 21 days in complete medium. Media was replaced every 2 days. Compound solutions were prepared in HEPES-buffered Ringer’s (RH) solution (NaCl 150 mM, KCl 5.2 mM, CaCl<sub>2</sub> 2.2 mM, MgCl<sub>2</sub> 0.2 mM, NaHCO<sub>3</sub> 6 mM, glucose 2.8 mM, HEPES 5 mM, water for injection), pH = 7.4, at a final concentration of 5 or 10 μM for tested drugs. For the A → B transport experiment, 0.2 mL of the compound solution was placed on the apical side of the cells and samples were taken from the basolateral compartment. For the B → A transport experiment, 0.8 mL of the solution was placed on the basolateral side of the cells and samples were taken from the apical side. Transport studies were done in Transwell polycarbonate: HTS 24-well plate inserts (surface area: 0.33 cm<sup>2</sup> to 0.4 μm pore size). Cells were equilibrated for 10 min in transport buffer prior to the transport experiment, and then incubations with compounds were performed at 37 °C under agitation. After 1 h, aliquots were taken from each compartment and sampled in 96-well plates with glass insert. Samples were analyzed by LC–MS/MS analysis. Permeation are calculated using the formulas below:</div><div class="NLM_p last"><span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_m001.gif" alt="" id="_i29" /></img></span><span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_m002.gif" alt="" id="_i30" /></img></span></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> BBB Permeation</h3><div class="NLM_p">To reproduce <i>in vitro</i> the human BBB, human umbilical cord blood is collected. Infants’ parents signed an informed consent form, in compliance with the French legislation. The protocol was approved by the French Ministry of Higher Education and Research (CODECOH Number DC2011-1321). All experiments were carried out in accordance with the approved protocol. Briefly, hematopoietic stem cells were isolated from the umibilical coord blood and cells were differentiated into endothelial cells as previously described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Then, endothelial cells are seeded on Transwell Costar polycarbonate inserts, 0.4 μm pore size, coated with Matrigel matrix (Corning), and co-cultured with brain pericytes for 6 days. After this period, endothelial cells display the major features of the blood–brain barrier observed <i>in vivo</i> and are then named brain-like endothelial cells (BLECs).<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28−30)</a> Toxicity and drug transport of tested compounds were evaluated in HEPES-buffered Ringer’s solution at 10 μM. The culture medium was removed and replaced with test drugs (with 1 μM sodium fluorescein used as an integrity control) in the donor compartment. After 60 min, aliquots were taken in abluminal and luminal compartments of the cell culture. Samples were analyzed by LC-MS/MS analysis.</div><div class="NLM_p">Endothelial permeability coefficient (Pe) is calculated as described previously.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">In this calculation method, both filter without cell permeability (PSf = insert filter + matrigel coating) and filter plus cell permeability (PSt = filter + matrigel + ECs) are taken into account according to the formula: 1/PSe = 1/PSt + 1/PSf, where PS is the permeability × surface area product (in microliters per minute) obtained by dividing the volume cleared from the donor to the receiver compartment (in μL) by the duration of the experiment (60 min).</div><div class="NLM_p last">The PSe values are divided by the surface area of the filter (1.2 cm<sup>2</sup>) to generate the endothelial permeability coefficient (Pe) in centimeters per minute.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Caco-2 Pump Out Assay</h3><div class="NLM_p">This assay was assessed as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Briefly, Caco-2 cells were seeded at 100,000 cells/cm<sup>2</sup> (20,000 cells/well) into Collagen type I 96-well plates and cultivated in complete medium. Media was replaced every 2 days. After a culture period of 6 days, Caco-2 cells in 96-well plates were washed one time in with RH solution and incubated for 120 min with 10 μM rhodamine 123 (Rho 123) or for 15 min with 5 μM 5-chloromethylfluorescein diacetate (CMFDA).</div><div class="NLM_p last">After an incubation period, Caco-2 cells were washed two times with RH buffer and incubated with or without test compounds. The clearance of the fluorescent dyes from Caco-2 cells (Kout) were monitored by fluorescence measurement (λex = 501 nm and λem = 538 nm for R123 and λex = 485 nm and λem = 538 nm for CMFDA) using a microplate fluorimeter (BioTek, H1, Vermont, Winooski). The amount of dye expelled from the cells was measured every 2 min over 1 h at 37 °C. The Kout of the dyes in presence or absence of test compounds (in RFU/min) were calculated as the slope of the curve of the cumulative amount of dye over time (Kout = <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_m003.gif" alt="" id="_i33" /></img></span>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>In Vivo</i> Experiments</h3><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Animals and Diets</h4><div class="NLM_p last">Ten to 12 week-old male C57Bl6 mice were purchased from Charles River (France) and fed ad libitum with a standard diet (UAR A04, Villemoison/Orge, France). All animals were maintained in standard animal cages under conventional laboratory conditions (12 h/12 h light/dark cycle, 22 °C) with ad libitum access to food and water. The animals were maintained in compliance with European standards for the care and use of laboratory animals and experimental protocols approved by the local Animal Ethical Committee (agreement no. 01134.03).</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Pharmacokinetics</h4><div class="NLM_p last">Compounds were dissolved in distilled water/0.1% Tween and administered orally at 32 μmol/kg to 8 week-old, male, C57Bl6 mice (approximately 25–30 g) (Charles River). Compounds were administered to overnight fasted animals. Three mice per time point were anesthetized with isoflurane, and aliquots taken from the retro-orbital sinus using sampling heparinated tubes (4 °C) at 10 min, 20 min, 30 min, 1 h, 2 h, and 4 h after administration of a single dose of compounds. The blood samples were centrifuged (5000<i>g</i>, 15 min) for plasma separation and stored at −80 °C before compound measurement. Plasma samples were thawed on ice. Aliquots were precipitated with ice-cold acetonitrile (:10 ratio) containing compound <b>3</b> (0.2 μM) as an internal standard. The samples were vigorously mixed with a vortex and centrifuged for 10 min at 10,000 rpm, 4 °C, and the supernatants were transferred into Matrix tubes for LC-MS/MS analysis. Spiked standard solutions (1, 3, 10, 30, 100, 300, 1000, 3000, 10,000, and 30,000 nM) were prepared the same way. After rodent sacrifice, gallbladders, livers, and intestines were removed. Gallbladders were immediately measured using a vernier caliper. Intestines were cut to isolate the duodenum, jejunum, ileum, and colon. All tissues were frozen in liquid nitrogen and stored at −80 °C. Compounds in tissues were extracted with a MeOH/CH<sub>3</sub>CN 50:50 mixture (using a vortex for feces or a Tissue Lyzer II from Qiagen for tissues). After centrifugation (10,000 rpm, 10 min, 4 °C) of the homogenate samples, supernatants were diluted (1 to 10) with ice-cold acetonitrile containing compound <b>3</b> (0.2 μM) as an internal standard. After the last centrifugation, the supernatants were transferred into Matrix tubes for LC-MS/MS analysis.</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Synthetic Materials and Methods</h3><div class="NLM_p last">All commercial reagents and solvents were used without further purification. Microwave-assisted chemical reactions were conducted on a CEM Discover synthesis system or a Biotage Initiator+ microwave synthesizer. Flash column chromatography was performed on prepacked columns (Grace Resolv flash cartridges, Grace). Preparative HPLC were performed using a Varian ProStar system using an Omnisphere 10 C<sub>18</sub> column (250 mm × 41.4 mm) Dynamax from Varian, Inc. or a Waters-2 system using a XBridge Prep C18 5 μm OBD (50 mm × 250 mm). A gradient starting from 10 %CH<sub>3</sub>CN/90% H<sub>2</sub>O/ 0.1% formic acid and reaching 100%CH<sub>3</sub>CN/0.1% formic acid at a flow rate of 80 mL/minutes was used on the Varian ProStar system. Products were detected by UV absorption at 215 nm and/or 254 nm. A gradient mixture of CH<sub>3</sub>CN and water in ammonium formate buffer at pH 9.2 or pH 3.8 and a flow rate at 80 mL/min was used on Waters-2 system. Products were detected by UV absorption and/or by MS. NMR spectra were recorded on a Bruker DRX-300 spectrometer. Chemical shifts are in parts per million (ppm). The assignments were made using one-dimensional (1D) <sup>1</sup>H and <sup>13</sup>C spectra and two-dimensional (2D) HSQC, HMBC and COSY spectra. LCMS analysis was performed on a Waters Alliance Micromass ZQ 2000, using an XBridge C18 column (3.5 μm particle size, dimensions 50 mm × 4.6 mm). A mixture of water and acetonitrile was used as mobile phase in gradient elution. pH of mobile phase was adjusted with HCOOH and NH<sub>4</sub>OH to form a buffer solution at pH 3.8. The analysis time is 5 min (at a flow rate at 2 mL/min). Purity (%) was determined by reversed-phase HPLC, using UV detection (215 nm), and all compound showed purity greater than 95%. Purification yields were not optimized. Final compounds were isolated as amorphous solids without collection of melting point data.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Procedure A</h3><div class="NLM_p last">In a round-bottom flask were added the isothioureido derivative (1 eq), potassium carbonate (1 eq), sodium iodide (0.5 eq), and acetonitrile (QS 0.2 M). The suspension was stirred at room temperature for 10 min, and benzyl halide (1 eq) was then added. The suspension was stirred at room temperature overnight. The reaction mixture was then evaporated; the residue was dissolved in EtOAc and washed with water and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated. The residue was purified by flash chromatography using as an eluent a mixture of cyclohexane/EtOAc.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Procedure B</h3><div class="NLM_p last">In a round-bottom flask were introduced the isothioureido-acetamide derivative (1 eq), ethyl acetate (QS 0.1 M), diisopropylethylamine (6 eq), and T<sub>3</sub>P (3 eq). The reaction mixture was heated at reflux for 24 h. Diisopropylethylamine and T<sub>3</sub>P were added until completion. The reaction mixture was then diluted in EtOAc and washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness. The residue was purified by flash chromatography using as an eluent a mixture of cyclohexane/EtOAc.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure C</h3><div class="NLM_p last">In a microwave tube were introduced the isothioureido-acetamide derivative (1 eq), ethyl acetate (QS 0.1 M), diisopropylethylamine (6 eq), and T3P (3 eq). The reaction mixture was heated under microwave irradiation at 150 °C for 10 min. The reaction mixture was then diluted with EtOAc and washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated. The residue was purified by flash chromatography using as an eluent a mixture of cyclohexane/EtOAc.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> General Procedure D</h3><div class="NLM_p last">In a microwave tubes were added 5-amino-2-thio-imidazole derivative (1 eq), phenylboronic derivative (1 eq), cesium carbonate (1.75 eq), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.175 eq). A mixture of 222 μL of water (QS 0.8 M), 594 μL of dimethoxyethane (QS 0.3 M), and 89.1 μL of ethanol (QS 0.5 M) was prepared and poured into the microwave tube. The reaction mixture was heated under microwave irradiation at 100 °C for 10 min. The reaction mixture was then evaporated to dryness, diluted in ethyl acetate, filtered on Celite, washed with water and brine, dried over MgSO<sub>4</sub>, and evaporated to dryness.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> General Procedure E</h3><div class="NLM_p last">In a round-bottom flask were introduced 3,5-difluoro-4-(hydroxymethyl)phenol (1.2 eq), methylbenzenesulfonic acid polyethyleneglycol ester derivatives (1 eq), potassium carbonate (1.2 eq), and acetonitrile (QS 0.3 M). The suspension was stirred under reflux overnight. The reaction mixture was then filtrated and evaporated. The residue was purified by flash chromatography using as an eluent a mixture of DCM/MeOH.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedure F</h3><div class="NLM_p">In a round-bottom flask were introduced [2,3-difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol derivatives (1 eq), triethylamine (1.5 eq), and dry DCM (QS 0.4 M) at 0 °C. Mesyl chloride (1.2 eq) was then added in the reaction mixture dropwise, and it was stirred at room temperature overnight. After several hours, triethylamine and mesylchloride could be added several times until completion. The reaction mixture was evaporated to dryness.</div><div id="sec4_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (3,4-Dimethoxyphenyl)methylamine (<b>1a</b>)</h4><div class="NLM_p last">In a 250 mL flask were added 3,4-dimethoxyaniline (3 g, 19.58 mmol) and sodium methoxide (5.29 g, 97.92 mmol) in 35 mL of dry methanol. Then, paraformaldehyde (1.18 g, 39.17 mmol) and 15 mL of dry methanol were added. Molecular sieve (4 Å) was then added, and the mixture was stirred overnight at room temperature. Sodium borohydride (0.74 g, 19.58 mmol) was then added, and the mixture was heated under reflux for 1 h. The mixture was then evaporated and dissolved in EtOAc and water, and the two phases were separated. The aqueous phase was then basified by addition of a saturated aqueous solution of NaHCO<sub>3</sub> and extracted by EtOAc. The organic phases were washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness to give the titled product as an oily residue (2.67 g, 77%). It was used without further purification in the next step of the synthesis. LC-MS: t<sub>R</sub> = 2.12 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 168.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 2.62 (d, <i>J</i> = 5.0 Hz, 3H), 3.61 (s, 3H), 3.69 (s, 3H), 5.20 (q, <i>J</i> = 4.9 Hz, 1H), 5.99 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 6.22 (d, <i>J</i> = 2.5 Hz, 1H), 6.71 (d, <i>J</i> = 8.5 Hz, 1H).</div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> [2-(3,4-Dimethoxy-<i>N</i>-methylanilino)-2-oxoethyl]ammonium Formate (<b>1b</b>)</h4><div class="NLM_p last">In a 250 mL flask were introduced a solution of 2.67 g of (3,4-dimethoxyphenyl)methylamine (<b>1a</b>) and 7.9 mL of DIEA in 45 mL of DCM (dried over Na<sub>2</sub>SO<sub>4</sub>). The solution was stirred at 0 °C. Then, a solution of 2.4 mL of chloroacetyl chloride in 30 mL of DCM (dried over Na<sub>2</sub>SO<sub>4</sub>) was added dropwise in the flask. The mixture was then evaporated to dryness to give a brown residue, which was used without further purification in the next step of the synthesis. The residue corresponding to 2-chloro-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide was dissolved in 25 mL of ethanol 95% and added dropwise in a 500 mL flask containing 320 mL of aqueous ammonia at 65 °C. The reaction mixture was then evaporated to dryness. The residue was dissolved in DCM and extracted several times with an aqueous solution of HCOOH 1 M. The aqueous phase was then evaporated to dryness, and the residue was triturated in acetonitrile. The supernatant was evaporated to dryness to give the titled product as a brown powder (3.82 g, 75% yield over two steps). MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 225.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.17 (s, 3H), 3.76–3.77 (m, 6H), 3.99 (s, 2H), 6.90 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 6.99–7.03 (m, 2H), 8.00 (brs, 3H), 8.20 (s, 1H).</div></div><div id="sec4_16_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> [2-(3,4-Dimethoxy-<i>N</i>-methylanilino)-2-oxoethyl]ammonium 2,2,2-Trifluoroacetate (<b>1c</b>)</h4><div class="NLM_p">In a 250 mL flask was added (3,4-dimethoxyphenyl)methylamine (<b>1a</b>) (903 mg, 5.41 mmol) in 4 mL of EtOAc. Then, 2-(<i>tert</i>-butoxycarbonylamino)acetic acid (1136 mg, 6.49 mmol), T3P (4.78 mL, 8.12 mmol), and DIEA (2.83 mL, 16.21 mmol) were added. The mixture was stirred at room temperature for 30 min. Then, the reaction mixture was diluted with EtOAc and washed with water and a saturated aqueous solution of NaHCO<sub>3</sub> and brine. The organic phase was dried over MgSO<sub>4</sub> and evaporated to dryness to give the <i>tert</i>-butyl <i>N</i>-[2-(3,4-dimethoxy-<i>N</i>-methylanilino)-2-oxoethyl]carbamate as a reddish powder (1.77 g, 100%). LC-MS: t<sub>R</sub> = 2.35 min. MS: [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 325.0. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ (ppm) 1.42 (s, 9H), 3.27 (s, 3H), 3.68 (s, 2H), 3.89 (m, 6H), 6.68 (d, <i>J</i> = 2.4 Hz, 1H), 6.76 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.86 (d, <i>J</i> = 8.5 Hz, 1H).</div><div class="NLM_p last">In a 50 mL flask, <i>tert</i>-butyl <i>N</i>-[2-(3,4-dimethoxy-<i>N</i>-methylanilino)-2-oxoethyl]carbamate (1770 mg, 5.46 mmol) was dissolved in 13.6 mL of DCM. TFA (5.53 mL, 72.21 mmol) was added, and the reaction mixture was stirred at room temperature for 30 min. The reaction mixture was evaporated to dryness to give a purple oil, corresponding to the expected product (1.85 g, 100%). The residue was used without further purification in the next step of the synthesis. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 225.1.</div></div><div id="sec4_16_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(3,4-Dimethoxyphenyl)-2-[3-(4-fluorophenyl)iisothioureido]-<i>N</i>-methylacetamide (<b>1d</b>)</h4><div class="NLM_p last">4-Fluorophenylisothiocyanate (1.51 g, 9.83 mmol) and TEA (1.59 mL, 11.79 mmol) were added in a 250 mL flask in 15 mL of ethanol. [2-(3,4-Dimethoxy-<i>N</i>-methylanilino)-2-oxoethyl]ammonium formate (3.2 g, 9.83 mmol) (<b>1b</b>) were dissolved in 115 mL of ethanol, TEA (1.33 mL, 9.83 mmol) were added, and the mixture was added dropwise at room temperature. After the addition, the reaction was over. The reaction mixture was evaporated to dryness and purified by flash chromatography using as an eluent a mixture of cyclohexane/EtOAc to give the titled product as a yellowish powder (2.8 g, 76%). LC-MS: t<sub>R</sub> = 2.83 min. MS [M – H]<sup>−</sup><i>m</i>/<i>z</i> = 244.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 2.49 (s, 3H), 3.78 (m, 6H), 4.00 (d, <i>J</i> = 4.1 Hz, 2H), 6.92 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.01–7.03 (m, 2H), 7.15 (m, 2H), 7.45 (m, 2H), 7.73 (m, 1H), 9.90 (s, 1H).</div></div><div id="sec4_16_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-[2-(2,6-Difluorobenzyl)-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>1e</b>)</h4><div class="NLM_p last">The titled product was obtained without purification as an oily residue (1.15 g, 91%), following Procedure A, using <i>N</i>-(3,4-dimethoxyphenyl)-2-[3-(4-fluorophenyl)isothioureido]-<i>N</i>-methylacetamide (<b>1d</b>) (940 mg) and 2-bromomethyl-1,3-difluorobenzene (518 mg). MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 504.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.16 (s, 3H), 3.69–3.76 (m, 8H), 4.19 (s, 2H), 6.61 (m, 2H), 6.79–6.89 (m, 2H), 6.95–7.00 (m, 4H), 7.05–7.13 (m, 3H), 7.38 (m, 1H).</div></div><div id="sec4_16_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> [2-(2,6-Difluorobenzylsulfanyl)-3-(4-fluorophenyl)-3<i>H</i>-imidazol-4-yl]-(3,4-dimethoxyphenyl)methylamine (<b>1</b>)</h4><div class="NLM_p last">In a 50 mL flask were added 2-[2-(2,6-difluorobenzyl)-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>1e</b>) (500 mg), 10 mL of EtOAc, NEt<sub>3</sub> (843 μL), and T3P (1.77 mL). The reaction mixture was then stirred at reflux for 28 h. After 8 h, NEt<sub>3</sub> (843 μL) and T3P (1.77 mL) were added. After 25 h, NEt<sub>3</sub> (422 μL) and T3P (885 μL) were added. After dilution with 20 mL of EtOAc, the solution was washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated. The residue was purified by flash chromatography using as an eluent a mixture of DCM/MeOH. The titled product was obtained as an oily residue (160 mg, 33%). LC-MS: t<sub>R</sub> = 3.13 min, MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 486.3. HRMS found 486.1437; C<sub>25</sub>H<sub>22</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>S requires 486.1463. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ (ppm) 2.92 (s, 3H), 3.80 (s, 3H), 3.82 (s, 3H), 4.16 (s, 2H), 6.16 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H), 6.30 (d, <i>J</i> = 2.7 Hz, 1H), 6.72 (d, <i>J</i> = 8.7 Hz, 1H), 6.78 (m, 2H), 6.83–6.85 (m, 4H), 6.92 (s, 1H), 7.19 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ (ppm) 25.9, 40.1, 55.9, 56.4, 99.9, 105.5, 111.2, 112.4, 113.6 (t, <i>J</i> = 19.3 Hz), 115.9 (d, <i>J</i> = 22.9 Hz), 124.4, 129.1, 129.2, 130.8, 138.1, 139.6, 142.7, 143.2, 149.6, 161.1 (dd, <i>J</i> = 250.0, 7.7 Hz), 162.2 (d, <i>J</i> = 249.0 Hz).</div></div><div id="sec4_16_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(3,4-Dimethoxyphenyl)-2-[3-(4-fluoro-3-methoxyphenyl)isothioureido]-<i>N</i>-methylacetamide (<b>2d</b>)</h4><div class="NLM_p last">In a 25 mL flask, TCDI (133 mg, 0.749 mmol) was dissolved in 3 mL of dioxane. [2-(3,4-Dimethoxy-<i>N</i>-methylanilino)-2-oxoethyl]ammonium 2,2,2-trifluoroacetate (<b>1c</b>) (230 mg, 0.681 mmol) in 3.50 mL of dioxane was then added dropwise. The solution was then stirred at room temperature for 1.5 h. 4-Fluoro-3-methoxyaniline (106 mg, 0.750 mmol) and NEt<sub>3</sub> (285 μL, 2.04 mmol) were added to the solution. The reaction mixture was stirred at 60 °C overnight. The solvent was then removed. The residue was dissolved in EtOAc and washed with water, with an aqueous HCl 0.1 N solution, and dried over MgSO<sub>4</sub>. After evaporation, the residue was purified by flash chromatography using as an eluent a mixture of cyclohexane/EtOAc (8/2) to give the titled product as an orange solid (136 mg, 49%). LC-MS: t<sub>R</sub> = 2.53 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 408.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.16 (s, 3H), 3.74–3.82 (m, 9H), 4.00 (d, <i>J</i> = 4.2 Hz, 2H), 6.84–6.96 (m, 2H), 6.98–7.06 (m, 2H), 7.15 (dd, <i>J</i> = 11.3, 8.7 Hz, 1H), 7.37 (dd, <i>J</i> = 7.9, 2.2 Hz, 1H), 7.77 (brs, 1H), 9.91 (s, 1H).</div></div><div id="sec4_16_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-[2-(2,6-Difluorobenzyl)-3-(4-fluoro-3-methoxyphenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide <b>(2e</b>)</h4><div class="NLM_p last">The titled product was obtained as a yellowish oil (156 mg, 91%) without purification, following Procedure A, using <i>N</i>-(3,4-dimethoxyphenyl)-2-[3-(4-fluoro-3-methoxyphenyl)isothioureido]-<i>N</i>-methylacetamide (<b>2d</b>) (124 mg, 304 μmol) and 2-bromomethyl-1,3-difluorobenzene (63 mg, 304 μmol). LC-MS: t<sub>R</sub> = 3.29 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 534.2. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ (ppm) 3.28 (s, 3H), 3.78–3.84 (m, 11H), 4.11 (brs, 2H), 5.82 (s, 1H), 6.29 (brs, 1H), 6.44 (d, <i>J</i> = 6.3 Hz, 1H), 6.61–6.89 (m 6H), 7.13–7.26 (m, 1H).</div></div><div id="sec4_16_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> [2-(2,6-Difluorobenzylsulfanyl)-3-(4-fluoro-3-methoxyphenyl)-3<i>H</i>-imidazol-4-yl]-(3,4-dimethoxyphenyl)methylamine (<b>2</b>)</h4><div class="NLM_p last">The titled product was obtained as an orange powder (143 mg, 63%), following Procedure C, using 2-[2-(2,6-difluorobenzyl)-3-(4-fluoro-3-methoxyphenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>2e</b>) (156 mg, 278 μmol). LC-MS: t<sub>R</sub> = 3.42 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 516.2. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ (ppm) 2.90 (s, 3H), 3.54 (s, 3H), 3.82 (s, 6H), 4.20 (s, 2H), 6.18 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.33 (d, <i>J</i> = 2.8 Hz, 1H), 6.54 (dd, <i>J</i> = 7.5, 2.4 Hz, 1H), 6.59–6.64 (m, 1H), 6.75 (d, <i>J</i> = 8.7 Hz, 1H), 6.78–6.86 (m, 2H), 6.98 (dd, <i>J</i> = 10.8, 8.6 Hz, 1H), 7.06 (s, 1H), 7.14–7.24 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ (ppm) 25.7, 39.9, 55.9, 56.0, 56.6, 99.7, 105.2, 111.1–111.4 (m), 112.6, 112.7 (d, <i>J</i> = 2.4 Hz), 113.6 (t, <i>J</i> = 19.4 Hz), 115.9 (d, <i>J</i> = 19.6 Hz), 119.7 (d, <i>J</i> = 7.3 Hz), 124.9, 129.2 (t, <i>J</i> = 10.2 Hz), 130.9 (d, <i>J</i> = 3.6 Hz), 138.6, 139.0, 142.6, 143.5, 147.5 (d, <i>J</i> = 11.6 Hz), 149.8, 152.0 (d, <i>J</i> = 248.9 Hz), 161.2 (dd, <i>J</i> = 249.9, 7.7 Hz).</div></div><div id="sec4_16_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> [2,6-Difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol (<b>P3i</b>) (Average MW = 627 g/mol)</h4><div class="NLM_p last">In a round-bottom flask were added methoxypolyethyleneglycol (average MW = 500 g/mol) (1500 mg, 3 mmol) in dry THF (10 mL). The solution was cooled at 0 °C. NaH (107.99 mg, 4.5 mmol) was added, and the reaction mixture was stirred at 0 °C to room temperature for 2 h. Then, 4-methylbenzenesulfonyl chloride (1143.9 mg, 6 mmol) was added at 0 °C, and the reaction mixture was stirred at room temperature for 24 h. The reaction mixture was then evaporated, and the residue was purified by flash chromatography using as an eluent a mixture of DCM/MeOH (94/6) to give a colorless oil corresponding to the expected 2-(<i>p</i>-tolylsulfonyloxy)polyethyleglycoxyl 4-methylbenzenesulfonate (1.68 g, 86%). LC-MS: t<sub>R</sub> = 2.82 min. MS [M + H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 644.3 (<i>n</i> = 10). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 2.41 (s, 3H), 3.23 (s, 3H), 3.44–3.49 (m, 36H), 3.57 (m, 2H), 4.10 (m, 2H), 7.48 (d, <i>J</i> = 8.0 Hz, 2H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H). The titled product <b>P3i</b> was then obtained as a colorless oil (676 mg, 70%), following Procedure E, using 2-(<i>p</i>-tolylsulfonyloxy)polyethyleglycoxyl 4-methylbenzenesulfonate (981 mg, 1.5 mmol) and 3,5-difluoro-4-(hydroxymethyl)phenol (288 mg, 1.8 mmol). LC-MS: t<sub>R</sub> = 2.58 min. MS [M + H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 632.2 (<i>n</i> = 10). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.23 (s, 3H), 3.41–3.56 (m, 42H), 3.72 (m, 2H), 4.11 (m, 2H), 4.40 (d, <i>J</i> = 5.5 Hz, 2H), 5.08 (t, <i>J</i> = 5.5 Hz, 1H), 6.71 (m, 2H).</div></div><div id="sec4_16_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(Chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene (<b>P3ii</b>) (Average MW = 646 g/mol)</h4><div class="NLM_p last">The titled product was obtained without purification (694 mg, 100%), following Procedure F, using [2,6-difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol <b>P3i</b> (676 mg). LC-MS: t<sub>R</sub> = 3.00 min. MS [M + H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 650.2 (<i>n</i> = 10).</div></div><div id="sec4_16_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-[2-[2,6-Difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>P3a</b>) (Average MW = 1012.7 g/mol)</h4><div class="NLM_p last">The titled product was obtained as a brown oil (499 mg, 47%), following Procedure A, using 2-(chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene <b>P3ii</b> (694 mg, 1.05 mmol) and <i>N</i>-(3,4-dimethoxyphenyl)-2-[3-(4-fluorophenyl)isothioureido]-<i>N</i>-methylacetamide (<b>1d</b>) (397 mg, 1.05 mmol). LC-MS: t<sub>R</sub> = 3.12 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 518.4 (<i>n</i> = 10). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.16 (s, 3H), 3.22 (s, 3H), 3.14–3.55 (m, 40H), 3.69–3.76 (m, 8H), 4.10 (s, 2H), 6.60–7.01 (m, 9H).</div></div><div id="sec4_16_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> [2-[2,6-Difluoro-4-(2-methoxypolyethyleneglycoxy)benzylsulfanyl]-3-(4-fluorophenyl)-3<i>H</i>-imidazol-4-yl]-(3,4-dimethoxyphenyl)methylamine (<b>P3</b>) (Average MW = 972.1 g/mol, <i>n</i> = 9–13)</h4><div class="NLM_p last">The titled compound was obtained after purification by preparative HPLC as an orange oil (131 mg, 27%), following Procedure B, using 2-[2-[2,6-difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>P3a</b>) (499 mg, 493 μmol). LC-MS: t<sub>R</sub> = 3.12 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 487.2 (<i>n</i> = 10). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 2.92 (s, 3H), 3.23 (s, 3H), 3.42–3.55 (m, 42H), 3.63–3.64 (m, 6H), 3.70–3.73 (m, 2H), 3.99 (s, 2H), 4.09–4.12 (m, 2H), 6.06 (dd, <i>J</i> = 8.6, 2.7 Hz, 1H), 6.21 (d, <i>J</i> = 2.7 Hz, 1H), 6.67–6.70 (m, 2H), 6.75 (d, <i>J</i> = 8.8 Hz, 1H), 6.96 (s, 1H), 7.09–7.22 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 26.1, 55.9, 56.5, 58.5, 68.6, 69.0, 70.0, 70.2, 70.3, 71.7, 99.1 (d, <i>J</i> = 28.0 Hz), 99.9, 105.4, 105.5 (t, <i>J</i> = 20.6 Hz), 113.7, 116.3 (d, <i>J</i> = 22.9 Hz), 124.3, 130.0 (d, <i>J</i> = 9.0 Hz), 131.5 (d, <i>J</i> = 3.6 Hz), 137.3, 140.1; 142.5, 143.4, 149.7, 161.7 (dd, <i>J</i> = 286.1, 11.7 Hz), 162.1 (d, <i>J</i> = 275.7 Hz).</div></div><div id="sec4_16_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> [2,6-Difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol (<b>P4i</b>) (Average MW = 947 g/mol)</h4><div class="NLM_p last">The titled product was obtained as a white viscous residue after purification by preparative HPLC (697 mg, 61%), following Procedure E, using polyethyeneglycol methyl ether tosylate (average molecular weight = 900 g/mol) (1080 mg, 1.2 mmol) and 3,5-difluoro-4-(hydroxymethyl)phenol (211 mg, 1.32 mmol). LC-MS: t<sub>R</sub> = 2.23 min. MS [M + H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 808.2 (<i>m</i> = 14). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.23 (s, 3H), 3.38–3.58 (m, 66H), 3.72 (m, 2H), 4.11 (m, 2H), 4.40 (s, 2H), 6.71 (m, 2H). 1H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.23 (s, 3H), 3.38–3.58 (m, 66H), 3.72 (m, 2H), 4.11 (m, 2H), 4.40 (s, 2H), 6.71 (m, 2H).</div></div><div id="sec4_16_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(Chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene (<b>P4ii</b>) (Average MW = 1033 g/mol)</h4><div class="NLM_p last">The titled product was obtained (710 mg, 100%), following Procedure F, using [2,6-difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol <b>P4i</b> (697 mg, 738 μmol). LC-MS: t<sub>R</sub> = 2.73 min. MS [M + 2H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 488.3 (<i>n</i> = 17).</div></div><div id="sec4_16_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-[2-[2,6-Difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>P4a</b>) (Average MW = 1209 g/mol)</h4><div class="NLM_p last">The titled product was obtained as a pale pink solid (146 mg, 17%), following Procedure A, using 2-(chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene <b>P4ii</b> (711 mg, 738 μmol) and <i>N</i>-(3,4-dimethoxyphenyl)-2-[3-(4-fluorophenyl)isothioureido]-<i>N</i>-methylacetamide (<b>1d</b>) (279 mg, 738 μmol). LC-MS: t<sub>R</sub> = 2.87 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 606.3 (<i>n</i> = 15).</div></div><div id="sec4_16_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> [2-[2,6-Difluoro-4-(2-methoxy-polyethyleneglycoxy)benzylsulfanyl]-3-(4-fluorophenyl)-3<i>H</i>-imidazol-4-yl]-(3,4-dimethoxyphenyl)methylamine (<b>P4</b>) (Average MW = 1204 g/mol, <i>n</i> = 10–22)</h4><div class="NLM_p last">The titled compound was obtained after purification by preparative HPLC as an orange oil (20 mg, 13%), following Procedure B, using 2-[2-[2,6-difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>P4a</b>) (average MW = 1209 g/mol) (148 mg, 122 μmol). LC-MS: t<sub>R</sub> = 2.85 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 619.2 (<i>n</i> = 16). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.96 (s, 3H), 3.36 (s, 3H), 3.50–3.72 (m, 80H), 3.74–3.77 (m, 6H), 3.78–3.88 (m, 4H), 4.04–4.14 (m, 4H), 6.15 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.27 (d, <i>J</i> = 2.8 Hz, 1H), 6.41–6.50 (m, 2H), 6.72 (d, <i>J</i> = 8.7 Hz, 1H), 6.96–7.07 (m, 5H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 25.8, 40.1, 55.8, 56.4, 58.6, 68.3, 69.2, 70.3, 70.4, 70.5, 70.8, 71.9, 98.1–98.7 (m), 100.1, 105.5, 105.6 (t, <i>J</i> = 20.5 Hz), 112.9, 115.7 (d, <i>J</i> = 23.0 Hz), 124.0, 129.3 (d, <i>J</i> = 8.8 Hz), 131.1 (d, <i>J</i> = 3.3 Hz), 138.0, 139.8, 142.8, 143.3, 149.8, 159.7 (t, <i>J</i> = 14.5 Hz), 161.6 (dd, <i>J</i> = 247.1, 11.3 Hz), 162.3 (d, <i>J</i> = 248.3 Hz).</div></div><div id="sec4_16_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> [2,6-Difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol (<b>P5i</b>) (Average MW = 2200 g/mol)</h4><div class="NLM_p last">The titled product was obtained without purification as a white solid (3.20 g, 100%), following Procedure E, using polyethyeneglycol methyl ether tosylate (average MW = 2000 g/mol) (2400 mg, 1.2 mmol) and 3,5-difluoro-4-(hydroxymethyl)phenol (211 mg, 1.32 mmol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.23 (s, 3H), 3.36–3.76 (m, 278H), 4.06–4.14 (m, 2H), 4.40 (brs, 2H), 5.08 (brs, 1H), 6.56–6.76 (m, 2H).</div></div><div id="sec4_16_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(Chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene (<b>P5ii</b>) (Average MW = 2220 g/mol)</h4><div class="NLM_p last">The titled product was obtained (2.94 g, 100%), following Procedure F, using [2,6-difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol <b>P5i</b> (2.91 g, 1.47 mmol).</div></div><div id="sec4_16_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-[2-[2,6-Difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (P5a) (Average MW = 2413 g/mol)</h4><div class="NLM_p last">The titled product was obtained as a yellow solid (693 mg, 20%), following Procedure A, using 2-(chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene <b>P5ii</b> (2.94 g, 1.47 mmol) and <i>N</i>-(3,4-dimethoxyphenyl)-2-[3-(4-fluorophenyl) isothioureido]-<i>N</i>-methylacetamide (<b>1d</b>) (553 mg, 1.47 mmol). LC-MS: t<sub>R</sub> = 3.54 min. MS [M + H + 3H<sub>3</sub>O]<sup>4+</sup> m/z = 609.4 (<i>n</i> = 42).</div></div><div id="sec4_16_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> [2-[2,6-Difluoro-4-(2-methoxypolyethyleneglycoxy)benzylsulfanyl]-3-(4-fluorophenyl)-3<i>H</i>-imidazol-4-yl]-(3,4-dimethoxyphenyl)methylamine (<b>P5</b>) (average MW = 2347 g/mol, <i>n</i> = 34–52)</h4><div class="NLM_p last">The titled product was obtained after purification by preparative HPLC as a yellowish solid (110 mg, 16%), following Procedure B, using 2-[2-[2,6-difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluorophenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methyl-acetamide <b>P5a</b> (693 mg, 287 μmol). LC-MS: t<sub>R</sub> = 3.02 min. MS [M + H + 2H<sub>3</sub>O]<sup>3+</sup><i>m</i>/<i>z</i> = 786.0 (<i>n</i> = 41). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.96 (s, 3H), 3.36–3.87 (m, 213H), 4.04–4.11 (m, 4H), 6.15 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.27 (d, <i>J</i> = 2.8 Hz, 1H), 6.41–6.50 (m, 2H), 6.72 (d, <i>J</i> = 8.7 Hz, 1H), 6.96–7.07 (m, 5H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 25.8, 40.1, 55.8, 56.4, 58.6, 68.3, 69.2, 70.3, 70.4, 70.5, 70.8, 71.9, 98.1–98.7 (m), 100.1, 105.5, 105.6 (t, <i>J</i> = 20.5 Hz), 112.9, 115.7 (d, <i>J</i> = 23.0 Hz), 124.0, 129.3 (d, <i>J</i> = 8.9 Hz), 131.1 (d, <i>J</i> = 3.3 Hz), 138.0, 139.8, 142.8, 143.3, 149.8; 159.7 (t, <i>J</i> = 14.5 Hz), 161.6 (dd, <i>J</i> = 247.1, 11.3 Hz), 162.3 (d, <i>J</i> = 248.3 Hz).</div></div><div id="sec4_16_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2,6-Difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol (<b>P6i</b>) (Average MW = 916 g/mol)</h4><div class="NLM_p last">The titled product was obtained as a white viscous residue (893 mg, 63%), following Procedure E, using polyethyeneglycol methyl ether tosylate (average MW = 900 g/mol) (1.32 g, 1.46 mmol) and 3,5-difluoro-4-(hydroxymethyl)phenol (260 mg, 1.62 mmol). LC-MS: t<sub>R</sub> = 2.23 min. MS [M + H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 896.6 (<i>n</i> = 16).</div></div><div id="sec4_16_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-(Chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene (<b>P6ii</b>) (Average MW = 935 g/mol)</h4><div class="NLM_p last">The titled product was obtained (912 mg, 100%), following Procedure E, using 2,6-difluoro-4-(methoxypolyethyleneglycoxy)phenyl]methanol <b>P6i</b> (893 mg, 1.02 mmol). LC-MS: t<sub>R</sub> = 2.75 min. MS [M + H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 914.5 (<i>n</i> = 16).</div></div><div id="sec4_16_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-[2-[2,6-Difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluoro-3-methoxyphenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>P6a</b>) (Average MW = 1209 g/mol)</h4><div class="NLM_p last">The titled product was obtained after purification by preparative HPLC as a pale pink solid (333 mg, 26%), following Procedure A, using 2-(chloromethyl)-1,3-difluoro-5-(2-methoxypolyethyleneglycoxy]benzene <b>P6ii</b> (912 mg, 1.02 mmol)) and <i>N</i>-(3,4-dimethoxyphenyl)-2-[3-(4-fluoro-3-methoxyphenyl)isothioureido]-<i>N</i>-methylacetamide (<b>2d</b>) (414 mg, 1.02 mmol). LC-MS: t<sub>R</sub> = 2.85 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 643.5 (<i>n</i> = 16). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 3.29 (s, 3H), 3.35 (s, 3H), 3.50–3.72 (m, 80H), 3.80–3.90 (m, 13H), 4.03–4.17 (m, 4H), 6.32 (brs, 1H), 6.46–6.56 (m, 3H), 6.70–7.02 (m, 5H).</div></div><div id="sec4_16_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> [2-[2,6-Difluoro-4-(2-methoxypolyethyleneglycoxy)benzylsulfanyl]-3-(4-fluoro-3-methoxyphenyl)-3<i>H</i>-imidazol-4-yl]-(3,4-dimethoxyphenyl)methylamine (<b>P6</b>) (Average MW = 1329 g/mol, <i>n</i> = 14–24)</h4><div class="NLM_p last">The titled product was obtained after purification by preparative HPLC as a pale orange oil (47 mg, 17%), following Procedure C, using 2-[2-[2,6-difluoro-4-(methoxypolyethyleneglycoxy)benzyl]-3-(4-fluoro-3-methoxyphenyl)isothioureido]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide <b>P6a</b> (333 mg, 263 μmol). LC-MS: t<sub>R</sub> = 2.90 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 678.6 (<i>n</i> = 18). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.93 (s, 3H), 3.36 (s, 3H), 3.48–3.72 (m, 76H), 3.73–3.78 (m, 6H), 3.79–3.85 (m, 2H), 4.04–4.13 (m, 4H), 6.17 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H), 6.31 (d, <i>J</i> = 2.6 Hz, 1H), 6.40–6.50 (m, 2H), 6.57 (dd, <i>J</i> = 7.6, 2.3 Hz, 1H), 6.63–6.70 (m, 1H), 6.75 (d, <i>J</i> = 8.7 Hz, 1H), 6.96–7.09 (m, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 25.8, 39.9, 55.8, 55.9, 56.5, 58.6, 68.3, 69.2, 70.4, 70.5, 70.8, 71.9, 98.1–98.5 (m), 99.9, 105.5, 105.6 (t, <i>J</i> = 20.2 Hz), 112.9 (d, <i>J</i> = 2.5 Hz), 113.1, 115.7 (d, <i>J</i> = 19.6 Hz), 119.8 (d, <i>J</i> = 7.3 Hz), 124.7, 131.2 (d, <i>J</i> = 3.6 Hz), 138.2, 139.3, 142.7, 143.6, 147.6 (d, <i>J</i> = 11.6 Hz), 150.0, 151.9 (d, <i>J</i> = 247.9 Hz), 159.7 (t, <i>J</i> = 14.1 Hz), 161. 7 (dd, <i>J</i> = 252.8, 5.6 Hz).</div></div><div id="sec4_16_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-[[(<i>Z</i>)-<i>C</i>-[(4-Bromo-2,6-difluorophenyl)methylsulfanyl]-<i>N</i>-(4-fluoro-3-methoxyphenyl) carbonimidoyl]amino]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>7a</b>)</h4><div class="NLM_p last">The titled product was obtained as an oily residue (4.02 g, 98%), following Procedure A, using <i>N</i>-(3,4-dimethoxyphenyl)-2-[[(<i>Z</i>)-<i>N</i>-(4-fluoro-3-methoxyphenyl)-<i>C</i>-sulfanylcarbonimidoyl]amino]-<i>N</i>-methylacetamide (<b>2d</b>) (2.74 g, 6.7 mmol) and 5-bromo-2-(chloromethyl)-1,3-difluorobenzene (1.62 g, 6.7 mmol). LC-MS: t<sub>R</sub> = 3.40 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 613.0. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ (ppm) 3.30 (s, 3H), 3.82 (s, 3H), 3.87 (s,3H), 3.91 (s, 3H), 3.85 (s, 2H), 4.07 (s, 2H), 5.80 (s, 1H), 6.31 (s, 1H), 6.44 (s, 1H), 6.70 (s, 1H), 6.78 (d, <i>J</i> = 8.3 Hz, 1H), 6.86 (d, <i>J</i> = 8.3 Hz, 1H), 6.93 (d, <i>J</i> = 9.0 Hz, 1H), 7.03–7.13 (m, 2H).</div></div><div id="sec4_16_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-[(4-Bromo-2,6-difluorophenyl) methylsulfanyl]-<i>N</i>-(3,4-dimethoxyphenyl)-3-(4-fluoro-3-methoxyphenyl)-<i>N</i>-methylimidazol-4-amine (<b>7b</b>)</h4><div class="NLM_p last">The titled product was obtained as a yellow oil (3.90 g, 100%), following Procedure C, using 2-[[(<i>Z</i>)-<i>C</i>-[(4-bromo-2,6-difluorophenyl)methylsulfanyl]-<i>N</i>-(4-fluoro-3-methoxyphenyl)carbonimidoyl]amino]-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylacetamide (<b>7a</b>) (4.02 g, 6.56 mmol). LC-MS: t<sub>R</sub> = 3.35 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 595.9. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ (ppm) 2.90 (s, 3H), 3.55 (s, 3H), 3.80 (s, 3H), 3.82 (s, 3H), 4.12 (s, 2H), 6.13–6.18 (dd, <i>J</i> = 8.5, 2.8 Hz, 1H), 6.30 (d, <i>J</i> = 2.8 Hz, 1H), 6.51–6.54 (dd, <i>J</i> = 7.6, 2.6 Hz, 1H), 6.58–6.63 (m, 1H), 6.74 (d, <i>J</i> = 8.5 Hz, 1H), 7.00–7.04 (m, 4H).</div></div><div id="sec4_16_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-[4-[[5-(3,4-dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]benzoic Acid (<b>7c</b>)</h4><div class="NLM_p last">The titled product was obtained as a white powder, after purification by preparative HPLC (528 mg, 52%), following Procedure D, using 2-[(4-bromo-2,6-difluorophenyl)methylsulfanyl]-<i>N</i>-(3,4-dimethoxyphenyl)-3-(4-fluoro-3-methoxyphenyl)-<i>N</i>-methylimidazol-4-amine (<b>7b</b>) (950 mg, 1.6 mmol) and 4-boronobenzoic acid (265 mg, 1.6 mmol). LC-MS: t<sub>R</sub> = 2.97 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 636. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 2.92 (s, 3H), 3.48 (s, 3H), 3.59 (s, 3H), 3.65 (s, 3H), 4.13 (s, 2H), 6.06 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 6.24 (d, <i>J</i> = 2.8 Hz, 1H), 6.61–6.67 (m, 1H), 6.75 (d, <i>J</i> = 8.8 Hz, 1H), 6.78 (dd, <i>J</i> = 7.9, 2.5 Hz, 1H), 7.02 (s, 1H), 7.17 (dd, <i>J</i> = 11.4, 8.4 Hz, 1H), 7.52 (d, <i>J</i> = 9.2 Hz, 2H), 7.87 (d, <i>J</i> = 8.4 Hz, 2H), 8.01 (d, <i>J</i> = 8.4 Hz, 2H), 13.08 (s, 1H).</div></div><div id="sec4_16_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-methoxypolyethyleneglycoxy]ethyl]benzamide (<b>P7</b>) (Average MW = 1081 g/mol, <i>n</i> = 4–13)</h4><div class="NLM_p last">In a 5 mL flask were added <b>7c</b> (100 mg, 0.16 mmol), TEA (21.23 μL, 0.16 mmol), DCC (32.46 mg, 0.16 mmol), HOBt (21.26 mg, 0.16 mmol), and 2-[2-methoxypolyethyleneglycoxy]ethanamine (average MW = 500 g/mol) (74.19 mg, 0.16 mmol) in 1 mL of DCM. The reaction mixture was stirred overnight at room temperature. The reaction mixture was evaporated and purified by preparative HPLC to give the titled product as a white powder (106 mg, 62%). LC-MS: t<sub>R</sub> = 2.88 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 1089 (<i>n</i> = 10). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.94 (s, 3H), 3.35 (s, 3H), 3.53 (s, 3H), 3.56–3.64 (m, 24H), 3.65–3.68 (m, 8H), 3.75 (s, 3H), 3.77 (s, 3H), 4.20 (s, 2H), 6.18 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.32 (d, <i>J</i> = 2.8 Hz, 1H), 6.61 (dd, <i>J</i> = 7.7, 2.6 Hz, 1H), 6.63–6.69 (m, 1H), 6.73 (d, <i>J</i> = 8.7 Hz, 1H), 7.00 (d, <i>J</i> = 10.9, 8.5 Hz, 1H), 7.02 (s, 1H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 7.63 (d, <i>J</i> = 8.6 Hz, 2H), 7.92 (d, <i>J</i> = 8.6 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 25.4, 34.3, 40.3, 56.2, 56.3, 56.9, 70.2, 70.9, 72.2, 100.5, 105.8, 110.2 (m), 113.4 (t, <i>J</i> = 9.3 Hz), 113.5, 116.1 (d, <i>J</i> = 19.5 Hz), 120.1 (d, <i>J</i> = 7.0 Hz), 125.1, 127.1, 128.3, 131.5 (d, <i>J</i> = 4.2 Hz), 135.2, 138.3, 139.8, 141.2, 142.2, 143.2, 143.9, 148.1 (d, <i>J</i> = 12.5 Hz), 150.3, 152.4 (d, <i>J</i> = 248.1 Hz), 161.8 (dd, <i>J</i> = 248.1, 8.9 Hz), 166.8.</div></div><div id="sec4_16_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> [4-[2-[2-Methoxypolyethyleneglycoxy]ethylcarbamoyl]phenyl]boronic Acid (<b>P8i</b>) (Average MW = 1009 g/mol, <i>n</i> = 15–21)</h4><div class="NLM_p last">In a 25 mL flask were added 4-boronobenzoic acid (30 mg, 0.18 mmol), 2-[2-methoxypolyethyleneglycoxy]ethanamine (average MW = 750 g/mol) (141.01 mg, 0.18 mmol), HOBt (24.5 mg, 0.18 mmol), DCC (37.3 mg, 0.18 mmol), and 25 μL of TEA in 400 μL of dichloromethane. The reaction mixture was stirred at room temperature overnight. The reaction mixture was concentrated under reduced pressure, and the residue was diluted in ethyl acetate and washed with water. The aqueous layer was extracted with dichloromethane, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the titled product as a colorless oil (110 mg, 66%). It was used without further purification in the next step of the synthesis. LC-MS: t<sub>R</sub> = 2.40 min. MS [M + H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 990 (<i>n</i> = 18). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 3.23 (s, 3H), 3.32 (s, 4H), 3.40–3.44 (m, 4H), 3.45–3.60 (m, 62H), 7.78 (d, <i>J</i> = 8.2 Hz, 2H), 7.84 (d, <i>J</i> = 8.2 Hz, 2H), 8.17 (s, 1H).</div></div><div id="sec4_16_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-methoxypolyethyleneglycoxy]ethyl]benzamide (<b>P8</b>) (Average MW = 1394 g/mol, <i>n</i> = 12–24)</h4><div class="NLM_p last">The titled product was obtained as an oily residue, after purification by preparative HPLC (40 mg, 43%), following Procedure D, using <b>7c</b> (40 mg, 67 μmol) and [4-[2-[2-methoxypolyethyleneglycoxy]ethylcarbamoyl]phenyl]boronic acid <b>P8i</b> (62. 4 mg, 67 μmol). LC-MS: t<sub>R</sub> = 3.02 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 1353 (<i>n</i> = 16). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.91 (s, 3H), 3.33 (s, 3H), 3.50 (s, 3H), 3.48–3.51 (m, 2H), 3.53–3.70 (m, 72H), 3.72 (s, 3H), 3.74 (s, 3H), 4.17 (s, 2H), 6.13–6.17 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.29 (d, <i>J</i> = 2.8 Hz, 1H), 6.57–6.60 (dd, <i>J</i> = 7.9, 2.4 Hz, 1H), 6.61–6.60 (m, 1H), 6.71 (d, <i>J</i> = 8.7 Hz, 1H), 6.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.00 (s, 1H), 6.99 (d, <i>J</i> = 8.4 Hz, 1H), 7.13 (d, <i>J</i> = 8.4 Hz, 2H), 7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.90 (d, <i>J</i> = 8.4 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.2, 40.3, 56.2, 56.3, 56.9, 59.0, 70.1, 70.7, 70.8, 70.9, 72.3, 100.4, 105.8, 109.8–110.5 (m), 113.4 (d, <i>J</i> = 2.6 Hz), 113.5, 113.5 (t, <i>J</i> = 19.7 Hz), 116.1 (d, <i>J</i> = 19.8 Hz), 120.1 (d, <i>J</i> = 7.2 Hz), 125.1, 127.2, 128.3, 131.6 (d, <i>J</i> = 3.5 Hz), 135.2, 138.3, 139.8, 141.2 (t, <i>J</i> = 1.7 Hz), 142.1 (t, <i>J</i> = 9.8 Hz), 143.2, 144.0, 148.0 (d, <i>J</i> = 11.5 Hz), 150.4, 152.4 (d, <i>J</i> = 247.9 Hz), 161.8 (dd, <i>J</i> = 248.9, 8.6 Hz), 166.8.</div></div><div id="sec4_16_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-methoxypolyethyleneglycoxy]ethyl]benzamide (<b>P9</b>) (Average MW = 1452 g/mol, <i>n</i> = 11–25)</h4><div class="NLM_p last">In a 5 mL flask were added 4-[4-[[5-(3,4-dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]benzoic acid (<b>7c</b>) (80 mg, 0,13 mmol), 2-[2-methoxypolyethyleneglycoxy]ethanamine (average MW = 750 g/mol) (98 mg, 0,13 mmol), HOBt (17 mg, 0,13 mmol), DCC (19 mg, 0,13 mmol), and TEA (18 μL, 0,13 mmol). The reaction mixture was stirred at room temperature for 48 h. The reaction mixture was evaporated to dryness. The crude was purified by preparative chromatography to give the desired product as a colorless oil (127 mg, 72%). LC–MS: t<sub>R</sub> = 2.73 min. MS [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 1398 (<i>n</i> = 17). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.90 (s, 3H), 3.31 (s, 3H), 3.48 (s, 3H), 3.58 (m, 68H), 3.70 (s, 3H), 3.73 (s, 3H), 4.15 (s, 2H), 6.13 (d, <i>J</i> = 8.6 Hz, 1H), 6.28 (s, 1H), 6.56–6.63 (m, 2H), 6.68 (d, <i>J</i> = 8.7 Hz, 1H), 6.94 (d, <i>J</i> = 11.0 Hz, 1H), 6.99 (s, 1H), 7.10 (d, <i>J</i> = 8.0 Hz, 2H), 7.32 (s, 1H), 7.58 (d, <i>J</i> = 8.2 Hz, 2H), 7.90 (d, <i>J</i> = 8.1 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.2, 40.2, 56.1, 56.2, 56.8, 58.9, 70.1, 70.5, 70.6, 70.8, 72.2, 100.4, 105.8, 110.1 (d, <i>J</i> = 25.6 Hz), 113.3 (d, <i>J</i> = 2.9 Hz), 113.4, 113.4 (t, <i>J</i> = 20.0 Hz), 116.0 (d, <i>J</i> = 19.8 Hz), 120.1 (d, <i>J</i> = 7.2 Hz), 125.0, 127.0, 128.3, 131.5 (d, <i>J</i> = 3.6 Hz), 135.1, 138.2, 139.7, 141.0, 142.1 (t, <i>J</i> = 10.2 Hz), 143.1, 143.9, 147.9 (d, <i>J</i> = 11.4 Hz), 150.3, 152.3 (d, <i>J</i> = 248.1 Hz), 161.7 (dd, <i>J</i> = 249.0, 8.9 Hz), 166.7.</div></div><div id="sec4_16_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> [4-[2-[2-Methoxypolyethyleneglycoxy]ethylcarbamoyl]phenyl]boronic Acid (<b>P10i</b>) (Average MW = 2164 g/mol, <i>n</i> = 36–53)</h4><div class="NLM_p last">In a 25 mL flask were added 4-boronobenzoic acid (20 mg, 0.12 mmol), 2-[2-methoxypolyethyleneglycoxy]ethanamine (average MW = 2000 g/mol) (243 mg, 0.12 mmol), HOBt (17 mg, 0.12 mmol), DCC (25 mg, 0.12 mmol), and TEA (16.26 μL, 0.12 mmol) in 400 μL of dichloromethane. The reaction mixture was stirred at room temperature overnight. HOBt (17 mg, 0.12 mmol), DCC (25 mg, 0.12 mmol), and TEA (16.26 μL, 0.12 mmol) were added again in the reaction mixture, and it was stirred at room temperature for 24 h at 40 °C. The reaction mixture was filtered and concentrated under reduced pressure. Purification of the crude by preparative HPLC gave the titled product as a white powder (166 mg, 64%). LC-MS: t<sub>R</sub> = 2.55 min. MS [M + 2H<sub>3</sub>O]<sup>+</sup><i>m</i>/<i>z</i> = 1098.5 (<i>n</i> = 45). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 3.36 (s, 3H), 3.47–3.75 (m, 176H), 6.27( s, 2H), 7.04 (s, 1H), 7.79 (d, <i>J</i> = 7.6 Hz, 2H), 7.91 (d, <i>J</i> = 7.6 Hz, 2H).</div></div><div id="sec4_16_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-methoxypolyethyleneglycoxy]ethyl]benzamide (<b>P10</b>) (Average MW = 2608 g/mol, <i>n</i> = 33–57)</h4><div class="NLM_p last">The titled product was obtained as an oily residue after a purification by preparative HPLC (93 mg, 47%), following Procedure D, using <b>7c</b> (45 mg, 76 μmol) and [4-[2-[2-methoxypolyethyleneglycoxy]ethylcarbamoyl]phenyl]boronic acid <b>P10i</b> (163.6 mg, 76 μmol). LC-MS: t<sub>R</sub> = 2.93 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 1347 (<i>n</i> = 46). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 3.33 (s, 3H), 3.49 (s, 3H), 3.51–3.66 (m, 180H), 3.71 (s, 3H), 3.74 (s, 3H), 4.16 (s, 2H), 6.12–6.16 (dd, <i>J</i> = 8.6, 2.7 Hz, 1H), 6.29 (d, <i>J</i> = 2.7 Hz, 1H), 6.55–6.64 (m, 2H), 6.69 (d, <i>J</i> = 8.6 Hz, 1H), 6.94–7.00 (dd, <i>J</i> = 10.8, 8.4 Hz, 1H), 6.99 (s, 1H), 7.10–7.14 (m, 1H), 7.13 (d, <i>J</i> = 8.4 Hz, 2H), 7.59 (d, <i>J</i> = 8.6 Hz, 2H), 7.89 (d, <i>J</i> = 8.6 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 25.9, 39.9, 55.8, 55.9, 56.5, 58.6, 69.7, 70.3, 70.4, 70.5, 71.8, 100.1, 105.5, 109.5–110.0 (m), 113.0 (d, <i>J</i> = 3.0 Hz), 113.1 (t, <i>J</i> = 19.6 Hz), 113.1, 115.7 (d, <i>J</i> = 19.2 Hz), 119.8 (d, <i>J</i> = 7.3 Hz), 124.7, 126.8, 127.9, 131.1 (d, <i>J</i> = 3.5 Hz), 134.8, 137.9, 139.4, 140.8 (t, <i>J</i> = 2.3 Hz), 141.8 (t, <i>J</i> = 9.9 Hz), 142.8, 143.5, 147.6 (d, <i>J</i> = 11.7 Hz), 150.0, 152.0 (d, <i>J</i> = 248.1 Hz), 161.4 (dd, <i>J</i> = 249.2, 8.8 Hz), 166.4.</div></div><div id="sec4_16_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-methoxypolyethyleneglycoxy]ethyl]benzamide (<b>P11</b>) (Average MW = 2574 g/mol, <i>n</i> = 31–57)</h4><div class="NLM_p last">In a 5 mL flask were added 4-[4-[[5-(3,4-dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]benzoic acid (<b>7c</b>) (150 mg, 0.24 mmol), 2-[2-methoxypolyethyleneglycoxy]ethanamine (average MW = 2000 g/mol) (486 mg, 0.24 mmol), HOBt (32 mg, 0.24 mmol), DCC (49 mg, 0.24 mmol), and TEA (33 μL, 0.24 mmol). The reaction mixture was stirred overnight at room temperature. The reaction mixture was evaporated to dryness. The crude was purified by preparative chromatography to give the desired product as a yellow powder (263 mg, 42%). LC-MS: t<sub>R</sub> = 2.76 min. MS [M + H + H<sub>3</sub>O]<sup>2+</sup><i>m</i>/<i>z</i> = 1346.7 (<i>n</i> = 46). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.89 (s, 3H), 3.31 (s, 3H), 3.48 (s, 3H), 3.58 (m, 182H), 3.70 (s, 3H), 3.73 (s, 3H), 4.14 (s, 2H), 6.11–6.15 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.27 (d, <i>J</i> = 2.8 Hz, 1H), 6.54 (dd, <i>J</i> = 7.6, 2.4 Hz, 1H), 6.58–6.63 (m, 1H), 6.68 (d, <i>J</i> = 8.8 Hz, 1H), 6.93–7.00 (dd, <i>J</i> = 10.9, 8.5 Hz, 1H), 6.98 (s, 1H), 7.10 (d, <i>J</i> = 8.5 Hz, 2H), 7.14 (s, 1H), 7.58 (d, <i>J</i> = 8.6 Hz, 2H), 7.88 (d, <i>J</i> = 8.6 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 25.9, 39.9, 55.8, 55.9, 56.5, 58.6, 69.7, 70.3, 70.4, 70.5, 71.8, 100.1, 105.5, 109.5–110.0 (m), 113.0 (d, <i>J</i> = 3.0 Hz), 113.1 (t, <i>J</i> = 19.6 Hz), 113.1, 115.7 (d, <i>J</i> = 19.2 Hz), 119.8 (d, <i>J</i> = 7.3 Hz), 124.7, 126.8, 127.9, 131.1 (d, <i>J</i> = 3.5 Hz), 134.8, 137.9, 139.4, 140.8 (t, <i>J</i> = 2.3 Hz), 141.8 (t, <i>J</i> = 9.9 Hz), 142.8, 143.5, 147.6 (d, <i>J</i> = 11.7 Hz), 150.0, 152.0 (d, <i>J</i> = 248.1 Hz), 161.4 (dd, <i>J</i> = 248.2, 8.8 Hz), 166.4.</div></div><div id="sec4_16_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-methoxypolyethyleneglycoxy]ethyl]benzamide (<b>P12</b>) (Average MW = 5831 g/mol, <i>m</i> = 100–138)</h4><div class="NLM_p last">In a 5 mL flask were added <b>7c</b> (80 mg, 0.13 mmol), TEA (17 μL, 0.13 mmol), DCC (26 mg, 0.13 mmol), HOBt (17 mg, 0.13 mmol), and 2-[2-methoxy polyethyleneglycoxy]ethanamine (average MW = 5000 g/mol) (614 mg, 0.13 mmol) in 1 mL of DCM. The reaction mixture was stirred overnight at room temperature. The reaction mixture was evaporated and purified by preparative HPLC to give the titled product as a white powder (465 mg, 67%). LC-MS: t<sub>R</sub> = 2.65 min. MS [M + 3H + H<sub>3</sub>O]<sup>4+</sup><i>m</i>/<i>z</i> = 1377.5 (<i>n</i> = 110). <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.93 (s, 3H), 3.35 (s, 3H), 3.50–3.80 (m, 480H), 3.68 (s, 3H), 3.72 (s, 3H), 3.76 (s, 3H), 4.22 (brs, 2H), 6.17 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 6.30 (d, <i>J</i> = 2.8 Hz, 1H), 6.55 (brs, 1H), 6.71 (d, <i>J</i> = 8.8 Hz, 1H), 6.93 (brs, 1H), 7.00–7.27 (m, 4H), 7.60 (d, <i>J</i> = 8.3 Hz, 2H), 7.93 (d, <i>J</i> = 8.3 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 25.5, 34.3, 40.4, 56.5, 56.7, 56.9, 70.1, 70.8, 72.2, 100.6, 105.7, 110.3 (m), 113.4 (t, <i>J</i> = 9.3 Hz), 113.6, 116.3 (d, <i>J</i> = 19.5 Hz), 120.5 (d, <i>J</i> = 7.0 Hz), 125.2, 127.1, 128.3, 131.4 (d, <i>J</i> = 4.2 Hz), 135.2, 138.2, 139.9, 141.3, 142.2, 143.1, 143.9, 148.4 (d, <i>J</i> = 12.5 Hz), 150.3, 152.6 (d, <i>J</i> = 248.1 Hz), 161.7 (dd, <i>J</i> = 248.1, 8.9 Hz), 166.6.</div></div><div id="sec4_16_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethyl]benzamide (<b>13</b>, <i>n</i> = 5)</h4><div class="NLM_p">In a 10 mL flask were <b>7c</b> (58 mg, 0,091 mmol), Et<sub>3</sub>N (12.3 μL, 0,069 mmol), DIC (14.3 μL, 0,091 mmol), HOBt (12.3 mg, 0,091 mmol), and mPEG5-NH<sub>2</sub> (22.9 mg, 0,091 mmol) in 1 mL of DCM. The reaction mixture was stirred overnight at room temperature. The crude mixture was purified by preparative HPLC to give the titled product (18 mg, 22.5%) as a yellow oil.</div><div class="NLM_p last">LC–MS: t<sub>R</sub> = 3.34 min. MS: [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 869.5. <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.92 (s, 3H), 3.29 (s, 3H), 3.44–3.48 (m, 2H), 3.50 (s, 3H), 3.52–3.57 (m, 6H), 3.58–3.62 (m, 4H), 3.61–3.66 (m, 8H), 3.72 (s, 3H), 3.75 (s, 3H), 4.17 (s, 2H), 6.15 (dd, <i>J</i> = 8.6, 2.8 Hz, 1H), 6.29 (d, <i>J</i> = 2.7 Hz, 1H), 6.59 (dd, <i>J</i> = 7.7, 2.6 Hz, 1H), 6.59–6.66 (m, 1H), 6.71 (d, <i>J</i> = 8.7 Hz, 1H), 6.98 (dd, <i>J</i> = 11.0, 8.5 Hz, 1H), 7.00 (s, 1H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 7.61 (d, <i>J</i> = 8.6 Hz, 2H), 7.90 (d, <i>J</i> = 8.6 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.2, 40.3, 40.3, 56.3, 56.4, 56.9, 59.0, 70.2, 70.7, 70.7, 70.9, 72.2, 100.4, 105.8, 110.2, 113.2–113.6, 113.5, 116.1 (d, <i>J</i> = 19.5 Hz), 120.2 (d, <i>J</i> = 7.2 Hz), 125.1, 127.2, 128.3, 131.6 (d, <i>J</i> = 3.6 Hz), 135.2, 138.3, 139.8, 141.2, 142.2 (t, J = 10.1 Hz), 143.2, 144.0, 148.0 (d, <i>J</i> = 11.6 Hz), 150.4, 152.4 (d, <i>J</i> = 248 Hz), 161.8 (dd, <i>J</i> = 249, 8.5 Hz), 166.8.</div></div><div id="sec4_16_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]benzamide (<b>14</b>, <i>n</i> = 7)</h4><div class="NLM_p">In a 10 mL flask were <b>7c</b> (44 mg, 0,069 mmol), Et<sub>3</sub>N (9.3 μL, 0,069 mmol), DIC (10.8 μL, 0,069 mmol), HOBt (9.3 mg, 0,069 mmol), and mPEG7-NH<sub>2</sub> (23.5 mg, 0,069 mmol) in 1 mL of DCM. The reaction mixture was stirred overnight at room temperature. The crude mixture was purified by preparative HPLC to give the titled product (37 mg, 54%) as a yellow oil.</div><div class="NLM_p last">LC-MS: t<sub>R</sub> = 3.30 min. MS: [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 957.5 <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.92 (s, 3H), 3.32 (s, 3H), 3.47–3.51 (m, 2H), 3.50 (s, 3H), 3.55–3.58 (m, 14H), 3.59–3.62 (m, 4H), 3.62–3.68 (m, 8H), 3.72 (s, 3H), 3.75 (s, 3H), 4.17 (s, 2H), 6.14 (dd, <i>J</i> = 8.6, 2.7 Hz, 1H), 6.28 (d, <i>J</i> = 2.7 Hz, 1H), 6.58 (dd, <i>J</i> = 7.5, 2.5 Hz, 1H), 6.59–6.64 (m, 1H), 6.70 (d, <i>J</i> = 8.6 Hz, 1H), 6.97 (dd, <i>J</i> = 10.9, 8.4 Hz, 1H), 6.99 (s, 1H), 7.12 (d, <i>J</i> = 8.6 Hz, 2H), 7.59 (d, <i>J</i> = 8.6 Hz, 2H), 7.90 (d, <i>J</i> = 8.6 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.2, 40.3, 40.3, 56.2, 56.3, 56.9, 59.0, 70.2, 70.6, 70.7, 70.8, 72.2, 100.4, 105.8, 110.0–110.4 (m), 113.2–113.5 (m), 113.4, 116.1 (d, <i>J</i> = 19.6 Hz), 120.1 (d, <i>J</i> = 7.4 Hz), 125.1, 127.2, 128.3, 131.6 (d, <i>J</i> = 3.6 Hz), 135.2, 138.3, 139.8, 141.2 (m), 142.1 (t, J = 10.2 Hz), 143.1, 143.9, 148.0 (d, <i>J</i> = 11.6 Hz), 150.3, 152.3 (d, <i>J</i> = 248 Hz), 161.8 (dd, <i>J</i> = 249, 8.8 Hz), 166.8.</div></div><div id="sec4_16_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]benzamide (<b>15</b>, <i>n</i> = 9)</h4><div class="NLM_p last">In a 10 mL flask were added <b>7c</b> (100 mg, 0,16 mmol), NEt<sub>3</sub> (21,23 μL, 0,16 mmol), DCC (32,46 mg, 0,16 mmol), HOBt (21,26 mg, 0,16 mmol), and mPEG9-NH<sub>2</sub> (74,19 mg, 0,16 mmol) in 1 mL of DCM. The reaction mixture was stirred 18 h at room temperature and concentrated.The crude mixture was purified by preparative HPLC to give the titled product (70 mg, 41.5%) as a yellow oil. LC-MS: t<sub>R</sub> = 2.85 min. MS: [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 1045.7. <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.90 (s, 3H), 3.31 (s, 3H), 3.46–3.50 (m, 2H), 3.49 (s, 3H), 3.54–3.58 (m, 22H), 3.58–3.60 (m, 4H), 3.61–3.66 (m, 8H), 3.71 (s, 3H), 3.73 (s, 3H), 4.16 (s, 2H), 6.14 (dd, <i>J</i> = 8.6, 2.7 Hz, 1H), 6.28 (d, <i>J</i> = 2.7 Hz, 1H), 6.58 (dd, J = 7.5, 2.5 Hz, 1H), 6.59–6.64 (m, 1H), 6.70 (d, <i>J</i> = 8.6 Hz, 1H), 6.97 (dd, <i>J</i> = 10.9, 8.4 Hz, 1H), 6.99 (s, 1H), 7.12 (d, <i>J</i> = 8.6 Hz, 2H), 7.59 (d, <i>J</i> = 8.6 Hz, 2H), 7.90 (d, <i>J</i> = 8.6 Hz, 2H).<sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.3, 40.3, 56.3, 56.3, 56.9, 59.0, 70.2, 70.7, 70.8, 70.9, 72.3, 100.5, 105.9, 110.2 (m, CH), 113.4 (dd, <i>J</i> = 9.3, 9.2 Hz), 113.5, 116.1 (d, <i>J</i> = 19.4 Hz), 120.1 (d, <i>J</i> = 7.0 Hz, CH), 125.1, 127.2, 128.3, 131.6 (d, <i>J</i> = 3.6 Hz), 135.2, 138.3, 139.8, 141.2 (m), 142.2 (t, <i>J</i> = 9.9 Hz), 143.2, 143.9, 148.0 (d, <i>J</i> = 11.3 Hz), 150.4, 152.3 (d, <i>J</i> = 248 Hz), 161.7 (dd, <i>J</i> = 248, 8.5 Hz), 166.8.</div></div><div id="sec4_16_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]benzamide) (<b>16</b>, <i>n</i> = 11)</h4><div class="NLM_p last">In a 10 mL flask were added <b>7c</b> (116 mg, 0,18 mmol), Et<sub>3</sub>N (24.6 μL, 0,18 mmol), DIC (28.6 μL, 0,18 mmol), HOBt (24.7 mg, 0,18 mmol), and mPEG11-NH<sub>2</sub> (94.1 mg, 0,18 mmol) in 1 mL of DCM. The reaction mixture was stirred 18 h at room temperature. The crude mixture was purified by preparative HPLC to give the titled product (79 mg, 38%) as a yellow oil. LC-MS: t<sub>R</sub> = 3.25 min. MS: [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 1133.7. <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.91 (s, 3H), 3.32 (s, 3H), 3.47–3.52 (m, 2H), 3.50 (s, 3H), 3.55–3.61 (m, 34H), 3.61–3.68 (m, 8H), 3.71 (s, 3H), 3.74 (s, 3H), 4.17 (s, 2H), 6.15 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.30 (d, <i>J</i> = 2.8 Hz, 1H), 6.59 (dd, <i>J</i> = 7.7, 2.6 Hz, 1H), 6.61–6.66 (m, 1H), 6.71 (d, <i>J</i> = 8.7 Hz, 1H), 6.98 (dd, <i>J</i> = 11.0, 8.4 Hz, 1H), 7.00 (s, 1H), 7.13 (d, <i>J</i> = 8.7 Hz, 2H), 7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.91 (d, <i>J</i> = 8.4 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.2, 40.2, 40.3, 56.2, 56.3, 56.8, 58.9, 70.1, 70.7, 70.8, 70.9, 72.2, 100.4, 105.8, 110.0–110.3 (m), 113.0–113.5 (m), 116.1 (d, <i>J</i> = 19.7 Hz), 120.1 (d, <i>J</i> = 7.3 Hz), 125.1, 127.2, 128.3, 131.5 (d, <i>J</i> = 3.7 Hz), 135.1, 138.2, 139.8, 141.1 (m), 142.1 (t, <i>J</i> = 9.8 Hz), 143.1, 143.9, 148.0 (d, <i>J</i> = 12.8 Hz), 150.3, 152.3 (d, <i>J</i> = 248 Hz), 161.8 (dd, <i>J</i> = 249, 8.7 Hz), 166.8.</div></div><div id="sec4_16_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]benzamide) (<b>17</b>, <i>n</i> = 16)</h4><div class="NLM_p last">In a 10 mL flask were added <b>7c</b> (85.5 mg, 0,135 mmol), Et<sub>3</sub>N (33.0 μL, 0,245 mmol), DIC (20.8 μL, 0,135 mmol), HOBt (18.2 mg, 0,135 mmol), and mPEG16-NH<sub>2</sub> (90.0 mg, 0,122 mmol) in 3 mL of DCM. The reaction mixture was stirred 18 h at room temperature. The crude mixture was purified by preparative HPLC to give the titled product (29.3 mg, 17.5%) as a yellow oil. LC-MS: t<sub>R</sub> = 2.83 min. MS: [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 1353.9. <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.94 (s, 3H), 3.36 (s, 3H), 3.50–3.55 (m, 5H), 3.57–3.54 (m, 54H), 3.65–3.70 (m, 8H), 3.75 (s, 3H), 3.77 (s, 3H), 4.20 (s, 2H), 6.18 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.32 (d, <i>J</i> = 2.8 Hz, 1H), 6.58–6.69 (m, <i>2</i>H), 6.74 (d, <i>J</i> = 8.7 Hz, 1H), 6.69–7.05 (m, 2H), 7.09–7.20 (m, 3H), 7.63 (d, <i>J</i> = 8.5 Hz, 2H), 7.93 (d, <i>J</i> = 8.5 Hz, 2H). <sup>13</sup>C NMR (75 MHz,CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.6, 40.7, 40.7, 56.6, 56.7, 57.3, 59.3, 70.6, 71.0, 71.1, 71.2, 72.6, 100.8, 106.2, 110.4–110.7 (m), 113.7–113.8 (m), 113.9, 116.5 (d, <i>J</i> = 19.6 Hz), 120.5 (d, <i>J</i> = 7.3 Hz), 125.5, 127.5, 128.7, 131.9 (d, <i>J</i> = 3.6 Hz), 135.6, 138.7, 140.2, 141.2 (m), 142.5 (t, <i>J</i> = 10.2 Hz), 143.5, 144.3, 148.4 (d, <i>J</i> = 11.6 Hz), 150.8, 152.7 (d, <i>J</i> = 248.2 Hz), 162.1 (dd, <i>J</i> = 249, 8.9 Hz), 167.2.</div></div><div id="sec4_16_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]benzamide) (<b>18</b>, <i>n</i> = 24)</h4><div class="NLM_p">In a 10 mL flask were added 4-[4-[[5-(3,4-dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]benzoic acid <b>7c</b> (57.8 mg, 0,091 mmol), Et<sub>3</sub>N (22.3 μL, 0,165 mmol), DIC (14.2 μL, 0,091 mmol), HOBt (12.3 mg, 0,091 mmol), and mPEG24-NH<sub>2</sub> (90.0 mg, 0,827 mmol) in 1 mL of DCM. The reaction mixture was stirred 18 h at room temperature. The crude mixture was purified by preparative HPLC to give the titled product (73.2 mg, 51%) as yellowish powder. LC-MS: t<sub>R</sub> = 2.78 min, MS: [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 1706.1.</div><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.94 (s, 3H), 3.36 (s, 3H), 3.51–3.54 (m, 5H), 3.58–3.65 (m, 86H), 3.66–3.69 (m, 8H), 3.74 (s, 3H), 3.77(s, 3H), 4.20 (s, 2H), 6.18 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.32 (d, <i>J</i> = 2.8 Hz, 1H), 6.58–6.68 (m, <i>2</i>H), 6.74 (d, <i>J</i> = 8.7 Hz, 1H), 6.96–7.05 (m, 2H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 7.63 (d, <i>J</i> = 8.5 Hz, 2H), 7.93 (d, <i>J</i> = 8.5 Hz, 2H).</div><div class="NLM_p last"><sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.6, 40.6, 40.7, 56.6, 56.7, 57.3, 59.4, 70.6, 71.0, 71.1, 71.3, 72.6, 100.8, 106.2, 110.4–110.8 (m), 113.7–113.9 (m), 113.8, 116.5 (d, <i>J</i> = 19.6 Hz), 120.5 (d, <i>J</i> = 7.2 Hz), 125.5, 127.5, 128.7, 132.0 (d, <i>J</i> = 3.6 Hz), 135.6, 138.7, 140.2, 141.2 (m), 142.6 (t, J = 9.8 Hz), 143.5, 144.3, 148.4 (d, <i>J</i> = 11.6 Hz), 150.8, 152.7 (d, <i>J</i> = 248.2 Hz), 162.2 (dd, <i>J</i> = 248.8, 9.0 Hz), 167.3.</div></div><div id="sec4_16_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (4-[4-[[5-(3,4-Dimethoxy-<i>N</i>-methylanilino)-1-(4-fluoro-3-methoxyphenyl)imidazol-2-yl]sulfanylmethyl]-3,5-difluorophenyl]-<i>N</i>-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]benzamide) (<b>19</b>, <i>n</i> = 36)</h4><div class="NLM_p last">In a 10 mL flask were added <b>7c</b> (38.9 mg, 0,0612 mmol), Et<sub>3</sub>N (15.0 μL, 0,111 mmol), DIC (9.49 μL, 0,0612 mmol), HOBt (8.27 mg, 0,0612 mmol), and mPEG36-NH2 (90.0 mg, 0,0557 mmol) in 1 mL of DCM. The reaction mixture was stirred 18 h at room temperature. The crude mixture was purified by preparative HPLC to give the titled product as a white powder (73.5 mg, 58%). LC-MS: t<sub>R</sub> = 2.75 min, MS: [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> = 1226.8. <sup>1</sup>H NMR (300 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 2.94 (s, 3H), 3.36 (s, 3H), 3.50–3.54 (m, 5H), 3.58–3.64 (m, 134H), 3.65–3.69 (m, 8H), 3.74 (s, 3H), 3.77(s, 3H), 4.20 (s, 2H), 6.17 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 6.31 (d, <i>J</i> = 2.8 Hz, 1H), 6.58–6.68 (m, <i>2</i>H), 6.73 (d, <i>J</i> = 8.6 Hz, 1H), 6.96–7.05 (m, 2H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 7.63 (d, <i>J</i> = 8.5 Hz, 2H), 7.92 (d, <i>J</i> = 8.5 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ (ppm) 26.6, 40.6, 40.7, 56.6, 56.7, 57.3, 59.4, 70.6, 71.0, 71.1, 71.3, 72.6, 100.8, 106.2, 110.4–110.8 (m), 113.7–113.9 (m), 113.8, 116.5 (d, <i>J</i> = 19.6 Hz), 120.5 (d, <i>J</i> = 7.2 Hz), 125.5, 127.5, 128.7, 132.0 (d, <i>J</i> = 3.6 Hz), 135.6, 138.7, 140.2, 141.6 (m), 142.6 (t, <i>J</i> = 9.8 Hz), 143.5, 144.3, 148.4 (d, <i>J</i> = 11.4 Hz), 150.7, 152.7 (d, <i>J</i> = 248.3 Hz), 162.2 (dd, <i>J</i> = 248.8, 9.1 Hz), 167.2.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01774" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01774?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01774</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01774/suppl_file/jm0c01774_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01774/suppl_file/jm0c01774_si_001.csv">jm0c01774_si_001.csv (1.11 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01774" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoit Deprez</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, EGID, F-59000 Lille, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1e7c7b7071776a307a7b6e6c7b645e6b70776833727772727b30786c"><span class="__cf_email__" data-cfemail="d9bbbcb7b6b0adf7bdbca9abbca399acb7b0aff4b5b0b5b5bcf7bfab">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Charton</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, EGID, F-59000 Lille, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6895-276X" title="Orcid link">http://orcid.org/0000-0001-6895-276X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#80eaf5ece9e5aee3e8e1f2f4efeec0f5eee9f6adece9ecece5aee6f2"><span class="__cf_email__" data-cfemail="315b445d58541f52595043455e5f71445f58471c5d585d5d541f5743">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanessa Hoguet</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuel Lasalle</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathieu Maingot</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geoffroy Dequirez</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajaa Boulahjar</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Leroux</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Piveteau</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrien Herledan</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre Biela</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Dumont</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oscar Chávez-Talavera</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loïc Belloy</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Duplan</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathalie Hennuyer</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Butruille</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophie Lestavel</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emmanuel Sevin</span> - <span class="hlFld-Affiliation affiliation">Univ.
Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maxime Culot</span> - <span class="hlFld-Affiliation affiliation">Univ.
Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7452-0867" title="Orcid link">http://orcid.org/0000-0001-7452-0867</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabien Gosselet</span> - <span class="hlFld-Affiliation affiliation">Univ.
Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bart Staels</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Tailleux</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.C. and A.T. contributed equally to this work.</p><span class="author-information-subsection-header">Author Contributions</span><p>M.L. and V.H. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the institutions that supported our laboratory: INSERM, Université de Lille, Institut Pasteur de Lille. This project was supported by Conseil Régional Nord-Pas de Calais, ERDF (convention no. 11003609), Etat DRRT, European Genomic Institute for Diabetes (EGID, ANR-10-LABX-46), the European Research Council (ERC Grant Immunobile, contract 694717), European Commission, INSERM, Université Lille 2 (Appel à projets “orientations stratégiques”: convention no. A007), and SATT Nord (M0075/SATTNORD), ANR (BABrain, convention n°ANR-17-CE14-0007-03), CPER CTRL17 FEDER TIIMaging. M.L. and V.H. are recipients of a doctoral fellowship of the French Ministère de la Recherche. NMR acquisitions were done at the Laboratoire d’Application de Résonance Magnétique Nucléaire (LARMN), Lille, France. B.S. is honorary member of the Institut Universitaire de France.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BLECs</td><td class="NLM_def"><p class="first last">brain-like endothelial cells</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">equiv.</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">GI</td><td class="NLM_def"><p class="first last">gastrointestinal</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like peptide-1</p></td></tr><tr><td class="NLM_term">GP-BAR1</td><td class="NLM_def"><p class="first last">G protein-coupled bile acid receptor 1</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TCDI</td><td class="NLM_def"><p class="first last">1,1-thiocarbonyldiimidazole</p></td></tr><tr><td class="NLM_term">TGR5</td><td class="NLM_def"><p class="first last">Takeda G protein-coupled receptor 5</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">1-propylphosphonic acid cyclic anhydride</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chess, R. B.</span></span> <span> </span><span class="NLM_article-title">Effect of pegylation on pharmaceuticals</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1038/nrd1033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1038%2Fnrd1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=12612647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=214-221&author=J.+M.+Harrisauthor=R.+B.+Chess&title=Effect+of+pegylation+on+pharmaceuticals&doi=10.1038%2Fnrd1033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of PEGylation on pharmaceuticals</span></div><div class="casAuthors">Harris, J. Milton; Chess, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein and peptide drugs hold great promise as therapeutic agents.  However, many are degraded by proteolytic enzymes, can be rapidly cleared by the kidneys, generate neutralizing antibodies and have a short circulating half-life.  PEGylation, the process by which polyethylene glycol chains are attached to protein and peptide drugs, can overcome these and other shortcomings.  By increasing the mol. mass of proteins and peptides and shielding them from proteolytic enzymes, PEGylation improves pharmacokinetics.  This article will review how PEGylation can result in drugs that are often more effective and safer, and which show improved patient convenience and compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLhPAuz8WjMLVg90H21EOLACvtfcHk0li54YhDYhTpZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D&md5=d6bb387e746740b10e088e1f55af37db</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1033%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26aulast%3DChess%26aufirst%3DR.%2BB.%26atitle%3DEffect%2520of%2520pegylation%2520on%2520pharmaceuticals%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D214%26epage%3D221%26doi%3D10.1038%2Fnrd1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasut, G.</span></span> <span> </span><span class="NLM_article-title">PEGylation, successful approach to drug delivery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(05)03575-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS1359-6446%2805%2903575-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=16243265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFers7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1451-1458&author=F.+M.+Veroneseauthor=G.+Pasut&title=PEGylation%2C+successful+approach+to+drug+delivery&doi=10.1016%2FS1359-6446%2805%2903575-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylation, successful approach to drug delivery</span></div><div class="casAuthors">Veronese, Francesco M.; Pasut, Gianfranco</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1451-1458</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  An overview of PEGylation, from its basic strategies of conjugation to the recent achievements and therapeutic applications.  PEGylation defines the modification of a protein, peptide or non-peptide mol. by the linking of one or more polyethylene glycol (PEG) chains.  This polymer is non-toxic, non-immunogenic, non-antigenic, highly sol. in water and FDA approved.  The PEG-drug conjugates have several advantages: a prolonged residence in body, a decreased degrdn. by metabolic enzymes and a redn. or elimination of protein immunogenicity.  Thanks to these favorable properties, PEGylation now plays an important role in drug delivery, enhancing the potentials of peptides and proteins as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWWjTRxbLaJ7Vg90H21EOLACvtfcHk0li54YhDYhTpZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFers7rF&md5=710be729f6e92d2169b4424f76e1c55e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903575-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903575-0%26sid%3Dliteratum%253Aachs%26aulast%3DVeronese%26aufirst%3DF.%2BM.%26aulast%3DPasut%26aufirst%3DG.%26atitle%3DPEGylation%252C%2520successful%2520approach%2520to%2520drug%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1451%26epage%3D1458%26doi%3D10.1016%2FS1359-6446%2805%2903575-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLuca, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span> <span> </span><span class="NLM_article-title">Emerging PEGylated drugs</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1517/14728210902907847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1517%2F14728210902907847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=19453284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Siu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=363-380&author=J.+S.+Kangauthor=P.+P.+DeLucaauthor=K.+C.+Lee&title=Emerging+PEGylated+drugs&doi=10.1517%2F14728210902907847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging PEGylated drugs</span></div><div class="casAuthors">Kang, Jung Seok; De Luca, Patrick P.; Lee, Kang Choon</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-380</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  PEGylation is a pharmaceutical technol. that involves the covalent attachment of polyethylene glycol (PEG) to a drug to improve its pharmacokinetic, pharmacodynamic, and immunol. profiles, and thus, enhance its therapeutic effect.  Currently, PEGylation is used to modify proteins, peptides, oligonucleotides, antibody fragments, and small org. mols.  Research groups are striving to improve the consistencies of PEGylated drugs and to PEGylate commercialized proteins and small org. mols.  Furthermore, the PEGylations of novel medications, like oligonucleotides and antibody fragments, are being pursued to improve their bioavailabilities.  This active research in the PEGylation field and the continued growth of the biopharmaceutical market predicts that PEGylated drugs have a bright future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFgW3aHbmjMrVg90H21EOLACvtfcHk0liJfMe1AI8f9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Siu7c%253D&md5=2e7546517bbc9f2c5c48cefdfbc5c999</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728210902907847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210902907847%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%2BS.%26aulast%3DDeLuca%26aufirst%3DP.%2BP.%26aulast%3DLee%26aufirst%3DK.%2BC.%26atitle%3DEmerging%2520PEGylated%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2009%26volume%3D14%26spage%3D363%26epage%3D380%26doi%3D10.1517%2F14728210902907847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogenboom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, U. S.</span></span> <span> </span><span class="NLM_article-title">Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6288</span>– <span class="NLM_lpage">6308</span>, <span class="refDoi"> DOI: 10.1002/anie.200902672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1002%2Fanie.200902672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=20648499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOqtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6288-6308&author=K.+Knopauthor=R.+Hoogenboomauthor=D.+Fischerauthor=U.+S.+Schubert&title=Poly%28ethylene+glycol%29+in+drug+delivery%3A+pros+and+cons+as+well+as+potential+alternatives&doi=10.1002%2Fanie.200902672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives</span></div><div class="casAuthors">Knop, Katrin; Hoogenboom, Richard; Fischer, Dagmar; Schubert, Ulrich S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">6288-6308</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Poly(ethylene glycol) (PEG) is the most used polymer and also the gold std. for stealth polymers in the emerging field of polymer-based drug delivery.  The properties that account for the overwhelming use of PEG in biomedical applications are outlined in this Review.  The first approved PEGylated products have already been on the market for 20 years.  A vast amt. of clin. experience has since been gained with this polymer-not only benefits, but possible side effects and complications have also been found.  The areas that might need consideration and more intensive and careful examn. can be divided into the following categories: hypersensitivity, unexpected changes in pharmacokinetic behavior, toxic side products, and an antagonism arising from the easy degrdn. of the polymer under mech. stress as a result of its ether structure and its non-biodegradability, as well as the resulting possible accumulation in the body.  These possible side effects will be discussed in this Review and alternative polymers will be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHbYINW5v_3rVg90H21EOLACvtfcHk0liJfMe1AI8f9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOqtLbN&md5=02ff87df9c11cf218d3799ecd259d2a0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fanie.200902672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200902672%26sid%3Dliteratum%253Aachs%26aulast%3DKnop%26aufirst%3DK.%26aulast%3DHoogenboom%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DSchubert%26aufirst%3DU.%2BS.%26atitle%3DPoly%2528ethylene%2520glycol%2529%2520in%2520drug%2520delivery%253A%2520pros%2520and%2520cons%2520as%2520well%2520as%2520potential%2520alternatives%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6288%26epage%3D6308%26doi%3D10.1002%2Fanie.200902672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, C.-Y.</span></span> <span> </span><span class="NLM_article-title">PEG-modified biopharmaceuticals</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1517/17425240802650568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1517%2F17425240802650568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=19236204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1-16&author=P.+Bailonauthor=C.-Y.+Won&title=PEG-modified+biopharmaceuticals&doi=10.1517%2F17425240802650568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PEG-modified biopharmaceuticals</span></div><div class="casAuthors">Bailon, Pascal; Won, Chee-Youb</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  PEGylation is a process in which one or more units of chem. activated polyethylene glycol reacts with a biomol., usually a protein, peptide, small mol. or oligonucleotide, creating a putative new mol. entity possessing physicochem. and physiol. characteristics that are distinct from its predecessor mols.  In recent years, PEGylation has been used not only as a drug delivery technol. but used also as a drug modification technol. to transform existing biopharmaceuticals clin. more efficacious than before their PEGylation.  PEGylation bestows several useful properties upon the native mol., resulting in improved pharmacokinetic and pharmacodynamic properties, which in turn enable the native mol. to achieve max. clin. potency.  In addn., PEGylation results in sustained clin. response with minimal dose and less frequency of dosing, leading to improved quality of life via increased patient compliance and reduced cost.  During the course of development of various pegylated protein therapeutics, several new insights have been gained.  This review article focuses on the approaches, strategies and the utilization of modern PEGylation concepts in the design and development of well-characterized pegylated protein therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf5II9oQ0hJLVg90H21EOLACvtfcHk0lgkfO27KalBiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVahsw%253D%253D&md5=acb7ff4e9a7e77a6135f47be428a46bf</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F17425240802650568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425240802650568%26sid%3Dliteratum%253Aachs%26aulast%3DBailon%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DC.-Y.%26atitle%3DPEG-modified%2520biopharmaceuticals%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2009%26volume%3D6%26spage%3D1%26epage%3D16%26doi%3D10.1517%2F17425240802650568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swierczewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span> <span> </span><span class="NLM_article-title">What is the future of PEGylated therapies?</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1517/14728214.2015.1113254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1517%2F14728214.2015.1113254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26583759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=531-536&author=M.+Swierczewskaauthor=K.+C.+Leeauthor=S.+Lee&title=What+is+the+future+of+PEGylated+therapies%3F&doi=10.1517%2F14728214.2015.1113254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">What is the future of PEGylated therapies?</span></div><div class="casAuthors">Swierczewska, Magdalena; Lee, Kang Choon; Lee, Seulki</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The tremendous potential of biol. drugs is hampered by short half-lives in vivo, resulting in significantly lower potency than activity seen in vitro.  These short-acting therapeutic agents require frequent dosing profiles that can reduce applicability to the clinic, particularly for chronic conditions.  Therefore, half-life extension technologies are entering the clinic to enable improved or new biol. therapies.  PEGylation is the first successful technol. to improve pharmacokinetic (PK) profiles of therapeutic agents and has been applied in the clinic for over 25 years.  Over 10 PEGylated therapeutics have entered the clinic since the early 1990s, and new PEGylated agents continue to expand clin. pipelines and drug patent life.  PEGylation is the most established half-life extension technol. in the clinic with proven safety in humans for over two decades.  Still, it is one of the most evolving and emerging technologies that will be applied for the next two decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaLx1Mvr3WGbVg90H21EOLACvtfcHk0lgkfO27KalBiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtbfJ&md5=67d3331c606da4f788861c91f6aa2439</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14728214.2015.1113254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2015.1113254%26sid%3Dliteratum%253Aachs%26aulast%3DSwierczewska%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DWhat%2520is%2520the%2520future%2520of%2520PEGylated%2520therapies%253F%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2015%26volume%3D20%26spage%3D531%26epage%3D536%26doi%3D10.1517%2F14728214.2015.1113254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turecek, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivens, I. A.</span></span> <span> </span><span class="NLM_article-title">PEGylation of biopharmaceuticals: A review of chemistry and nonclinical safety information of approved drugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2015.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.xphs.2015.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26869412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFegu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=460-475&author=P.+L.+Turecekauthor=M.+J.+Bossardauthor=F.+Schoetensauthor=I.+A.+Ivens&title=PEGylation+of+biopharmaceuticals%3A+A+review+of+chemistry+and+nonclinical+safety+information+of+approved+drugs&doi=10.1016%2Fj.xphs.2015.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs</span></div><div class="casAuthors">Turecek, Peter L.; Bossard, Mary J.; Schoetens, Freddy; Ivens, Inge A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">460-475</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Modification of biopharmaceutical mols. by covalent conjugation of polyethylene glycol (PEG) mols. is known to enhance pharmacol. and pharmaceutical properties of proteins and other large mols. and has been used successfully in 12 approved drugs.  Both linear and branched-chain PEG reagents with mol. sizes of up to 40 kDa have been used with a variety of different PEG derivs. with different linker chemistries.  This review describes the properties of PEG itself, the history and evolution of PEGylation chem., and provides examples of PEGylated drugs with an established medical history.  A trend toward the use of complex PEG architectures and larger PEG polymers, but with very pure and well-characterized PEG reagents is described.  Nonclin. toxicol. findings related to PEG in approved PEGylated biopharmaceuticals are summarized.  The effect attributed to the PEG part of the mols. as obsd. in 5 of the 12 marketed products was cellular vacuolation seen microscopically mainly in phagocytic cells which is likely related to their biol. function to absorb and remove particles and macromols. from blood and tissues.  Experience with marketed PEGylated products indicates that adverse effects in toxicol. studies are usually related to the active part of the drug but not to the PEG moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwuuECcM7dMLVg90H21EOLACvtfcHk0lgkfO27KalBiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFegu7fK&md5=c1aa0cf83b58d8707c9c79b9825f737d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2015.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2015.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DTurecek%26aufirst%3DP.%2BL.%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DIvens%26aufirst%3DI.%2BA.%26atitle%3DPEGylation%2520of%2520biopharmaceuticals%253A%2520A%2520review%2520of%2520chemistry%2520and%2520nonclinical%2520safety%2520information%2520of%2520approved%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26spage%3D460%26epage%3D475%26doi%3D10.1016%2Fj.xphs.2015.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Current drug research on PEGylation with small molecular agents</span>. <i>Prog. Polym. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/j.progpolymsci.2012.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.progpolymsci.2012.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=421-444&author=W.+Liauthor=P.+Zhanauthor=E.+De+Clercqauthor=H.+Louauthor=X.+Liu&title=Current+drug+research+on+PEGylation+with+small+molecular+agents&doi=10.1016%2Fj.progpolymsci.2012.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current drug research on PEGylation with small molecular agents</span></div><div class="casAuthors">Li, Wenjun; Zhan, Peng; De Clercq, Erik; Lou, Hongxiang; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Polymer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">421-444</span>CODEN:
                <span class="NLM_cas:coden">PRPSB8</span>;
        ISSN:<span class="NLM_cas:issn">0079-6700</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  PEGylation, covalent attaching polyethylene glycol (PEG) polymers to therapeutic agents, is one of the most promising techniques to improve the therapeutic effect of drugs.  Initially, this technol. is mainly applied with macromol. drugs, such as proteins, enzymes, with ten PEGylated biomacromols. approved by the FDA for the treatment of related diseases.  The clin. successful use of PEGylated macromol. drug has promoted the application of this technol. with small mols. drugs to overcome shortcomings assocd. with therapy, such as possible low soly., high toxicity, undesirable pharmaceutical characteristics and nonspecific biodistribution profiles.  So far, 4 PEGylated small drugs were taken into clin. trials.  This review mainly focuses on the recent advances of PEGylated small mols., including their general configuration, and the current merits and limits of PEG modification.  Herein PEG delivery systems are distinguished by therapeutic application (anti-tumor, anti-inflammatory, etc.) and their corresponding PEGylated small mols. are described in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1c3uJ8cWgm7Vg90H21EOLACvtfcHk0lidGRR9fAI1Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE&md5=eb609a4d59ce7e8cc5cf443ce8def9b4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.progpolymsci.2012.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.progpolymsci.2012.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DCurrent%2520drug%2520research%2520on%2520PEGylation%2520with%2520small%2520molecular%2520agents%26jtitle%3DProg.%2520Polym.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D421%26epage%3D444%26doi%3D10.1016%2Fj.progpolymsci.2012.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, D. H.</span></span> <span> </span><span class="NLM_article-title">Emerging PEGylated non-biologic drugs</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1080/14728214.2019.1604684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1080%2F14728214.2019.1604684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=30957581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFymsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=107-119&author=E.+J.+Parkauthor=J.+Choiauthor=K.+C.+Leeauthor=D.+H.+Na&title=Emerging+PEGylated+non-biologic+drugs&doi=10.1080%2F14728214.2019.1604684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging PEGylated non-biologic drugs</span></div><div class="casAuthors">Park, Eun Ji; Choi, Jiyoung; Lee, Kang Choon; Na, Dong Hee</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-119</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  PEGylation is a well-established technol. for improving the therapeutic value of drugs by attaching polyethylene glycol (PEG).  The first PEGylated enzyme products appeared on the market in the early 1990s; currently, more than 18 PEGylated products have been approved by Food and Drug Administration, which encompass various classes of drug mols., such as enzymes, interferons, granulocyte colony-stimulating factors, hormones, antibody fragments, coagulation factors, oligonucleotide aptamers, synthetic peptides, and small org. mols.  While PEGylated products mainly comprise biol. drugs, such as recombinant proteins and enzymes, non-biol. drugs have recently emerged as a target for PEGylation.  This review focuses on the recent development of PEGylated non-biol. drugs, such as small org. mols., synthetic peptides, and aptamers.  Several PEGylated versions of anti-cancer drugs, opioid agonists, glucagon-like peptide-1 receptor agonists, and oligonucleotide aptamers are in active development stage, and it is likely that they will have a dramatic impact on the market.  Although some safety concerns about PEG in clin. trials have been recently issued, PEGylation is still a com. attractive proposition as a half-life extension technol. for long-acting drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz1IR_nY7BprVg90H21EOLACvtfcHk0lidGRR9fAI1Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFymsbw%253D&md5=497649fb4495b387f97b761bee0cedb3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F14728214.2019.1604684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728214.2019.1604684%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DNa%26aufirst%3DD.%2BH.%26atitle%3DEmerging%2520PEGylated%2520non-biologic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2019%26volume%3D24%26spage%3D107%26epage%3D119%26doi%3D10.1080%2F14728214.2019.1604684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilyuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, C. F.,  III</span></span> <span> </span><span class="NLM_article-title">Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1021/ml400370w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400370w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=133-137&author=S.+Asanoauthor=J.+Gavrilyukauthor=D.+R.+Burtonauthor=C.+F.+Barbas&title=Preparation+and+activities+of+macromolecule+conjugates+of+the+CCR5+antagonist+Maraviroc&doi=10.1021%2Fml400370w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc</span></div><div class="casAuthors">Asano, Shigehiro; Gavrilyuk, Julia; Burton, Dennis R.; Barbas, Carlos F., III</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-137</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CCR5 antagonists are among the most advanced approaches in HIV therapy and may also be relevant to treatment of graft-vs.-host disease and Staphylococcus aureus infection.  To expand the potential of the only approved CCR5 antagonist, Maraviroc, we studied derivs. that would enable functional linkage of Maraviroc to long-lived carriers.  Through targeted synthesis, we discovered an effective linkage site on Maraviroc and demonstrate the potential of these derivs. to prep. potent chem. programmed antibodies and PEGylated derivs.  The resulting compds. effectively neutralized a variety of HIV-1 isolates.  Both chem. programmed antibody and PEGylation approaches extend the neutralization activity of serum circulating Maraviroc.  Derivation of a successful conjugation strategy for Maraviroc should further enable its use in chem. programmed vaccines, novel bispecific antibodies, and topical microbicides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3dDcVML2YWbVg90H21EOLACvtfcHk0ljN3gCLaXtI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P&md5=ea7c9d3c1c6161e1115a9a67de4bcce3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml400370w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400370w%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DGavrilyuk%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DPreparation%2520and%2520activities%2520of%2520macromolecule%2520conjugates%2520of%2520the%2520CCR5%2520antagonist%2520Maraviroc%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D133%26epage%3D137%26doi%3D10.1021%2Fml400370w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirtzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katre, N. V.</span></span> <span> </span><span class="NLM_article-title">Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">15064</span>– <span class="NLM_lpage">15070</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)68146-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS0021-9258%2818%2968146-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=3049599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADyaL1cXlvFOjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=15064-15070&author=M.+J.+Knaufauthor=D.+P.+Bellauthor=P.+Hirtzerauthor=Z.+P.+Luoauthor=J.+D.+Youngauthor=N.+V.+Katre&title=Relationship+of+effective+molecular+size+to+systemic+clearance+in+rats+of+recombinant+interleukin-2+chemically+modified+with+water-soluble+polymers&doi=10.1016%2FS0021-9258%2818%2968146-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers</span></div><div class="casAuthors">Knauf, Michael J.; Bell, Dick P.; Hirtzer, Pam; Luo, Zhen Ping; Young, John D.; Katre, Nandini V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">15064-70</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The effects of a variety of chem. modification of recombinant human interleukin-2 (rIL-2) on its pharmacokinetic behavior in rats were examd.  Unmodified rIL-2 is cleared from plasma with half-lives of 3 and 44 min for the α and β phases.  Modification of rIL-2 with monomethoxy polyethylene glycol or polyoxyethylated glycerol increased the half-lives as much as 20-fold, although the vol. of distribution remained unchanged at 88 mL/kg.  The clearance rates correlated with the effective mol. size of the modified protein detd. by size exclusion chromatog.  Clearance decreased rapidly as the effective mol. size increased from 19.5 to 70 kDa, whereas above 70 kDa the clearance decreased more slowly.  This abrupt change at 70 kDa may be related to the permeability threshold of the kidney glomerular membrane which retains proteins larger than albumin in the plasma.  Using the relationship between clearance and effective mol. size, the clearance rates of mixts. of modified rIL-2 could be predicted based on their av. effective mol. size.  Since the effectiveness of rIL-2 therapy is likely to be related to its pharmacokinetic behavior, the ability to design a mol. with a predictable time course in plasma provides a means to study this relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtM7K-zEKBLVg90H21EOLACvtfcHk0ljN3gCLaXtI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlvFOjtbo%253D&md5=e04f80283ef305c90a097629afb5fe9c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2968146-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252968146-3%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DM.%2BJ.%26aulast%3DBell%26aufirst%3DD.%2BP.%26aulast%3DHirtzer%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DZ.%2BP.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DKatre%26aufirst%3DN.%2BV.%26atitle%3DRelationship%2520of%2520effective%2520molecular%2520size%2520to%2520systemic%2520clearance%2520in%2520rats%2520of%2520recombinant%2520interleukin-2%2520chemically%2520modified%2520with%2520water-soluble%2520polymers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26spage%3D15064%26epage%3D15070%26doi%3D10.1016%2FS0021-9258%2818%2968146-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caliceti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, F. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(03)00108-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS0169-409X%2803%2900108-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=14499706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1yqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=1261-1277&author=P.+Calicetiauthor=F.+M.+Veronese&title=Pharmacokinetic+and+biodistribution+properties+of+poly%28ethylene+glycol%29-protein+conjugates&doi=10.1016%2FS0169-409X%2803%2900108-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates</span></div><div class="casAuthors">Caliceti, Paolo; Veronese, Francesco M.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-1277</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Peptide and protein PEGylation is usually undertaken to improve the biopharmaceutical properties of these drugs and, to date, several examples of conjugates with long permanence in the body as well as with localization ability in disease sites were reported.  Although a no. of studies on the in vivo behavior and fate of conjugates were performed, forecasting their pharmacokinetics is a difficult task since the pharmacokinetic profile is detd. by a no. of parameters which include physiol. and anatomical aspects of the recipient and physico-chem. properties of the deriv.  The most relevant perturbations of the protein mol. following PEG conjugation are: size enlargement, protein surface and glycosylation function masking, charge modification, and epitope shielding.  In particular, size enlargement slows down kidney ultrafiltration and promotes the accumulation into permeable tissues by the passive enhanced permeation and retention mechanism.  Charge and glycosylation function masking is revealed predominantly in reduced phagocytosis by the RES and liver cells.  Protein shielding reduces proteolysis and immune system recognition, which are important routes of elimination.  The specific effect of PEGylation on protein physico-chem. and biol. properties is strictly detd. by protein and polymer properties as well as by the adopted PEGylation strategy.  Relevant parameters to be considered in protein-polymer conjugates are: protein structure, mol. wt. and compn., polymer mol. wt. and shape, no. of linked polymer chains and conjugation chem.  The examples reported in this review show that general considerations could be useful in developing a target product, although significant deviations from the expected results can not be excluded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUnGBuleSog7Vg90H21EOLACvtfcHk0li8Lk45IMeX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1yqsb0%253D&md5=d26bf5b68a7aa9d1f4f0d10feb3e9593</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2803%2900108-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252803%252900108-X%26sid%3Dliteratum%253Aachs%26aulast%3DCaliceti%26aufirst%3DP.%26aulast%3DVeronese%26aufirst%3DF.%2BM.%26atitle%3DPharmacokinetic%2520and%2520biodistribution%2520properties%2520of%2520poly%2528ethylene%2520glycol%2529-protein%2520conjugates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D1261%26epage%3D1277%26doi%3D10.1016%2FS0169-409X%2803%2900108-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">PEGylated leuprolide with improved pharmacokinetic properties</span>. <i>Bioorg.Med. Chem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115306</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2020.115306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.bmc.2020.115306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=31926774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115306&author=M.+Fuauthor=X.+Zhuangauthor=T.+Zhangauthor=Y.+Guanauthor=Q.+Mengauthor=Y.+Zhang&title=PEGylated+leuprolide+with+improved+pharmacokinetic+properties&doi=10.1016%2Fj.bmc.2020.115306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylated leuprolide with improved pharmacokinetic properties</span></div><div class="casAuthors">Fu, Mian; Zhuang, Xiaomei; Zhang, Tianhong; Guan, Ying; Meng, Qingbin; Zhang, Yongjun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">115306</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist widely used in androgen deprivation therapy for the treatment of advanced prostate cancer, suffers from a short circulating half-life like other peptide therapeutics.  As an attempt to improve its pharmacokinetic properties, two PEGylated leuprolides with different mol. wt. were synthesized utilizing N-hydroxysuccinimidyl (NHS) conjugation chem.  The reaction conditions, including reaction temp., reaction time and feed ratio of the reactants, were optimized to obtain a higher yield.  Reverse-phase high performance liq. chromatog. (RP-HPLC) characterization indicates a high purity of the resulting conjugates.  Matrix-assisted laser desorption mass spectrometry (MALDI-MS) characterization suggests a 1:1 PEGylation.  1H NMR study reveals that the reaction occurs on the imidazolyl group on the histidine residue and the conjugates are stable in pH7.4 aq. solns.  The in vitro bioactivity of the conjugates was evaluated using both hormone-sensitive and hormone-insensitive cell lines.  It was found that the PEGylated peptides can still counteract the stimulatory action of androgens and the mitogenic action of epidermal growth factor on cell proliferation.  The in vivo bioactivity of the conjugates was also tested.  Like the unmodified peptide, administration of the conjugates to male rats leads to an initial testosterone surge, followed by a suppression of testosterone secretion.  Pharmacokinetics of the drugs after i.v. and s.c. administrations were detd.  In both cases, a prolonged circulating half-life, an increased AUC, and a decreased Cl_F were obsd. for the PEGylated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnpaELD5IQl7Vg90H21EOLACvtfcHk0li8Lk45IMeX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Kqtw%253D%253D&md5=6e4f95a9853db14b3bb95de17f19b4a2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2020.115306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2020.115306%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DM.%26aulast%3DZhuang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPEGylated%2520leuprolide%2520with%2520improved%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.Med.%2520Chem%26date%3D2020%26volume%3D28%26spage%3D115306%26doi%3D10.1016%2Fj.bmc.2020.115306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fishburn, C. S.</span></span> <span> </span><span class="NLM_article-title">The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">4167</span>– <span class="NLM_lpage">4183</span>, <span class="refDoi"> DOI: 10.1002/jps.21278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1002%2Fjps.21278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=18200508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sgt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=4167-4183&author=C.+S.+Fishburn&title=The+pharmacology+of+PEGylation%3A+balancing+PD+with+PK+to+generate+novel+therapeutics&doi=10.1002%2Fjps.21278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics</span></div><div class="casAuthors">Fishburn, C. Simone</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4167-4183</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Conjugation of macromols. to polyethylene glycol (PEG) has emerged recently as an effective strategy to alter the pharmacokinetic (PK) profiles of a variety of drugs, and thereby to improve their therapeutic potential.  PEG conjugation increases retention of drugs in the circulation by protecting against enzymic digestion, slowing filtration by the kidneys and reducing the generation of neutralizing antibodies.  Often, PEGylation leads to a loss in binding affinity due to steric interference with the drug-target binding interaction.  This loss in potency is offset by the longer circulating half-life of the drugs, and the resulting change in PK-PD profile has led in some cases to enabling of drugs that otherwise could not be developed, and in others to improvements in existing drugs.  Thus, whereas most approaches to drug development seek to increase the activity of drugs directly, the creation of PEGylated drugs seeks to balance the pharmacodynamic (PD) and pharmacokinetic properties to produce novel therapies that will meet with both increased efficacy and greater compliance in the clin. setting.  This review examines some of the PEGylated drugs developed in recent years, and highlights some of the different strategies taken to employ PEG to maximize the overall PK-PD profiles of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC7WViWdoJF7Vg90H21EOLACvtfcHk0lg8eceUvoqeCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sgt7rI&md5=d5e71d245c490eb575d9eda654badd45</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjps.21278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21278%26sid%3Dliteratum%253Aachs%26aulast%3DFishburn%26aufirst%3DC.%2BS.%26atitle%3DThe%2520pharmacology%2520of%2520PEGylation%253A%2520balancing%2520PD%2520with%2520PK%2520to%2520generate%2520novel%2520therapeutics%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D4167%26epage%3D4183%26doi%3D10.1002%2Fjps.21278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itadani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Identification of membrane-type receptor for bile acids (M-BAR)</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(02)02550-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS0006-291X%2802%2902550-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=12419312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot12kt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=714-719&author=T.+Maruyamaauthor=Y.+Miyamotoauthor=T.+Nakamuraauthor=Y.+Tamaiauthor=H.+Okadaauthor=E.+Sugiyamaauthor=T.+Nakamuraauthor=H.+Itadaniauthor=K.+Tanaka&title=Identification+of+membrane-type+receptor+for+bile+acids+%28M-BAR%29&doi=10.1016%2FS0006-291X%2802%2902550-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of membrane-type receptor for bile acids (M-BAR)</span></div><div class="casAuthors">Maruyama, Takaharu; Miyamoto, Yasuhisa; Nakamura, Takao; Tamai, Yoshitaka; Okada, Hiromasa; Sugiyama, Eiji; Nakamura, Tatsuji; Itadani, Hiraku; Tanaka, Kenichi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">714-719</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Bile acids play an essential role in the solubilization and absorption of dietary fat and lipid-sol. vitamins.  Bile acids also modulate the transcription of various genes for enzymes and transport proteins for their own and cholesterol homeostasis through binding to nuclear receptors.  Here we report a novel category of bile acid receptor, a membrane-type G protein-coupled receptor (GPCR), BG37.  Bile acids induced rapid and dose-dependent elevation of intracellular cAMP levels in BG37-expressing cells, but not in mock-transfected cells, independently of nuclear receptor expression.  The rank order of potency of various bile acids for BG37-expressing cells was different from that for the nuclear receptor-mediated response.  These observations demonstrate the presence of two independent signaling pathways for bile acids; membrane-type GPCR for rapid signaling and nuclear receptors for delayed signaling.  Expression of BG37 was detected in various specific tissues, suggesting its physiol. role, although it remains to be further characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFW81vc2oQfLVg90H21EOLACvtfcHk0lg8eceUvoqeCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot12kt78%253D&md5=6d3133ccf80e6222d7beb52ae31f3324</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2902550-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252902550-0%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DTamai%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DE.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DItadani%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520membrane-type%2520receptor%2520for%2520bile%2520acids%2520%2528M-BAR%2529%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D298%26spage%3D714%26epage%3D719%26doi%3D10.1016%2FS0006-291X%2802%2902550-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span> <span> </span><span class="NLM_article-title">Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.01.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.bbrc.2005.01.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=15721318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFSisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2005&pages=386-390&author=S.+Katsumaauthor=A.+Hirasawaauthor=G.+Tsujimoto&title=Bile+acids+promote+glucagon-like+peptide-1+secretion+through+TGR5+in+a+murine+enteroendocrine+cell+line+STC-1&doi=10.1016%2Fj.bbrc.2005.01.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1</span></div><div class="casAuthors">Katsuma, Susumu; Hirasawa, Akira; Tsujimoto, Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">386-390</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Bile acids play essential roles in the absorption of dietary lipids and in the regulation of bile acid biosynthesis.  Recently, a G protein-coupled receptor, TGR5, was identified as a cell-surface bile acid receptor.  In this study, we show that bile acids promote glucagon-like peptide-1 (GLP-1) secretion through TGR5 in a murine enteroendocrine cell line STC-1.  In STC-1 cells, bile acids promoted GLP-1 secretion in a dose-dependent manner.  As STC-1 cells express TGR5 mRNA, we examd. whether bile acids induce GLP-1 secretion through TGR5.  RNA interference expts. showed that reduced expression of TGR5 resulted in reduced secretion of GLP-1.  Furthermore, transient transfection of STC-1 cells with an expression plasmid contg. TGR5 significantly enhanced GLP-1 secretion, indicating that bile acids promote GLP-1 secretion through TGR5 in STC-1 cells.  Bile acids induced rapid and dose-dependent elevation of intracellular cAMP levels in STC-1 cells.  An adenylate cyclase inhibitor, MDL 12330A, significantly suppressed bile acid-promoted GLP-1 secretion, suggesting that bile acids induce GLP-1 secretion via intracellular cAMP prodn. in STC-1 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvgEFEJrvpGrVg90H21EOLACvtfcHk0ljuEFz1aYdXoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFSisbo%253D&md5=8ce72806c7bc190a28031f37845d2291</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.01.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.01.139%26sid%3Dliteratum%253Aachs%26aulast%3DKatsuma%26aufirst%3DS.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DBile%2520acids%2520promote%2520glucagon-like%2520peptide-1%2520secretion%2520through%2520TGR5%2520in%2520a%2520murine%2520enteroendocrine%2520cell%2520line%2520STC-1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D329%26spage%3D386%26epage%3D390%26doi%3D10.1016%2Fj.bbrc.2005.01.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houten, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffolete, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messaddeq, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harney, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezaki, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span> <span> </span><span class="NLM_article-title">Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>439</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1038/nature04330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1038%2Fnature04330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=16400329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2006&pages=484-489&author=M.+Watanabeauthor=S.+M.+Houtenauthor=C.+Matakiauthor=M.+A.+Christoffoleteauthor=B.+W.+Kimauthor=H.+Satoauthor=N.+Messaddeqauthor=J.+W.+Harneyauthor=O.+Ezakiauthor=T.+Kodamaauthor=K.+Schoonjansauthor=A.+C.+Biancoauthor=J.+Auwerx&title=Bile+acids+induce+energy+expenditure+by+promoting+intracellular+thyroid+hormone+activation&doi=10.1038%2Fnature04330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation</span></div><div class="casAuthors">Watanabe, Mitsuhiro; Houten, Sander M.; Mataki, Chikage; Christoffolete, Marcelo A.; Kim, Brian W.; Sato, Hiroyuki; Messaddeq, Nadia; Harney, John W.; Ezaki, Osamu; Kodama, Tatsuhiko; Schoonjans, Kristina; Bianco, Antonio C.; Auwerx, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">7075</span>),
    <span class="NLM_cas:pages">484-489</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">While bile acids (BAs) have long been known to be essential in dietary lipid absorption and cholesterol catabolism, in recent years an important role for BAs as signaling mols. has emerged.  BAs activate mitogen-activated protein kinase pathways, are ligands for the G-protein-coupled receptor (GPCR) TGR5 and activate nuclear hormone receptors such as farnesoid X receptor α (FXR-α; NR1H4).  FXR-α regulates the enterohepatic recycling and biosynthesis of BAs by controlling the expression of genes such as the short heterodimer partner (SHP; NR0B2) that inhibits the activity of other nuclear receptors.  The FXR-α-mediated SHP induction also underlies the downregulation of the hepatic fatty acid and triglyceride biosynthesis and very-low-d. lipoprotein prodn. mediated by sterol-regulatory-element-binding protein 1c.  This indicates that BAs might be able to function beyond the control of BA homeostasis as general metabolic integrators.  The administration of BAs to mice increases energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin.  This novel metabolic effect of BAs is critically dependent on induction of the cyclic-AMP-dependent thyroid hormone activating enzyme type 2 iodothyronine deiodinase (D2) because it is lost in D2-/- mice.  Treatment of brown adipocytes and human skeletal myocytes with BA increases D2 activity and oxygen consumption.  These effects are independent of FXR-α, and instead are mediated by increased cAMP prodn. that stems from the binding of BAs with the G-protein-coupled receptor TGR5.  In both rodents and humans, the most thermogenically important tissues are specifically targeted by this mechanism because they coexpress D2 and TGR5.  The BA-TGR5-cAMP-D2 signaling pathway is therefore a crucial mechanism for fine-tuning energy homeostasis that can be targeted to improve metabolic control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvq784CAfKkrVg90H21EOLACvtfcHk0ljuEFz1aYdXoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWmuw%253D%253D&md5=13c8bfe241fac294ba3fb1de99577d67</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature04330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04330%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DHouten%26aufirst%3DS.%2BM.%26aulast%3DMataki%26aufirst%3DC.%26aulast%3DChristoffolete%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DB.%2BW.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DMessaddeq%26aufirst%3DN.%26aulast%3DHarney%26aufirst%3DJ.%2BW.%26aulast%3DEzaki%26aufirst%3DO.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DBianco%26aufirst%3DA.%2BC.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DBile%2520acids%2520induce%2520energy%2520expenditure%2520by%2520promoting%2520intracellular%2520thyroid%2520hormone%2520activation%26jtitle%3DNature%26date%3D2006%26volume%3D439%26spage%3D484%26epage%3D489%26doi%3D10.1038%2Fnature04330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmstrom, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umetani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span> <span> </span><span class="NLM_article-title">The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1210/me.2010-0460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1210%2Fme.2010-0460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=21454404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsl2msLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1066-1071&author=T.+Liauthor=S.+R.+Holmstromauthor=S.+Kirauthor=M.+Umetaniauthor=D.+R.+Schmidtauthor=S.+A.+Kliewerauthor=D.+J.+Mangelsdorf&title=The+G+protein-coupled+bile+acid+receptor%2C+TGR5%2C+stimulates+gallbladder+filling&doi=10.1210%2Fme.2010-0460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling</span></div><div class="casAuthors">Li, Tingting; Holmstrom, Sam R.; Kir, Serkan; Umetani, Michihisa; Schmidt, Daniel R.; Kliewer, Steven A.; Mangelsdorf, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">TGR5 is a G protein-coupled bile acid receptor present in brown adipose tissue and intestine, where its agonism increases energy expenditure and lowers blood glucose.  Thus, it is an attractive drug target for treating human metabolic disease.  However, TGR5 is also highly expressed in gallbladder, where its functions are less well characterized.  Here, we demonstrate that TGR5 stimulates the filling of the gallbladder with bile.  Gallbladder vol. was increased in wild-type but not Tgr5-/- mice by administration of either the naturally occurring TGR5 agonist, lithocholic acid, or the synthetic TGR5 agonist, INT-777.  These effects were independent of fibroblast growth factor 15, an enteric hormone previously shown to stimulate gallbladder filling.  Ex vivo analyses using gallbladder tissue showed that TGR5 activation increased cAMP concns. and caused smooth muscle relaxation in a TGR5-dependent manner.  These data reveal a novel, gallbladder-intrinsic mechanism for regulating gallbladder contractility.  They further suggest that TGR5 agonists should be assessed for effects on human gallbladder as they are developed for treating metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfl9_dLsVML7Vg90H21EOLACvtfcHk0ljuEFz1aYdXoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsl2msLs%253D&md5=90d4a0754fe69f55b6a9b207351cd1a9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fme.2010-0460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2010-0460%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DHolmstrom%26aufirst%3DS.%2BR.%26aulast%3DKir%26aufirst%3DS.%26aulast%3DUmetani%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DD.%2BR.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520G%2520protein-coupled%2520bile%2520acid%2520receptor%252C%2520TGR5%252C%2520stimulates%2520gallbladder%2520filling%26jtitle%3DMol.%2520Endocrinol.%26date%3D2011%26volume%3D25%26spage%3D1066%26epage%3D1071%26doi%3D10.1210%2Fme.2010-0460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antidiabetic activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10475</span>– <span class="NLM_lpage">10489</span>, <span class="refDoi"> DOI: 10.1021/jm301071h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301071h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10475-10489&author=H.+Duanauthor=M.+Ningauthor=X.+Chenauthor=Q.+Zouauthor=L.+Zhangauthor=Y.+Fengauthor=L.+Zhangauthor=Y.+Lengauthor=J.+Shen&title=Design%2C+synthesis%2C+and+antidiabetic+activity+of+4-Phenoxynicotinamide+and+4-Phenoxypyrimidine-5-carboxamide+derivatives+as+potent+and+orally+efficacious+TGR5+agonists&doi=10.1021%2Fjm301071h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Antidiabetic Activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide Derivatives as Potent and Orally Efficacious TGR5 Agonists</span></div><div class="casAuthors">Duan, Hongliang; Ning, Mengmeng; Chen, Xiaoyan; Zou, Qingan; Zhang, Liming; Feng, Ying; Zhang, Lina; Leng, Ying; Shen, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10475-10489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivs. as potent and orally efficacious TGR5 agonists are reported.  Several 4-phenoxynicotinamide derivs. were found to activate human and mouse TGR5 (hTGR5 and mTGR5) with EC50 values in the low nanomolar range.  Compd. I, with an EC50 value of 0.72 nM on hTGR5 and an EC50 value of 6.2 nM on mTGR5, was selected for further in vivo efficacy studies.  This compd. exhibited a significant dose-dependent glucagon-like peptide-1 (GLP-1) secretion effect.  A single oral dose of I (50 mg/kg) significantly reduced blood glucose levels in db/db mice and caused a 49% redn. in the area under the blood glucose curve (AUC)0-120 min following an oral glucose tolerance test (OGTT) in imprinting control region (ICR) mice.  However, the compd. I stimulated gallbladder filling, which might result in side effects to the gallbladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6wEfPKvXJbVg90H21EOLACvtfcHk0lj4553LvO1Uzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfF&md5=2b031e54d7f089c039fcc8f87d42df4c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm301071h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301071h%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DH.%26aulast%3DNing%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antidiabetic%2520activity%2520of%25204-Phenoxynicotinamide%2520and%25204-Phenoxypyrimidine-5-carboxamide%2520derivatives%2520as%2520potent%2520and%2520orally%2520efficacious%2520TGR5%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10475%26epage%3D10489%26doi%3D10.1021%2Fjm301071h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nodop
Mazurek, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaude, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthukumarana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilpin, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinallo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzmich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harcken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerny, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modis, L. K.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Bile Acid Receptor 1 stimulation mediates arterial vasodilation through a KCa1.1 (BKCa)-dependent mechanism</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.210005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1124%2Fjpet.113.210005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=24399854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFajtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=421-431&author=R.+M.+Fryerauthor=K.+J.+Ngauthor=S.+G.+Nodop%0AMazurekauthor=L.+Patnaudeauthor=D.+J.+Skowauthor=A.+Muthukumaranaauthor=K.+E.+Gilpinauthor=R.+M.+Dinalloauthor=D.+Kuzmichauthor=J.+Lordauthor=S.+Sanyalauthor=H.+Yuauthor=C.+Harckenauthor=M.+A.+Cernyauthor=E.+R.+Hickeyauthor=L.+K.+Modis&title=G+Protein-Coupled+Bile+Acid+Receptor+1+stimulation+mediates+arterial+vasodilation+through+a+KCa1.1+%28BKCa%29-dependent+mechanism&doi=10.1124%2Fjpet.113.210005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled bile acid receptor 1 stimulation mediates arterial vasodilation through a KCa1.1 (BKCa)-dependent mechanism</span></div><div class="casAuthors">Fryer, Ryan M.; Ng, Khing Jow; Mazurek, Suzanne G. Nodop; Patnaude, Lori; Skow, Donna J.; Muthukumarana, Akalushi; Gilpin, Kyle E.; Dinallo, Roger M.; Kuzmich, Daniel; Lord, John; Sanyal, Sulagna; Yu, Hui; Harcken, Christian; Cerny, Matthew C.; Hickey, Eugene R.; Modis, Louise K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">421-431, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Bile acids (BAs) and BA receptors, including G protein-coupled bile acid receptor 1 (GPBAR1), represent novel targets for the treatment of metabolic and inflammatory disorders.  However, BAs elicit myriad effects on cardiovascular function, although this has not been specifically ascribed to GPBAR1.  This study was designed to test whether stimulation of GPBAR1 elicits effects on cardiovascular function that are mechanism based that can be identified in acute ex vivo and in vivo cardiovascular models, to delineate whether effects were due to pathways known to be modulated by BAs, and to establish whether a therapeutic window between in vivo cardiovascular liabilities and on-target efficacy could be defined.  The results demonstrated that the infusion of three structurally diverse and selective GPBAR1 agonists produced marked redns. in vascular tone and blood pressure in dog, but not in rat, as well as reflex tachycardia and a pos. inotropic response, effects that manifested in an enhanced cardiac output.  Changes in cardiovascular function were unrelated to modulation of the levothyroxine/thyroxine axis and were nitric oxide independent.  A direct effect on vascular tone was confirmed in dog isolated vascular rings, whereby concn.-dependent decreases in tension that were tightly correlated with redns. in vascular tone obsd. in vivo and were blocked by iberiotoxin.  Compd. concns. in which cardiovascular effects occurred, both ex vivo and in vivo, could not be sepd. from those necessary for modulation of GPBAR1-mediated efficacy, resulting in project termination.  These results are the first to clearly demonstrate direct and potent peripheral arterial vasodilation due to GPBAR1 stimulation in vivo through activation of large conductance Ca2+ activated potassium channel KCa1.1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbGVwYRqt84LVg90H21EOLACvtfcHk0lj4553LvO1Uzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFajtL0%253D&md5=fe48570c7b439077da6787b5a292d369</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.210005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.210005%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DNg%26aufirst%3DK.%2BJ.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%2BG.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DSkow%26aufirst%3DD.%2BJ.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DGilpin%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DKuzmich%26aufirst%3DD.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DHarcken%26aufirst%3DC.%26aulast%3DCerny%26aufirst%3DM.%2BA.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DModis%26aufirst%3DL.%2BK.%26atitle%3DG%2520Protein-Coupled%2520Bile%2520Acid%2520Receptor%25201%2520stimulation%2520mediates%2520arterial%2520vasodilation%2520through%2520a%2520KCa1.1%2520%2528BKCa%2529-dependent%2520mechanism%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D421%26epage%3D431%26doi%3D10.1124%2Fjpet.113.210005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasalle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoguet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennuyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piveteau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belloy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lestavel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorchies, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulahjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herledan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tailleux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span> <span> </span><span class="NLM_article-title">Topical intestinal aminoimidazole agonists of G-Protein-Coupled Bile Acid Receptor 1 promote Glucagon Like Peptide-1 secretion and improve glucose tolerance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4185</span>– <span class="NLM_lpage">4211</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01873</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01873" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4185-4211&author=M.+Lasalleauthor=V.+Hoguetauthor=N.+Hennuyerauthor=F.+Lerouxauthor=C.+Piveteauauthor=L.+Belloyauthor=S.+Lestavelauthor=E.+Vallezauthor=E.+Dorchiesauthor=I.+Duplanauthor=E.+Sevinauthor=M.+Culotauthor=F.+Gosseletauthor=R.+Boulahjarauthor=A.+Herledanauthor=B.+Staelsauthor=B.+Deprezauthor=A.+Tailleuxauthor=J.+Charton&title=Topical+intestinal+aminoimidazole+agonists+of+G-Protein-Coupled+Bile+Acid+Receptor+1+promote+Glucagon+Like+Peptide-1+secretion+and+improve+glucose+tolerance&doi=10.1021%2Facs.jmedchem.6b01873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance</span></div><div class="casAuthors">Lasalle, Manuel; Hoguet, Vanessa; Hennuyer, Nathalie; Leroux, Florence; Piveteau, Catherine; Belloy, Loic; Lestavel, Sophie; Vallez, Emmanuelle; Dorchies, Emilie; Duplan, Isabelle; Sevin, Emmanuel; Culot, Maxime; Gosselet, Fabien; Boulahjar, Rajaa; Herledan, Adrien; Staels, Bart; Deprez, Benoit; Tailleux, Anne; Charton, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4185-4211</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The role of the G-Protein-coupled Bile Acid Receptor TGR5 in various organs, tissues and cell types, specifically in intestinal endocrine L-cells and brown adipose tissue, has made it a promising therapeutical target in several diseases, esp. type-2 diabetes and metabolic syndrome.  However, recent studies have shown deleterious on-target effects of systemic TGR5 agonists.  To avoid these systemic effects while stimulating Glucagon Like Peptide-1 (GLP-1) secreting enteroendocrine L-cells, the authors have designed TGR5 agonists with low intestinal permeability.  In this paper, the authors describe their synthesis, characterization, and biol. evaluation.  Amongst them, compd. I is a potent GLP-1 secretagogue, has low effect on gallbladder vol., and improves glucose homeostasis in a preclin. murine model of diet-induced obesity and insulin-resistance, making the proof of concept of the potential of topical intestinal TGR5 agonists as therapeutic agents in type-2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR4_PCsJZjAbVg90H21EOLACvtfcHk0lj4553LvO1Uzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLY%253D&md5=717a5fdbb957d4f6949bf032d0eb6386</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01873%26sid%3Dliteratum%253Aachs%26aulast%3DLasalle%26aufirst%3DM.%26aulast%3DHoguet%26aufirst%3DV.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DBelloy%26aufirst%3DL.%26aulast%3DLestavel%26aufirst%3DS.%26aulast%3DVallez%26aufirst%3DE.%26aulast%3DDorchies%26aufirst%3DE.%26aulast%3DDuplan%26aufirst%3DI.%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DGosselet%26aufirst%3DF.%26aulast%3DBoulahjar%26aufirst%3DR.%26aulast%3DHerledan%26aufirst%3DA.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DTailleux%26aufirst%3DA.%26aulast%3DCharton%26aufirst%3DJ.%26atitle%3DTopical%2520intestinal%2520aminoimidazole%2520agonists%2520of%2520G-Protein-Coupled%2520Bile%2520Acid%2520Receptor%25201%2520promote%2520Glucagon%2520Like%2520Peptide-1%2520secretion%2520and%2520improve%2520glucose%2520tolerance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4185%26epage%3D4211%26doi%3D10.1021%2Facs.jmedchem.6b01873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span> <span> </span><span class="NLM_article-title">Bile Acid Reabsorption Inhibitors (BARI): novel hypolipidemic drugs</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.2174/092986706776361003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.2174%2F092986706776361003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=16611081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=997-1016&author=W.+Kramerauthor=H.+Glombik&title=Bile+Acid+Reabsorption+Inhibitors+%28BARI%29%3A+novel+hypolipidemic+drugs&doi=10.2174%2F092986706776361003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs</span></div><div class="casAuthors">Kramer, Werner; Glombik, Heiner</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">997-1016</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The enterohepatic circulation of bile acids is a major regulator of serum cholesterol homeostasis.  After biosynthesis from cholesterol in the liver, bile acids are secreted with bile into the lumen of the small intestine to aid in the digestion and absorption of fat and fat-sol. vitamins.  The bile acids are nearly quant. reabsorbed in the terminal ileum by a Na+-dependent transport system (IBAT) and are transported with portal blood to the liver and taken up by a second Na+-/bile acid cotransporter (LBAT) to be resecreted into bile.  In the liver bile acids inhibit the rate-limiting enzyme for the conversion of cholesterol into bile acid: cholesterol-7α-hydroxylase; interruption of the enterohepatic circulation of bile acids withdraws this feedback inhibition and leads to an upregulation of hepatic LDL-receptors with a concomitant decrease of serum LDL-levels.  Specific inhibitors of the ileal bile acid transporter belonging to different chemotypes have been developed in recent years for this purpose, some now entering clin. stage.  To exert a profound systemic effect these compds. do not need to be available systemically but can act from the luminal side of the small intestine, which offers the advantage to avoid the well-known adverse side effects of other hypolipidemic drugs like statins due to metab. and drug-drug interactions in the liver.  This implies several aspects in compd. optimization and drug development quite different from std. procedures, for example the concept of low absorption drugs was established to avoid systemic side effects.  This review article covers the mechanistic and therapeutic principles of the approach and presents an overview on the mol. target, the discovery of specific inhibitors and resp. optimization strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXNSDtAqiZbVg90H21EOLACvtfcHk0lggBR5nYLGpJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D&md5=8411f5d6f3e3218ad5ba6cb8fe2075c4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F092986706776361003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361003%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DGlombik%26aufirst%3DH.%26atitle%3DBile%2520Acid%2520Reabsorption%2520Inhibitors%2520%2528BARI%2529%253A%2520novel%2520hypolipidemic%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D997%26epage%3D1016%26doi%3D10.2174%2F092986706776361003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charmot, D.</span></span> <span> </span><span class="NLM_article-title">Non-systemic drugs: a critical review</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1434</span>– <span class="NLM_lpage">1445</span>, <span class="refDoi"> DOI: 10.2174/138161212799504858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.2174%2F138161212799504858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=22300258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1434-1445&author=D.+Charmot&title=Non-systemic+drugs%3A+a+critical+review&doi=10.2174%2F138161212799504858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Non-systemic drugs: a critical review</span></div><div class="casAuthors">Charmot, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1434-1445</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Non-systemic drugs act within the intestinal lumen without reaching the systemic circulation.  The first generation included polymeric resins that sequester phosphate ions, potassium ions, or bile acids for the treatment of electrolyte imbalances or hypercholesteremia.  The field has evolved towards non-absorbable small mols. or peptides targeting luminal enzymes or transporters for the treatment of mineral metab. disorders, diabetes, gastrointestinal (GI) disorders, and enteric infections.  From a drug design and development perspective, non-systemic agents offer novel opportunities to address unmet medical needs while minimizing toxicity risks, but also present new challenges, including developing a better understanding and control of non-transcellular leakage pathways into the systemic circulation.  The pharmacokinetic-pharmacodynamic relationship of drugs acting in the GI tract can be complex due to the variability of intestinal transit, interaction with chyme, and the complex environment of the surface epithelia.  We review the main classes of nonabsorbable agents at various stages of development, and their therapeutic potential and limitations.  The rapid progress in the identification of intestinal receptors and transporters, their functional characterization and role in metabolic and inflammatory disorders, will undoubtedly renew interest in the development of novel, safe, non-systemic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdEQRhLF7irVg90H21EOLACvtfcHk0lggBR5nYLGpJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKku7g%253D&md5=7a391aa741bb1a4bba9516b0f39acee1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F138161212799504858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799504858%26sid%3Dliteratum%253Aachs%26aulast%3DCharmot%26aufirst%3DD.%26atitle%3DNon-systemic%2520drugs%253A%2520a%2520critical%2520review%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1434%26epage%3D1445%26doi%3D10.2174%2F138161212799504858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasalle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulahjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoguet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Obbergen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span> <span> </span><span class="NLM_article-title">Access to newly functionalized imidazole derivatives: efficient synthesis of novel 5-amino-2-thioimidazoles using propylphosphonic anhydride (®T3P)</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2015.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.tetlet.2015.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFerug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=1011-1014&author=M.+Lasalleauthor=S.+Piconauthor=R.+Boulahjarauthor=V.+Hoguetauthor=J.+Van+Obbergenauthor=P.+Rousselauthor=B.+Deprezauthor=J.+Charton&title=Access+to+newly+functionalized+imidazole+derivatives%3A+efficient+synthesis+of+novel+5-amino-2-thioimidazoles+using+propylphosphonic+anhydride+%28%C2%AET3P%29&doi=10.1016%2Fj.tetlet.2015.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Access to newly functionalized imidazole derivatives: efficient synthesis of novel 5-amino-2-thioimidazoles using propylphosphonic anhydride (®T3P)</span></div><div class="casAuthors">Lasalle, Manuel; Picon, Sylvain; Boulahjar, Rajaa; Hoguet, Vanessa; Van Obbergen, Jolien; Roussel, Pascal; Deprez, Benoit; Charton, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1011-1014</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We describe here an efficient method to synthesize 5-amino-2-thioimidazole compds. by T3P-mediated cyclization of N-acetamidoisothiourea intermediates.  E.g., in presence of T3P, cyclization/cyclodehydration of N-acetamidoisothiourea intermediate (I) gave 58% imidazole deriv. (II).  The newly functionalized 5-amino-2-thioimidazole compds. are finally obtained in 5 steps from an amine as starting block.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDvXr2kChRcLVg90H21EOLACvtfcHk0lggBR5nYLGpJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFerug%253D%253D&md5=9bbd1dc423a88c19aea1808c85f3472b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DLasalle%26aufirst%3DM.%26aulast%3DPicon%26aufirst%3DS.%26aulast%3DBoulahjar%26aufirst%3DR.%26aulast%3DHoguet%26aufirst%3DV.%26aulast%3DVan%2BObbergen%26aufirst%3DJ.%26aulast%3DRoussel%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DCharton%26aufirst%3DJ.%26atitle%3DAccess%2520to%2520newly%2520functionalized%2520imidazole%2520derivatives%253A%2520efficient%2520synthesis%2520of%2520novel%25205-amino-2-thioimidazoles%2520using%2520propylphosphonic%2520anhydride%2520%2528%25C2%25AET3P%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D1011%26epage%3D1014%26doi%3D10.1016%2Fj.tetlet.2015.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versele, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselet, F.</span></span> <span> </span><span class="NLM_article-title">A miniaturized pump out method for characterizing molecule interaction with ABC transporters</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5529</span>, <span class="refDoi"> DOI: 10.3390/ijms20225529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.3390%2Fijms20225529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BB3cXptV2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=5529&author=E.+Sevinauthor=L.+Dehouckauthor=R.+Verseleauthor=M.+Culotauthor=F.+Gosselet&title=A+miniaturized+pump+out+method+for+characterizing+molecule+interaction+with+ABC+transporters&doi=10.3390%2Fijms20225529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A miniaturized pump out method for characterizing molecule interaction with ABC transporters</span></div><div class="casAuthors">Sevin, Emmanuel; Dehouck, Lucie; Versele, Romain; Culot, Maxime; Gosselet, Fabien</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5529</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Characterizing interaction of newly synthesized mols. with efflux pumps remains essential to improve their efficacy and safety.  Caco-2 cell line cultivated on inserts is widely used for measuring apparent permeability of drugs across biol. barriers, and for estg. their interaction with efflux pumps such as P-gp, BCRP and MRPs.  However, this method remains time consuming and expensive.  In addn., detection method is required for measuring mol. passage across cell monolayer and false results can be generated if drugs concns. used are too high as demonstrated with quinidine.  For this reason, we developed a new protocol based on the use of Caco-2 cell directly seeded on 96- or 384-well plates and the use of fluorescent substrates for efflux pumps.  We clearly obsd. that the new method reduces costs for mol. screening and leads to higher throughput compared to traditional use of Caco-2 cell model.  This accelerated model could provide quick feedback regarding the mol. design during the early stage of drug discovery and therefore reduce the no. of compds. to be further evaluated using the traditional Caco-2 insert method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpscFNnKALlMLVg90H21EOLACvtfcHk0lhtNglfmeFGaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXptV2qs7g%253D&md5=c2e1da8bb788bec0cfb4445753dcc5a0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fijms20225529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20225529%26sid%3Dliteratum%253Aachs%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DDehouck%26aufirst%3DL.%26aulast%3DVersele%26aufirst%3DR.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DGosselet%26aufirst%3DF.%26atitle%3DA%2520miniaturized%2520pump%2520out%2520method%2520for%2520characterizing%2520molecule%2520interaction%2520with%2520ABC%2520transporters%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D5529%26doi%3D10.3390%2Fijms20225529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brighton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rievaj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhre, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span> <span> </span><span class="NLM_article-title">Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">3961</span>– <span class="NLM_lpage">3970</span>, <span class="refDoi"> DOI: 10.1210/en.2015-1321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1210%2Fen.2015-1321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26280129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Ojur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=3961-3970&author=C.+A.+Brightonauthor=J.+Rievajauthor=R.+E.+Kuhreauthor=L.+L.+Glassauthor=K.+Schoonjansauthor=J.+J.+Holstauthor=F.+M.+Gribbleauthor=F.+Reimann&title=Bile+acids+trigger+GLP-1+release+predominantly+by+accessing+basolaterally+located+G+protein-coupled+bile+acid+receptors&doi=10.1210%2Fen.2015-1321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors</span></div><div class="casAuthors">Brighton, Cheryl A.; Rievaj, Juraj; Kuhre, Rune E.; Glass, Leslie L.; Schoonjans, Kristina; Holst, Jens J.; Gribble, Fiona M.; Reimann, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3961-3970</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Bile acids are well-recognized stimuli of glucagon-like peptide-1 (GLP-1) secretion.  This action has been attributed to activation of the G protein-coupled bile acid receptor GPBAR1(TGR5), although other potential bile acid sensors include the nuclear farnesoid receptor and the apical sodium coupled bile acid transporter ASBT.  The aim of this study was to identify pathways important for GLP-1 release and to det. whether bile acids target their receptors on GLP-1-secreting L-cells from the apical or basolateral compartment.  Using transgenic mice expressing fluorescent sensors specifically in L-cells, we obsd. that taurodeoxycholate (TDCA) and taurolithocholate (TLCA) increased intracellular cAMP and Ca2+.  In primary intestinal cultures, TDCA was a more potent GLP-1 secretagogue than taurocholate (TCA) and TLCA, correlating with a stronger Ca2+ response to TDCA.  Using small-vol. Ussing chambers optimized for measuring GLP-1 secretion, we found that both a GPBAR1 agonist and TDCA stimulated GLP-1 release better when applied from the basolateral than from the luminal direction and that luminal TDCA was ineffective when intestinal tissue was pretreated with an ASBT inhibitor.  ASBT inhibition had no significant effect in nonpolarized primary cultures.  Studies in the perfused rat gut confirmed that vascularly administered TDCA was more effective than luminal TDCA.  Intestinal primary cultures and Ussing chamber- mounted tissues from GPBAR1-knockout mice did not secrete GLP-1 in response to either TLCA or TDCA.  We conclude that the action of bile acids on GLP-1 secretion is predominantly mediated by GPBAR1 located on the basolateral L-cell membrane, suggesting that stimulation of gut hormone secretion may include postabsorptive mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopfu7ri_IsarVg90H21EOLACvtfcHk0lhtNglfmeFGaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Ojur8%253D&md5=84e055a3542eaafd10875b3890e0eccc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1210%2Fen.2015-1321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2015-1321%26sid%3Dliteratum%253Aachs%26aulast%3DBrighton%26aufirst%3DC.%2BA.%26aulast%3DRievaj%26aufirst%3DJ.%26aulast%3DKuhre%26aufirst%3DR.%2BE.%26aulast%3DGlass%26aufirst%3DL.%2BL.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DReimann%26aufirst%3DF.%26atitle%3DBile%2520acids%2520trigger%2520GLP-1%2520release%2520predominantly%2520by%2520accessing%2520basolaterally%2520located%2520G%2520protein-coupled%2520bile%2520acid%2520receptors%26jtitle%3DEndocrinology%26date%3D2015%26volume%3D156%26spage%3D3961%26epage%3D3970%26doi%3D10.1210%2Fen.2015-1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedroso, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tellechea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidalgo-Carvalho, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span> <span> </span><span class="NLM_article-title">Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e16114</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0016114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1371%2Fjournal.pone.0016114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=21283630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Glsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=D.+C.+S.+Pedrosoauthor=A.+Tellecheaauthor=L.+Mouraauthor=I.+Fidalgo-Carvalhoauthor=J.+Duarteauthor=E.+Carvalhoauthor=L.+Ferreira&title=Improved+survival%2C+vascular+differentiation+and+wound+healing+potential+of+stem+cells+co-cultured+with+endothelial+cells&doi=10.1371%2Fjournal.pone.0016114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells</span></div><div class="casAuthors">Pedroso, Dora C. S.; Tellechea, Ana; Moura, Liane; Fidalgo-Carvalho, Isabel; Duarte, Joao; Carvalho, Eugenia; Ferreira, Lino</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e16114</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In this study, we developed a methodol. to improve the survival, vascular differentiation and regenerative potential of umbilical cord blood (UCB)-derived hematopoietic stem cells (CD34+ cells), by co-culturing the stem cells in a 3D fibrin gel with CD34+-derived endothelial cells (ECs).  ECs differentiated from CD34+ cells appear to have superior angiogenic properties to fully differentiated ECs, such as human umbilical vein endothelial cells (HUVECs).  Our results indicate that the pro-survival effect of CD34+-derived ECs on CD34+ cells is mediated, at least in part, by bioactive factors released from ECs.  This effect likely involves the secretion of novel cytokines, including interleukin-17 (IL-17) and interleukin-10 (IL-10), and the activation of the ERK 1/2 pathway in CD34+ cells.  We also show that the endothelial differentiation of CD34+ cells in co-culture with CD34+-derived ECs is mediated by a combination of sol. and insol. factors.  The regenerative potential of this co-culture system was demonstrated in a chronic wound diabetic animal model.  The co-transplantation of CD34+ cells with CD34+-derived ECs improved the wound healing relatively to controls, by decreasing the inflammatory reaction and increasing the neovascularization of the wound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqII4x8qj1KLVg90H21EOLACvtfcHk0lhtNglfmeFGaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Glsro%253D&md5=2e2363c684f0324a388e2dc6149dd48a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0016114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0016114%26sid%3Dliteratum%253Aachs%26aulast%3DPedroso%26aufirst%3DD.%2BC.%2BS.%26aulast%3DTellechea%26aufirst%3DA.%26aulast%3DMoura%26aufirst%3DL.%26aulast%3DFidalgo-Carvalho%26aufirst%3DI.%26aulast%3DDuarte%26aufirst%3DJ.%26aulast%3DCarvalho%26aufirst%3DE.%26aulast%3DFerreira%26aufirst%3DL.%26atitle%3DImproved%2520survival%252C%2520vascular%2520differentiation%2520and%2520wound%2520healing%2520potential%2520of%2520stem%2520cells%2520co-cultured%2520with%2520endothelial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0016114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aday, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coisne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhardt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span> <span> </span><span class="NLM_article-title">A stable and reproducible human Blood-Brain Barrier model derived from hematopoietic stem cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e99733</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0099733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1371%2Fjournal.pone.0099733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=24936790" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=R.+Cecchelliauthor=S.+Adayauthor=E.+Sevinauthor=C.+Almeidaauthor=M.+Culotauthor=L.+Dehouckauthor=C.+Coisneauthor=B.+Engelhardtauthor=M.-P.+Dehouckauthor=L.+Ferreira&title=A+stable+and+reproducible+human+Blood-Brain+Barrier+model+derived+from+hematopoietic+stem+cells&doi=10.1371%2Fjournal.pone.0099733"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0099733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0099733%26sid%3Dliteratum%253Aachs%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DAday%26aufirst%3DS.%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DAlmeida%26aufirst%3DC.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DDehouck%26aufirst%3DL.%26aulast%3DCoisne%26aufirst%3DC.%26aulast%3DEngelhardt%26aufirst%3DB.%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DFerreira%26aufirst%3DL.%26atitle%3DA%2520stable%2520and%2520reproducible%2520human%2520Blood-Brain%2520Barrier%2520model%2520derived%2520from%2520hematopoietic%2520stem%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0099733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elhaik Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macheto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresler, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Oliveira, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liraz-Zaltsman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeri, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, I.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier cellular responses toward organophosphates: natural compensatory processes and exogenous interventions to rescue barrier properties</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">359</span>, <span class="refDoi"> DOI: 10.3389/fncel.2018.00359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.3389%2Ffncel.2018.00359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=30459557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFSmsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=359&author=O.+Ravidauthor=S.+Elhaik+Goldmanauthor=D.+Machetoauthor=Y.+Breslerauthor=R.+I.+De+Oliveiraauthor=S.+Liraz-Zaltsmanauthor=F.+Gosseletauthor=L.+Dehouckauthor=M.+S.+Beeriauthor=I.+Cooper&title=Blood-Brain+Barrier+cellular+responses+toward+organophosphates%3A+natural+compensatory+processes+and+exogenous+interventions+to+rescue+barrier+properties&doi=10.3389%2Ffncel.2018.00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier cellular responses toward organophosphates: natural compensatory processes and exogenous interventions to rescue barrier properties</span></div><div class="casAuthors">Ravid, Orly; Goldman, Shirin Elhaik; Macheto, David; Bresler, Yael; De Oliveira, Raquel Ines; Liraz-Zaltsman, Sigal; Gosselet, Fabien; Dehouck, Lucie; Beeri, Michal Schnaider; Cooper, Itzik</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">359</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The insecticide parathion) and as chem. warfare nerve agents.  Blood-brain barrier (BBB) leakage has been shown in rodents exposed to PX, which is an organophosphate oxon.  In this study, we investigated the cellular mechanisms involved in BBB reaction after acute exposure to PX in an established in vitro BBB system made of stem-cell derived, human brain-like endothelial cells (BLECs) together with brain pericytes that closely mimic the in vivo BBB.  Our results show that PX directly affects the BBB in vitro both at toxic and non-toxic concns. by attenuating tight junctional (TJ) protein expression and that only above a certain threshold the paracellular barrier integrity is compromised.  Below this threshold, BLECs exhibit a morphol. coping mechanism in which they enlarge their cell area thus preventing the formation of meaningful intercellular gaps and maintaining barrier integrity.  Importantly, we demonstrate that reversal of the apoptotic cell death induced by PX, by a pan-caspase-inhibitor ZVAD-FMK (ZVAD) can reduce PX-induced cell death and elevate cell area but do not prevent the induced BBB permeability, implying that TJ complex functionality is hindered.  This is corroborated by formation of ROS at all toxic concns. of PX and which are even higher with ZVAD.  We suggest that while lower levels of ROS can induce compensating mechanisms, higher PX-induced oxidative stress levels interfere with barrier integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0lO7kjzRm_bVg90H21EOLACvtfcHk0lj4qBgDDAWwiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFSmsLbE&md5=20a74a60cd795c721d6f358c1819b8fd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2018.00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2018.00359%26sid%3Dliteratum%253Aachs%26aulast%3DRavid%26aufirst%3DO.%26aulast%3DElhaik%2BGoldman%26aufirst%3DS.%26aulast%3DMacheto%26aufirst%3DD.%26aulast%3DBresler%26aufirst%3DY.%26aulast%3DDe%2BOliveira%26aufirst%3DR.%2BI.%26aulast%3DLiraz-Zaltsman%26aufirst%3DS.%26aulast%3DGosselet%26aufirst%3DF.%26aulast%3DDehouck%26aufirst%3DL.%26aulast%3DBeeri%26aufirst%3DM.%2BS.%26aulast%3DCooper%26aufirst%3DI.%26atitle%3DBlood-Brain%2520Barrier%2520cellular%2520responses%2520toward%2520organophosphates%253A%2520natural%2520compensatory%2520processes%2520and%2520exogenous%2520interventions%2520to%2520rescue%2520barrier%2520properties%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2018%26volume%3D12%26spage%3D359%26doi%3D10.3389%2Ffncel.2018.00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aday, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallier-Vanuxeem, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span> <span> </span><span class="NLM_article-title">Stem cell-based human blood-brain barrier models for drug discovery and delivery</span>. <i>Trends Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.tibtech.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.tibtech.2016.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26838094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVegtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=382-393&author=S.+Adayauthor=R.+Cecchelliauthor=D.+Hallier-Vanuxeemauthor=M.+P.+Dehouckauthor=L.+Ferreira&title=Stem+cell-based+human+blood-brain+barrier+models+for+drug+discovery+and+delivery&doi=10.1016%2Fj.tibtech.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery</span></div><div class="casAuthors">Aday, S.; Cecchelli, R.; Hallier-Vanuxeem, D.; Dehouck, M. P.; Ferreira, L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-393</span>CODEN:
                <span class="NLM_cas:coden">TRBIDM</span>;
        ISSN:<span class="NLM_cas:issn">0167-7799</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of novel neuropharmaceuticals requires the evaluation of blood-brain barrier (BBB) permeability and toxicity.  Recent studies have highlighted differences in the BBB among different species, with the most important differences involving the expression of P-glycoprotein (P-gp), multidrug resistance-assocd. proteins, transporters, and claudins.  In addn., functional studies have shown that brain pharmacokinetics of P-glycoprotein substrates are different in humans and rodents.  Therefore, human BBB models may be an important platform for initial drug screening before in vivo studies.  This strategy might help to reduce costs in drug development and failures in clin. studies.  We review the differences in the BBB among species, recent advances in the generation of human BBB models, and their applications in drug discovery and delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDN1Tf9LkGnLVg90H21EOLACvtfcHk0lj4qBgDDAWwiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVegtro%253D&md5=f6ef907b292f719a6dc945888c59f7c6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tibtech.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibtech.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DAday%26aufirst%3DS.%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DHallier-Vanuxeem%26aufirst%3DD.%26aulast%3DDehouck%26aufirst%3DM.%2BP.%26aulast%3DFerreira%26aufirst%3DL.%26atitle%3DStem%2520cell-based%2520human%2520blood-brain%2520barrier%2520models%2520for%2520drug%2520discovery%2520and%2520delivery%26jtitle%3DTrends%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D382%26epage%3D393%26doi%3D10.1016%2Fj.tibtech.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolliet-Riant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brée, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruchart, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillement, J. P.</span></span> <span> </span><span class="NLM_article-title">Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1790</span>– <span class="NLM_lpage">1797</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1992.tb10055.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1111%2Fj.1471-4159.1992.tb10055.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1560234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADyaK38Xit1Olsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1992&pages=1790-1797&author=M.-P.+Dehouckauthor=P.+Jolliet-Riantauthor=F.+Br%C3%A9eauthor=J.-C.+Fruchartauthor=R.+Cecchelliauthor=J.+P.+Tillement&title=Drug+transfer+across+the+blood-brain+barrier%3A+correlation+between+in+vitro+and+in+vivo+models&doi=10.1111%2Fj.1471-4159.1992.tb10055.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transfer across the blood-brain barrier:  correlation between in vitro and in vivo models</span></div><div class="casAuthors">Dehouck, Marie Pierre; Jolliet-Riant, Pascale; Bree, Francoise; Fruchart, Jean Charles; Cecchelli, Romeo; Tillement, Jean Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1790-7</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To assess the drug transport across the blood-brain barrier (BBB), the authors compared the maximal brain extn. values at time O [E(0) values] obtained using either in vitro or in vivo methods.  The in vitro BBB model consisted of a coculture of brain capillary endothelial cells growing on one side of a filter and astrocytes on the other.  The in vivo model used intracarotid injection in anesthetized rats.  Eleven compds. were tested.  They were selected because they exhibit quant. different brain extn. rates: very low for inulin and sucrose, low for oxicam-related nonsteroidal antiinflammatory drugs and diclofenac, and high for propranolol and diazepam.  As these compds. are apparently transferred by a passive diffusion mechanism, two others, glucose and leucine, were added that cross the BBB by a known carrier-mediated process.  The in vivo and in vitro E(0) values showed a strong correlation as indicated by the Spearman's correlation coeff. (r = 0.88, p <0.01).  The relative ease with which such cocultures can be produced in large quantities could facilitate the screening of new centrally acting drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBoWOtr2M6BbVg90H21EOLACvtfcHk0lilSRoYs_Q_Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xit1Olsb8%253D&md5=07e0a0cbf719c2b36d095027d0b440d1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1992.tb10055.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1992.tb10055.x%26sid%3Dliteratum%253Aachs%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DJolliet-Riant%26aufirst%3DP.%26aulast%3DBr%25C3%25A9e%26aufirst%3DF.%26aulast%3DFruchart%26aufirst%3DJ.-C.%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DTillement%26aufirst%3DJ.%2BP.%26atitle%3DDrug%2520transfer%2520across%2520the%2520blood-brain%2520barrier%253A%2520correlation%2520between%2520in%2520vitro%2520and%2520in%2520vivo%2520models%26jtitle%3DJ.%2520Neurochem.%26date%3D1992%26volume%3D58%26spage%3D1790%26epage%3D1797%26doi%3D10.1111%2Fj.1471-4159.1992.tb10055.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously described TGR5 agonist <b>24</b> and general structure of the PEGylated TGR5 agonists of this work.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to <b>1</b> and <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) paraformaldehyde, MeONa, room temp., 16 h, (ii) NaBH<sub>4</sub>, MeOH, reflux, 1–3 h, 77%; (b) (i) Boc-Gly-OH, T3P, DIEA, EtOAc, room temp., 30 min to 48 h, 100%, (ii) TFA(30%)/DCM, room temp., 30 min, 100%; (c) (i) chloroacetyl chloride, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min, (ii) aq. NH<sub>3</sub>, EtOH, 65 °C, 1 h, then HCOOH, 75% (over two steps); (d) 4-fluorophenylisothiocyanate, NEt<sub>3</sub>, EtOH, room temp., 15 min, 76%; (d′) 4-fluoro-3-methoxy-aniline, TCDI, NEt<sub>3</sub>, dioxane, room temp. to 60 °C, overnight, 49%; (e) 2-bromomethyl-1,3-difluorobenzene, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, room temp., 16 h, 91%; (f) T3P, DIEA, EtOAC, 150 °C (μW), 10–40 min, or reflux, 24 h, 33–63%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to <b>P3</b>–<b>P6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) poly(ethylene glycol) methyl ether tosylate (average Mn = 600, 900, and 2000 g/mol), K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux, overnight, 61–100%; (b) TEA, mesyl chloride, DCM, room temp., overnight, 100%; (c) <b>P3ii</b>–<b>P6ii</b>, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, room temperature, overnight, 17–47%; (d) T3P, DIEA, EtOAC, 150 °C (μW), 10–40 min, or reflux (classical heating), 24 h, 13–27%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to <b>P8</b> and <b>P10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-bromo-2-(chloromethyl)-1,3-difluoro-benzene, NaI, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, room temp., overnight, 98%; (b) T3P, DIEA, EtOAc, 150 °C (μW), 10 min, 100%; (c) 2-[2-methoxypolyethyleneglycoxy]ethanamine (average Mn = 750 and 2000 g/mol), TEA, DCC, HOBt, DCM, room temp., overnight, 64–66%; (d) <b>P8i</b> or <b>P10i</b>, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, H<sub>2</sub>O/DME/EtOH, 100 °C (μW), 10 min, 43–47%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to <b>P7</b>–<b>P12</b> and <b>13</b>–<b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-carboxyphenylboronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub> or PdCl<sub>2</sub>dppf, H<sub>2</sub>O/DME/EtOH, 100 °C (μW), 10 min, 52%; (b) mPEG-NH<sub>2</sub> (average Mn = 500, 750, 2000, and 5000 g/mol) or mPEGn-NH<sub>2</sub>, TEA, DCC, or DIC, HOBt, DCM, room temp., overnight.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of the number of PEG units (<i>n</i>) on microsomal stability. (A) Intrinsic clearance Cl<sub>int</sub> (μL/min/mg) for compounds <b>P3</b> and <b>P4</b> (series 1) as a function of size. (B) Intrinsic clearance Cl<sub>int</sub> (μL/min/mg) for compounds <b>P7</b> and <b>P9</b> (series 2) with or without CYP3A4 inhibitor (ketoconazole, 5 μM). (C) Intrinsic clearance Cl<sub>int</sub> (μL/min/mg) for series 1 and 2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Apparent permeability on Caco-2 cell monolayer P<sub>app A-B</sub> (from the apical side to the basolateral side) for series 1 (gray, compounds <b>P3</b> and <b>P4</b>) and series 2 (black, compounds <b>P7</b> and <b>P9</b>) depending on the number of PEG units (for <i>n</i> ≥ 13 P<sub>app</sub>A-B < 0.2 × 10<sup>–6</sup> cm/s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Apparent permeability on Caco-2 cell monolayer: A-B (from apical to basolateral) and B-A (from basolateral to apical) for compounds <b>P7</b> and <b>P9</b> depending on the number of PEG units. Permeability is expressed in 10<sup>–6</sup> cm/s.(for <i>n</i> ≥ 13 PappA-B < 0.2 × 10<sup>–6</sup> cm/s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Effect of PEGylated analogs on rate of excretion of rhodamine 123. (b) Effect of PEGylated analogs on the rate of excretion of CMFDA. (c) Effect of polyethylene glycol amine (mPEGn-NH<sub>2</sub>) on the rate of excretion of rhodamine 123. Specific inhibitors for P-gp/BCRP (verapamil), MRPx (MK571) were used as positive control. Acetanomiphen and diazepam were used as negative controls. Data were represented as means + s.e.m. (<i>n</i> = 8–15), *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 (ANOVA–Dunnett test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma, liver, and gallbladder exposure in C57Bl6 mice following oral dosing (32 μmol/kg) of compounds <b>P7</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b> (<i>n</i> = 3 mice/time points).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/medium/jm0c01774_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Time course of compounds <b>P7</b>, <b>P9</b>, <b>P11</b>, and <b>P12</b> concentrations in duodenum, jejunum, ileum, and colon of C57Bl6 mice, after a single oral administration (32 μmol/kg), mean ± s.e.m. (<i>n</i> = 3 mice/time points).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01774/20210204/images/large/jm0c01774_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01774&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chess, R. B.</span></span> <span> </span><span class="NLM_article-title">Effect of pegylation on pharmaceuticals</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1038/nrd1033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1038%2Fnrd1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=12612647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=214-221&author=J.+M.+Harrisauthor=R.+B.+Chess&title=Effect+of+pegylation+on+pharmaceuticals&doi=10.1038%2Fnrd1033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of PEGylation on pharmaceuticals</span></div><div class="casAuthors">Harris, J. Milton; Chess, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein and peptide drugs hold great promise as therapeutic agents.  However, many are degraded by proteolytic enzymes, can be rapidly cleared by the kidneys, generate neutralizing antibodies and have a short circulating half-life.  PEGylation, the process by which polyethylene glycol chains are attached to protein and peptide drugs, can overcome these and other shortcomings.  By increasing the mol. mass of proteins and peptides and shielding them from proteolytic enzymes, PEGylation improves pharmacokinetics.  This article will review how PEGylation can result in drugs that are often more effective and safer, and which show improved patient convenience and compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLhPAuz8WjMLVg90H21EOLACvtfcHk0lhZKiU46axgtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D&md5=d6bb387e746740b10e088e1f55af37db</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1033%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26aulast%3DChess%26aufirst%3DR.%2BB.%26atitle%3DEffect%2520of%2520pegylation%2520on%2520pharmaceuticals%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D214%26epage%3D221%26doi%3D10.1038%2Fnrd1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasut, G.</span></span> <span> </span><span class="NLM_article-title">PEGylation, successful approach to drug delivery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(05)03575-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS1359-6446%2805%2903575-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=16243265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFers7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1451-1458&author=F.+M.+Veroneseauthor=G.+Pasut&title=PEGylation%2C+successful+approach+to+drug+delivery&doi=10.1016%2FS1359-6446%2805%2903575-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylation, successful approach to drug delivery</span></div><div class="casAuthors">Veronese, Francesco M.; Pasut, Gianfranco</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1451-1458</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  An overview of PEGylation, from its basic strategies of conjugation to the recent achievements and therapeutic applications.  PEGylation defines the modification of a protein, peptide or non-peptide mol. by the linking of one or more polyethylene glycol (PEG) chains.  This polymer is non-toxic, non-immunogenic, non-antigenic, highly sol. in water and FDA approved.  The PEG-drug conjugates have several advantages: a prolonged residence in body, a decreased degrdn. by metabolic enzymes and a redn. or elimination of protein immunogenicity.  Thanks to these favorable properties, PEGylation now plays an important role in drug delivery, enhancing the potentials of peptides and proteins as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWWjTRxbLaJ7Vg90H21EOLACvtfcHk0lhFfflo1Mlx6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFers7rF&md5=710be729f6e92d2169b4424f76e1c55e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903575-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903575-0%26sid%3Dliteratum%253Aachs%26aulast%3DVeronese%26aufirst%3DF.%2BM.%26aulast%3DPasut%26aufirst%3DG.%26atitle%3DPEGylation%252C%2520successful%2520approach%2520to%2520drug%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1451%26epage%3D1458%26doi%3D10.1016%2FS1359-6446%2805%2903575-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLuca, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span> <span> </span><span class="NLM_article-title">Emerging PEGylated drugs</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1517/14728210902907847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1517%2F14728210902907847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=19453284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Siu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=363-380&author=J.+S.+Kangauthor=P.+P.+DeLucaauthor=K.+C.+Lee&title=Emerging+PEGylated+drugs&doi=10.1517%2F14728210902907847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging PEGylated drugs</span></div><div class="casAuthors">Kang, Jung Seok; De Luca, Patrick P.; Lee, Kang Choon</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-380</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  PEGylation is a pharmaceutical technol. that involves the covalent attachment of polyethylene glycol (PEG) to a drug to improve its pharmacokinetic, pharmacodynamic, and immunol. profiles, and thus, enhance its therapeutic effect.  Currently, PEGylation is used to modify proteins, peptides, oligonucleotides, antibody fragments, and small org. mols.  Research groups are striving to improve the consistencies of PEGylated drugs and to PEGylate commercialized proteins and small org. mols.  Furthermore, the PEGylations of novel medications, like oligonucleotides and antibody fragments, are being pursued to improve their bioavailabilities.  This active research in the PEGylation field and the continued growth of the biopharmaceutical market predicts that PEGylated drugs have a bright future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFgW3aHbmjMrVg90H21EOLACvtfcHk0lhFfflo1Mlx6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Siu7c%253D&md5=2e7546517bbc9f2c5c48cefdfbc5c999</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728210902907847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210902907847%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%2BS.%26aulast%3DDeLuca%26aufirst%3DP.%2BP.%26aulast%3DLee%26aufirst%3DK.%2BC.%26atitle%3DEmerging%2520PEGylated%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2009%26volume%3D14%26spage%3D363%26epage%3D380%26doi%3D10.1517%2F14728210902907847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogenboom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, U. S.</span></span> <span> </span><span class="NLM_article-title">Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6288</span>– <span class="NLM_lpage">6308</span>, <span class="refDoi"> DOI: 10.1002/anie.200902672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1002%2Fanie.200902672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=20648499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOqtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6288-6308&author=K.+Knopauthor=R.+Hoogenboomauthor=D.+Fischerauthor=U.+S.+Schubert&title=Poly%28ethylene+glycol%29+in+drug+delivery%3A+pros+and+cons+as+well+as+potential+alternatives&doi=10.1002%2Fanie.200902672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives</span></div><div class="casAuthors">Knop, Katrin; Hoogenboom, Richard; Fischer, Dagmar; Schubert, Ulrich S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">6288-6308</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Poly(ethylene glycol) (PEG) is the most used polymer and also the gold std. for stealth polymers in the emerging field of polymer-based drug delivery.  The properties that account for the overwhelming use of PEG in biomedical applications are outlined in this Review.  The first approved PEGylated products have already been on the market for 20 years.  A vast amt. of clin. experience has since been gained with this polymer-not only benefits, but possible side effects and complications have also been found.  The areas that might need consideration and more intensive and careful examn. can be divided into the following categories: hypersensitivity, unexpected changes in pharmacokinetic behavior, toxic side products, and an antagonism arising from the easy degrdn. of the polymer under mech. stress as a result of its ether structure and its non-biodegradability, as well as the resulting possible accumulation in the body.  These possible side effects will be discussed in this Review and alternative polymers will be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHbYINW5v_3rVg90H21EOLACvtfcHk0lhKy9fQ8-hGqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOqtLbN&md5=02ff87df9c11cf218d3799ecd259d2a0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fanie.200902672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200902672%26sid%3Dliteratum%253Aachs%26aulast%3DKnop%26aufirst%3DK.%26aulast%3DHoogenboom%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DSchubert%26aufirst%3DU.%2BS.%26atitle%3DPoly%2528ethylene%2520glycol%2529%2520in%2520drug%2520delivery%253A%2520pros%2520and%2520cons%2520as%2520well%2520as%2520potential%2520alternatives%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6288%26epage%3D6308%26doi%3D10.1002%2Fanie.200902672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, C.-Y.</span></span> <span> </span><span class="NLM_article-title">PEG-modified biopharmaceuticals</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1517/17425240802650568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1517%2F17425240802650568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=19236204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1-16&author=P.+Bailonauthor=C.-Y.+Won&title=PEG-modified+biopharmaceuticals&doi=10.1517%2F17425240802650568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PEG-modified biopharmaceuticals</span></div><div class="casAuthors">Bailon, Pascal; Won, Chee-Youb</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  PEGylation is a process in which one or more units of chem. activated polyethylene glycol reacts with a biomol., usually a protein, peptide, small mol. or oligonucleotide, creating a putative new mol. entity possessing physicochem. and physiol. characteristics that are distinct from its predecessor mols.  In recent years, PEGylation has been used not only as a drug delivery technol. but used also as a drug modification technol. to transform existing biopharmaceuticals clin. more efficacious than before their PEGylation.  PEGylation bestows several useful properties upon the native mol., resulting in improved pharmacokinetic and pharmacodynamic properties, which in turn enable the native mol. to achieve max. clin. potency.  In addn., PEGylation results in sustained clin. response with minimal dose and less frequency of dosing, leading to improved quality of life via increased patient compliance and reduced cost.  During the course of development of various pegylated protein therapeutics, several new insights have been gained.  This review article focuses on the approaches, strategies and the utilization of modern PEGylation concepts in the design and development of well-characterized pegylated protein therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf5II9oQ0hJLVg90H21EOLACvtfcHk0lhKy9fQ8-hGqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVahsw%253D%253D&md5=acb7ff4e9a7e77a6135f47be428a46bf</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F17425240802650568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425240802650568%26sid%3Dliteratum%253Aachs%26aulast%3DBailon%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DC.-Y.%26atitle%3DPEG-modified%2520biopharmaceuticals%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2009%26volume%3D6%26spage%3D1%26epage%3D16%26doi%3D10.1517%2F17425240802650568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swierczewska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span> <span> </span><span class="NLM_article-title">What is the future of PEGylated therapies?</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1517/14728214.2015.1113254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1517%2F14728214.2015.1113254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26583759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=531-536&author=M.+Swierczewskaauthor=K.+C.+Leeauthor=S.+Lee&title=What+is+the+future+of+PEGylated+therapies%3F&doi=10.1517%2F14728214.2015.1113254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">What is the future of PEGylated therapies?</span></div><div class="casAuthors">Swierczewska, Magdalena; Lee, Kang Choon; Lee, Seulki</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The tremendous potential of biol. drugs is hampered by short half-lives in vivo, resulting in significantly lower potency than activity seen in vitro.  These short-acting therapeutic agents require frequent dosing profiles that can reduce applicability to the clinic, particularly for chronic conditions.  Therefore, half-life extension technologies are entering the clinic to enable improved or new biol. therapies.  PEGylation is the first successful technol. to improve pharmacokinetic (PK) profiles of therapeutic agents and has been applied in the clinic for over 25 years.  Over 10 PEGylated therapeutics have entered the clinic since the early 1990s, and new PEGylated agents continue to expand clin. pipelines and drug patent life.  PEGylation is the most established half-life extension technol. in the clinic with proven safety in humans for over two decades.  Still, it is one of the most evolving and emerging technologies that will be applied for the next two decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaLx1Mvr3WGbVg90H21EOLACvtfcHk0lhKy9fQ8-hGqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtbfJ&md5=67d3331c606da4f788861c91f6aa2439</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14728214.2015.1113254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2015.1113254%26sid%3Dliteratum%253Aachs%26aulast%3DSwierczewska%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DWhat%2520is%2520the%2520future%2520of%2520PEGylated%2520therapies%253F%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2015%26volume%3D20%26spage%3D531%26epage%3D536%26doi%3D10.1517%2F14728214.2015.1113254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turecek, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivens, I. A.</span></span> <span> </span><span class="NLM_article-title">PEGylation of biopharmaceuticals: A review of chemistry and nonclinical safety information of approved drugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2015.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.xphs.2015.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26869412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFegu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=460-475&author=P.+L.+Turecekauthor=M.+J.+Bossardauthor=F.+Schoetensauthor=I.+A.+Ivens&title=PEGylation+of+biopharmaceuticals%3A+A+review+of+chemistry+and+nonclinical+safety+information+of+approved+drugs&doi=10.1016%2Fj.xphs.2015.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs</span></div><div class="casAuthors">Turecek, Peter L.; Bossard, Mary J.; Schoetens, Freddy; Ivens, Inge A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">460-475</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Modification of biopharmaceutical mols. by covalent conjugation of polyethylene glycol (PEG) mols. is known to enhance pharmacol. and pharmaceutical properties of proteins and other large mols. and has been used successfully in 12 approved drugs.  Both linear and branched-chain PEG reagents with mol. sizes of up to 40 kDa have been used with a variety of different PEG derivs. with different linker chemistries.  This review describes the properties of PEG itself, the history and evolution of PEGylation chem., and provides examples of PEGylated drugs with an established medical history.  A trend toward the use of complex PEG architectures and larger PEG polymers, but with very pure and well-characterized PEG reagents is described.  Nonclin. toxicol. findings related to PEG in approved PEGylated biopharmaceuticals are summarized.  The effect attributed to the PEG part of the mols. as obsd. in 5 of the 12 marketed products was cellular vacuolation seen microscopically mainly in phagocytic cells which is likely related to their biol. function to absorb and remove particles and macromols. from blood and tissues.  Experience with marketed PEGylated products indicates that adverse effects in toxicol. studies are usually related to the active part of the drug but not to the PEG moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwuuECcM7dMLVg90H21EOLACvtfcHk0liSiDLqPq5W7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFegu7fK&md5=c1aa0cf83b58d8707c9c79b9825f737d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2015.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2015.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DTurecek%26aufirst%3DP.%2BL.%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DIvens%26aufirst%3DI.%2BA.%26atitle%3DPEGylation%2520of%2520biopharmaceuticals%253A%2520A%2520review%2520of%2520chemistry%2520and%2520nonclinical%2520safety%2520information%2520of%2520approved%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26spage%3D460%26epage%3D475%26doi%3D10.1016%2Fj.xphs.2015.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Current drug research on PEGylation with small molecular agents</span>. <i>Prog. Polym. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/j.progpolymsci.2012.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.progpolymsci.2012.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=421-444&author=W.+Liauthor=P.+Zhanauthor=E.+De+Clercqauthor=H.+Louauthor=X.+Liu&title=Current+drug+research+on+PEGylation+with+small+molecular+agents&doi=10.1016%2Fj.progpolymsci.2012.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current drug research on PEGylation with small molecular agents</span></div><div class="casAuthors">Li, Wenjun; Zhan, Peng; De Clercq, Erik; Lou, Hongxiang; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Polymer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">421-444</span>CODEN:
                <span class="NLM_cas:coden">PRPSB8</span>;
        ISSN:<span class="NLM_cas:issn">0079-6700</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  PEGylation, covalent attaching polyethylene glycol (PEG) polymers to therapeutic agents, is one of the most promising techniques to improve the therapeutic effect of drugs.  Initially, this technol. is mainly applied with macromol. drugs, such as proteins, enzymes, with ten PEGylated biomacromols. approved by the FDA for the treatment of related diseases.  The clin. successful use of PEGylated macromol. drug has promoted the application of this technol. with small mols. drugs to overcome shortcomings assocd. with therapy, such as possible low soly., high toxicity, undesirable pharmaceutical characteristics and nonspecific biodistribution profiles.  So far, 4 PEGylated small drugs were taken into clin. trials.  This review mainly focuses on the recent advances of PEGylated small mols., including their general configuration, and the current merits and limits of PEG modification.  Herein PEG delivery systems are distinguished by therapeutic application (anti-tumor, anti-inflammatory, etc.) and their corresponding PEGylated small mols. are described in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1c3uJ8cWgm7Vg90H21EOLACvtfcHk0liSiDLqPq5W7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE&md5=eb609a4d59ce7e8cc5cf443ce8def9b4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.progpolymsci.2012.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.progpolymsci.2012.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DCurrent%2520drug%2520research%2520on%2520PEGylation%2520with%2520small%2520molecular%2520agents%26jtitle%3DProg.%2520Polym.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D421%26epage%3D444%26doi%3D10.1016%2Fj.progpolymsci.2012.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, D. H.</span></span> <span> </span><span class="NLM_article-title">Emerging PEGylated non-biologic drugs</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1080/14728214.2019.1604684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1080%2F14728214.2019.1604684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=30957581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFymsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=107-119&author=E.+J.+Parkauthor=J.+Choiauthor=K.+C.+Leeauthor=D.+H.+Na&title=Emerging+PEGylated+non-biologic+drugs&doi=10.1080%2F14728214.2019.1604684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging PEGylated non-biologic drugs</span></div><div class="casAuthors">Park, Eun Ji; Choi, Jiyoung; Lee, Kang Choon; Na, Dong Hee</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-119</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  PEGylation is a well-established technol. for improving the therapeutic value of drugs by attaching polyethylene glycol (PEG).  The first PEGylated enzyme products appeared on the market in the early 1990s; currently, more than 18 PEGylated products have been approved by Food and Drug Administration, which encompass various classes of drug mols., such as enzymes, interferons, granulocyte colony-stimulating factors, hormones, antibody fragments, coagulation factors, oligonucleotide aptamers, synthetic peptides, and small org. mols.  While PEGylated products mainly comprise biol. drugs, such as recombinant proteins and enzymes, non-biol. drugs have recently emerged as a target for PEGylation.  This review focuses on the recent development of PEGylated non-biol. drugs, such as small org. mols., synthetic peptides, and aptamers.  Several PEGylated versions of anti-cancer drugs, opioid agonists, glucagon-like peptide-1 receptor agonists, and oligonucleotide aptamers are in active development stage, and it is likely that they will have a dramatic impact on the market.  Although some safety concerns about PEG in clin. trials have been recently issued, PEGylation is still a com. attractive proposition as a half-life extension technol. for long-acting drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz1IR_nY7BprVg90H21EOLACvtfcHk0lh0P7oi77rhTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFymsbw%253D&md5=497649fb4495b387f97b761bee0cedb3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F14728214.2019.1604684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728214.2019.1604684%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DNa%26aufirst%3DD.%2BH.%26atitle%3DEmerging%2520PEGylated%2520non-biologic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2019%26volume%3D24%26spage%3D107%26epage%3D119%26doi%3D10.1080%2F14728214.2019.1604684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilyuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, C. F.,  III</span></span> <span> </span><span class="NLM_article-title">Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1021/ml400370w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400370w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=133-137&author=S.+Asanoauthor=J.+Gavrilyukauthor=D.+R.+Burtonauthor=C.+F.+Barbas&title=Preparation+and+activities+of+macromolecule+conjugates+of+the+CCR5+antagonist+Maraviroc&doi=10.1021%2Fml400370w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc</span></div><div class="casAuthors">Asano, Shigehiro; Gavrilyuk, Julia; Burton, Dennis R.; Barbas, Carlos F., III</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-137</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CCR5 antagonists are among the most advanced approaches in HIV therapy and may also be relevant to treatment of graft-vs.-host disease and Staphylococcus aureus infection.  To expand the potential of the only approved CCR5 antagonist, Maraviroc, we studied derivs. that would enable functional linkage of Maraviroc to long-lived carriers.  Through targeted synthesis, we discovered an effective linkage site on Maraviroc and demonstrate the potential of these derivs. to prep. potent chem. programmed antibodies and PEGylated derivs.  The resulting compds. effectively neutralized a variety of HIV-1 isolates.  Both chem. programmed antibody and PEGylation approaches extend the neutralization activity of serum circulating Maraviroc.  Derivation of a successful conjugation strategy for Maraviroc should further enable its use in chem. programmed vaccines, novel bispecific antibodies, and topical microbicides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3dDcVML2YWbVg90H21EOLACvtfcHk0lh0P7oi77rhTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P&md5=ea7c9d3c1c6161e1115a9a67de4bcce3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml400370w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400370w%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DGavrilyuk%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DPreparation%2520and%2520activities%2520of%2520macromolecule%2520conjugates%2520of%2520the%2520CCR5%2520antagonist%2520Maraviroc%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D133%26epage%3D137%26doi%3D10.1021%2Fml400370w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirtzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katre, N. V.</span></span> <span> </span><span class="NLM_article-title">Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">15064</span>– <span class="NLM_lpage">15070</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)68146-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS0021-9258%2818%2968146-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=3049599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADyaL1cXlvFOjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=15064-15070&author=M.+J.+Knaufauthor=D.+P.+Bellauthor=P.+Hirtzerauthor=Z.+P.+Luoauthor=J.+D.+Youngauthor=N.+V.+Katre&title=Relationship+of+effective+molecular+size+to+systemic+clearance+in+rats+of+recombinant+interleukin-2+chemically+modified+with+water-soluble+polymers&doi=10.1016%2FS0021-9258%2818%2968146-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers</span></div><div class="casAuthors">Knauf, Michael J.; Bell, Dick P.; Hirtzer, Pam; Luo, Zhen Ping; Young, John D.; Katre, Nandini V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">15064-70</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The effects of a variety of chem. modification of recombinant human interleukin-2 (rIL-2) on its pharmacokinetic behavior in rats were examd.  Unmodified rIL-2 is cleared from plasma with half-lives of 3 and 44 min for the α and β phases.  Modification of rIL-2 with monomethoxy polyethylene glycol or polyoxyethylated glycerol increased the half-lives as much as 20-fold, although the vol. of distribution remained unchanged at 88 mL/kg.  The clearance rates correlated with the effective mol. size of the modified protein detd. by size exclusion chromatog.  Clearance decreased rapidly as the effective mol. size increased from 19.5 to 70 kDa, whereas above 70 kDa the clearance decreased more slowly.  This abrupt change at 70 kDa may be related to the permeability threshold of the kidney glomerular membrane which retains proteins larger than albumin in the plasma.  Using the relationship between clearance and effective mol. size, the clearance rates of mixts. of modified rIL-2 could be predicted based on their av. effective mol. size.  Since the effectiveness of rIL-2 therapy is likely to be related to its pharmacokinetic behavior, the ability to design a mol. with a predictable time course in plasma provides a means to study this relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtM7K-zEKBLVg90H21EOLACvtfcHk0ljlBVTU_GBl5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlvFOjtbo%253D&md5=e04f80283ef305c90a097629afb5fe9c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2968146-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252968146-3%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DM.%2BJ.%26aulast%3DBell%26aufirst%3DD.%2BP.%26aulast%3DHirtzer%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DZ.%2BP.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DKatre%26aufirst%3DN.%2BV.%26atitle%3DRelationship%2520of%2520effective%2520molecular%2520size%2520to%2520systemic%2520clearance%2520in%2520rats%2520of%2520recombinant%2520interleukin-2%2520chemically%2520modified%2520with%2520water-soluble%2520polymers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26spage%3D15064%26epage%3D15070%26doi%3D10.1016%2FS0021-9258%2818%2968146-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caliceti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, F. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(03)00108-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS0169-409X%2803%2900108-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=14499706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1yqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=1261-1277&author=P.+Calicetiauthor=F.+M.+Veronese&title=Pharmacokinetic+and+biodistribution+properties+of+poly%28ethylene+glycol%29-protein+conjugates&doi=10.1016%2FS0169-409X%2803%2900108-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates</span></div><div class="casAuthors">Caliceti, Paolo; Veronese, Francesco M.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-1277</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Peptide and protein PEGylation is usually undertaken to improve the biopharmaceutical properties of these drugs and, to date, several examples of conjugates with long permanence in the body as well as with localization ability in disease sites were reported.  Although a no. of studies on the in vivo behavior and fate of conjugates were performed, forecasting their pharmacokinetics is a difficult task since the pharmacokinetic profile is detd. by a no. of parameters which include physiol. and anatomical aspects of the recipient and physico-chem. properties of the deriv.  The most relevant perturbations of the protein mol. following PEG conjugation are: size enlargement, protein surface and glycosylation function masking, charge modification, and epitope shielding.  In particular, size enlargement slows down kidney ultrafiltration and promotes the accumulation into permeable tissues by the passive enhanced permeation and retention mechanism.  Charge and glycosylation function masking is revealed predominantly in reduced phagocytosis by the RES and liver cells.  Protein shielding reduces proteolysis and immune system recognition, which are important routes of elimination.  The specific effect of PEGylation on protein physico-chem. and biol. properties is strictly detd. by protein and polymer properties as well as by the adopted PEGylation strategy.  Relevant parameters to be considered in protein-polymer conjugates are: protein structure, mol. wt. and compn., polymer mol. wt. and shape, no. of linked polymer chains and conjugation chem.  The examples reported in this review show that general considerations could be useful in developing a target product, although significant deviations from the expected results can not be excluded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUnGBuleSog7Vg90H21EOLACvtfcHk0ljlBVTU_GBl5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1yqsb0%253D&md5=d26bf5b68a7aa9d1f4f0d10feb3e9593</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2803%2900108-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252803%252900108-X%26sid%3Dliteratum%253Aachs%26aulast%3DCaliceti%26aufirst%3DP.%26aulast%3DVeronese%26aufirst%3DF.%2BM.%26atitle%3DPharmacokinetic%2520and%2520biodistribution%2520properties%2520of%2520poly%2528ethylene%2520glycol%2529-protein%2520conjugates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D1261%26epage%3D1277%26doi%3D10.1016%2FS0169-409X%2803%2900108-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">PEGylated leuprolide with improved pharmacokinetic properties</span>. <i>Bioorg.Med. Chem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115306</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2020.115306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.bmc.2020.115306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=31926774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115306&author=M.+Fuauthor=X.+Zhuangauthor=T.+Zhangauthor=Y.+Guanauthor=Q.+Mengauthor=Y.+Zhang&title=PEGylated+leuprolide+with+improved+pharmacokinetic+properties&doi=10.1016%2Fj.bmc.2020.115306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylated leuprolide with improved pharmacokinetic properties</span></div><div class="casAuthors">Fu, Mian; Zhuang, Xiaomei; Zhang, Tianhong; Guan, Ying; Meng, Qingbin; Zhang, Yongjun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">115306</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist widely used in androgen deprivation therapy for the treatment of advanced prostate cancer, suffers from a short circulating half-life like other peptide therapeutics.  As an attempt to improve its pharmacokinetic properties, two PEGylated leuprolides with different mol. wt. were synthesized utilizing N-hydroxysuccinimidyl (NHS) conjugation chem.  The reaction conditions, including reaction temp., reaction time and feed ratio of the reactants, were optimized to obtain a higher yield.  Reverse-phase high performance liq. chromatog. (RP-HPLC) characterization indicates a high purity of the resulting conjugates.  Matrix-assisted laser desorption mass spectrometry (MALDI-MS) characterization suggests a 1:1 PEGylation.  1H NMR study reveals that the reaction occurs on the imidazolyl group on the histidine residue and the conjugates are stable in pH7.4 aq. solns.  The in vitro bioactivity of the conjugates was evaluated using both hormone-sensitive and hormone-insensitive cell lines.  It was found that the PEGylated peptides can still counteract the stimulatory action of androgens and the mitogenic action of epidermal growth factor on cell proliferation.  The in vivo bioactivity of the conjugates was also tested.  Like the unmodified peptide, administration of the conjugates to male rats leads to an initial testosterone surge, followed by a suppression of testosterone secretion.  Pharmacokinetics of the drugs after i.v. and s.c. administrations were detd.  In both cases, a prolonged circulating half-life, an increased AUC, and a decreased Cl_F were obsd. for the PEGylated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnpaELD5IQl7Vg90H21EOLACvtfcHk0lhkWeOzdMwoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Kqtw%253D%253D&md5=6e4f95a9853db14b3bb95de17f19b4a2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2020.115306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2020.115306%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DM.%26aulast%3DZhuang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPEGylated%2520leuprolide%2520with%2520improved%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.Med.%2520Chem%26date%3D2020%26volume%3D28%26spage%3D115306%26doi%3D10.1016%2Fj.bmc.2020.115306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fishburn, C. S.</span></span> <span> </span><span class="NLM_article-title">The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">4167</span>– <span class="NLM_lpage">4183</span>, <span class="refDoi"> DOI: 10.1002/jps.21278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1002%2Fjps.21278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=18200508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sgt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=4167-4183&author=C.+S.+Fishburn&title=The+pharmacology+of+PEGylation%3A+balancing+PD+with+PK+to+generate+novel+therapeutics&doi=10.1002%2Fjps.21278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics</span></div><div class="casAuthors">Fishburn, C. Simone</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4167-4183</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Conjugation of macromols. to polyethylene glycol (PEG) has emerged recently as an effective strategy to alter the pharmacokinetic (PK) profiles of a variety of drugs, and thereby to improve their therapeutic potential.  PEG conjugation increases retention of drugs in the circulation by protecting against enzymic digestion, slowing filtration by the kidneys and reducing the generation of neutralizing antibodies.  Often, PEGylation leads to a loss in binding affinity due to steric interference with the drug-target binding interaction.  This loss in potency is offset by the longer circulating half-life of the drugs, and the resulting change in PK-PD profile has led in some cases to enabling of drugs that otherwise could not be developed, and in others to improvements in existing drugs.  Thus, whereas most approaches to drug development seek to increase the activity of drugs directly, the creation of PEGylated drugs seeks to balance the pharmacodynamic (PD) and pharmacokinetic properties to produce novel therapies that will meet with both increased efficacy and greater compliance in the clin. setting.  This review examines some of the PEGylated drugs developed in recent years, and highlights some of the different strategies taken to employ PEG to maximize the overall PK-PD profiles of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC7WViWdoJF7Vg90H21EOLACvtfcHk0lhkWeOzdMwoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sgt7rI&md5=d5e71d245c490eb575d9eda654badd45</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjps.21278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21278%26sid%3Dliteratum%253Aachs%26aulast%3DFishburn%26aufirst%3DC.%2BS.%26atitle%3DThe%2520pharmacology%2520of%2520PEGylation%253A%2520balancing%2520PD%2520with%2520PK%2520to%2520generate%2520novel%2520therapeutics%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D4167%26epage%3D4183%26doi%3D10.1002%2Fjps.21278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itadani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Identification of membrane-type receptor for bile acids (M-BAR)</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(02)02550-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2FS0006-291X%2802%2902550-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=12419312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot12kt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=714-719&author=T.+Maruyamaauthor=Y.+Miyamotoauthor=T.+Nakamuraauthor=Y.+Tamaiauthor=H.+Okadaauthor=E.+Sugiyamaauthor=T.+Nakamuraauthor=H.+Itadaniauthor=K.+Tanaka&title=Identification+of+membrane-type+receptor+for+bile+acids+%28M-BAR%29&doi=10.1016%2FS0006-291X%2802%2902550-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of membrane-type receptor for bile acids (M-BAR)</span></div><div class="casAuthors">Maruyama, Takaharu; Miyamoto, Yasuhisa; Nakamura, Takao; Tamai, Yoshitaka; Okada, Hiromasa; Sugiyama, Eiji; Nakamura, Tatsuji; Itadani, Hiraku; Tanaka, Kenichi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">714-719</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Bile acids play an essential role in the solubilization and absorption of dietary fat and lipid-sol. vitamins.  Bile acids also modulate the transcription of various genes for enzymes and transport proteins for their own and cholesterol homeostasis through binding to nuclear receptors.  Here we report a novel category of bile acid receptor, a membrane-type G protein-coupled receptor (GPCR), BG37.  Bile acids induced rapid and dose-dependent elevation of intracellular cAMP levels in BG37-expressing cells, but not in mock-transfected cells, independently of nuclear receptor expression.  The rank order of potency of various bile acids for BG37-expressing cells was different from that for the nuclear receptor-mediated response.  These observations demonstrate the presence of two independent signaling pathways for bile acids; membrane-type GPCR for rapid signaling and nuclear receptors for delayed signaling.  Expression of BG37 was detected in various specific tissues, suggesting its physiol. role, although it remains to be further characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFW81vc2oQfLVg90H21EOLACvtfcHk0lhkWeOzdMwoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot12kt78%253D&md5=6d3133ccf80e6222d7beb52ae31f3324</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2902550-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252902550-0%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DTamai%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DE.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DItadani%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520membrane-type%2520receptor%2520for%2520bile%2520acids%2520%2528M-BAR%2529%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D298%26spage%3D714%26epage%3D719%26doi%3D10.1016%2FS0006-291X%2802%2902550-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span> <span> </span><span class="NLM_article-title">Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.01.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.bbrc.2005.01.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=15721318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFSisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2005&pages=386-390&author=S.+Katsumaauthor=A.+Hirasawaauthor=G.+Tsujimoto&title=Bile+acids+promote+glucagon-like+peptide-1+secretion+through+TGR5+in+a+murine+enteroendocrine+cell+line+STC-1&doi=10.1016%2Fj.bbrc.2005.01.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1</span></div><div class="casAuthors">Katsuma, Susumu; Hirasawa, Akira; Tsujimoto, Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">386-390</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Bile acids play essential roles in the absorption of dietary lipids and in the regulation of bile acid biosynthesis.  Recently, a G protein-coupled receptor, TGR5, was identified as a cell-surface bile acid receptor.  In this study, we show that bile acids promote glucagon-like peptide-1 (GLP-1) secretion through TGR5 in a murine enteroendocrine cell line STC-1.  In STC-1 cells, bile acids promoted GLP-1 secretion in a dose-dependent manner.  As STC-1 cells express TGR5 mRNA, we examd. whether bile acids induce GLP-1 secretion through TGR5.  RNA interference expts. showed that reduced expression of TGR5 resulted in reduced secretion of GLP-1.  Furthermore, transient transfection of STC-1 cells with an expression plasmid contg. TGR5 significantly enhanced GLP-1 secretion, indicating that bile acids promote GLP-1 secretion through TGR5 in STC-1 cells.  Bile acids induced rapid and dose-dependent elevation of intracellular cAMP levels in STC-1 cells.  An adenylate cyclase inhibitor, MDL 12330A, significantly suppressed bile acid-promoted GLP-1 secretion, suggesting that bile acids induce GLP-1 secretion via intracellular cAMP prodn. in STC-1 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvgEFEJrvpGrVg90H21EOLACvtfcHk0lixNQ9BSN15vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFSisbo%253D&md5=8ce72806c7bc190a28031f37845d2291</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.01.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.01.139%26sid%3Dliteratum%253Aachs%26aulast%3DKatsuma%26aufirst%3DS.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DBile%2520acids%2520promote%2520glucagon-like%2520peptide-1%2520secretion%2520through%2520TGR5%2520in%2520a%2520murine%2520enteroendocrine%2520cell%2520line%2520STC-1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D329%26spage%3D386%26epage%3D390%26doi%3D10.1016%2Fj.bbrc.2005.01.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houten, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffolete, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messaddeq, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harney, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezaki, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span> <span> </span><span class="NLM_article-title">Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>439</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1038/nature04330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1038%2Fnature04330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=16400329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2006&pages=484-489&author=M.+Watanabeauthor=S.+M.+Houtenauthor=C.+Matakiauthor=M.+A.+Christoffoleteauthor=B.+W.+Kimauthor=H.+Satoauthor=N.+Messaddeqauthor=J.+W.+Harneyauthor=O.+Ezakiauthor=T.+Kodamaauthor=K.+Schoonjansauthor=A.+C.+Biancoauthor=J.+Auwerx&title=Bile+acids+induce+energy+expenditure+by+promoting+intracellular+thyroid+hormone+activation&doi=10.1038%2Fnature04330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation</span></div><div class="casAuthors">Watanabe, Mitsuhiro; Houten, Sander M.; Mataki, Chikage; Christoffolete, Marcelo A.; Kim, Brian W.; Sato, Hiroyuki; Messaddeq, Nadia; Harney, John W.; Ezaki, Osamu; Kodama, Tatsuhiko; Schoonjans, Kristina; Bianco, Antonio C.; Auwerx, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">7075</span>),
    <span class="NLM_cas:pages">484-489</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">While bile acids (BAs) have long been known to be essential in dietary lipid absorption and cholesterol catabolism, in recent years an important role for BAs as signaling mols. has emerged.  BAs activate mitogen-activated protein kinase pathways, are ligands for the G-protein-coupled receptor (GPCR) TGR5 and activate nuclear hormone receptors such as farnesoid X receptor α (FXR-α; NR1H4).  FXR-α regulates the enterohepatic recycling and biosynthesis of BAs by controlling the expression of genes such as the short heterodimer partner (SHP; NR0B2) that inhibits the activity of other nuclear receptors.  The FXR-α-mediated SHP induction also underlies the downregulation of the hepatic fatty acid and triglyceride biosynthesis and very-low-d. lipoprotein prodn. mediated by sterol-regulatory-element-binding protein 1c.  This indicates that BAs might be able to function beyond the control of BA homeostasis as general metabolic integrators.  The administration of BAs to mice increases energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin.  This novel metabolic effect of BAs is critically dependent on induction of the cyclic-AMP-dependent thyroid hormone activating enzyme type 2 iodothyronine deiodinase (D2) because it is lost in D2-/- mice.  Treatment of brown adipocytes and human skeletal myocytes with BA increases D2 activity and oxygen consumption.  These effects are independent of FXR-α, and instead are mediated by increased cAMP prodn. that stems from the binding of BAs with the G-protein-coupled receptor TGR5.  In both rodents and humans, the most thermogenically important tissues are specifically targeted by this mechanism because they coexpress D2 and TGR5.  The BA-TGR5-cAMP-D2 signaling pathway is therefore a crucial mechanism for fine-tuning energy homeostasis that can be targeted to improve metabolic control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvq784CAfKkrVg90H21EOLACvtfcHk0lixNQ9BSN15vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWmuw%253D%253D&md5=13c8bfe241fac294ba3fb1de99577d67</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature04330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04330%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DHouten%26aufirst%3DS.%2BM.%26aulast%3DMataki%26aufirst%3DC.%26aulast%3DChristoffolete%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DB.%2BW.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DMessaddeq%26aufirst%3DN.%26aulast%3DHarney%26aufirst%3DJ.%2BW.%26aulast%3DEzaki%26aufirst%3DO.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DBianco%26aufirst%3DA.%2BC.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DBile%2520acids%2520induce%2520energy%2520expenditure%2520by%2520promoting%2520intracellular%2520thyroid%2520hormone%2520activation%26jtitle%3DNature%26date%3D2006%26volume%3D439%26spage%3D484%26epage%3D489%26doi%3D10.1038%2Fnature04330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmstrom, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umetani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span> <span> </span><span class="NLM_article-title">The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1210/me.2010-0460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1210%2Fme.2010-0460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=21454404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsl2msLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1066-1071&author=T.+Liauthor=S.+R.+Holmstromauthor=S.+Kirauthor=M.+Umetaniauthor=D.+R.+Schmidtauthor=S.+A.+Kliewerauthor=D.+J.+Mangelsdorf&title=The+G+protein-coupled+bile+acid+receptor%2C+TGR5%2C+stimulates+gallbladder+filling&doi=10.1210%2Fme.2010-0460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling</span></div><div class="casAuthors">Li, Tingting; Holmstrom, Sam R.; Kir, Serkan; Umetani, Michihisa; Schmidt, Daniel R.; Kliewer, Steven A.; Mangelsdorf, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">TGR5 is a G protein-coupled bile acid receptor present in brown adipose tissue and intestine, where its agonism increases energy expenditure and lowers blood glucose.  Thus, it is an attractive drug target for treating human metabolic disease.  However, TGR5 is also highly expressed in gallbladder, where its functions are less well characterized.  Here, we demonstrate that TGR5 stimulates the filling of the gallbladder with bile.  Gallbladder vol. was increased in wild-type but not Tgr5-/- mice by administration of either the naturally occurring TGR5 agonist, lithocholic acid, or the synthetic TGR5 agonist, INT-777.  These effects were independent of fibroblast growth factor 15, an enteric hormone previously shown to stimulate gallbladder filling.  Ex vivo analyses using gallbladder tissue showed that TGR5 activation increased cAMP concns. and caused smooth muscle relaxation in a TGR5-dependent manner.  These data reveal a novel, gallbladder-intrinsic mechanism for regulating gallbladder contractility.  They further suggest that TGR5 agonists should be assessed for effects on human gallbladder as they are developed for treating metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfl9_dLsVML7Vg90H21EOLACvtfcHk0liKje2SG8VnDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsl2msLs%253D&md5=90d4a0754fe69f55b6a9b207351cd1a9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fme.2010-0460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2010-0460%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DHolmstrom%26aufirst%3DS.%2BR.%26aulast%3DKir%26aufirst%3DS.%26aulast%3DUmetani%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DD.%2BR.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520G%2520protein-coupled%2520bile%2520acid%2520receptor%252C%2520TGR5%252C%2520stimulates%2520gallbladder%2520filling%26jtitle%3DMol.%2520Endocrinol.%26date%3D2011%26volume%3D25%26spage%3D1066%26epage%3D1071%26doi%3D10.1210%2Fme.2010-0460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antidiabetic activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10475</span>– <span class="NLM_lpage">10489</span>, <span class="refDoi"> DOI: 10.1021/jm301071h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301071h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10475-10489&author=H.+Duanauthor=M.+Ningauthor=X.+Chenauthor=Q.+Zouauthor=L.+Zhangauthor=Y.+Fengauthor=L.+Zhangauthor=Y.+Lengauthor=J.+Shen&title=Design%2C+synthesis%2C+and+antidiabetic+activity+of+4-Phenoxynicotinamide+and+4-Phenoxypyrimidine-5-carboxamide+derivatives+as+potent+and+orally+efficacious+TGR5+agonists&doi=10.1021%2Fjm301071h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Antidiabetic Activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide Derivatives as Potent and Orally Efficacious TGR5 Agonists</span></div><div class="casAuthors">Duan, Hongliang; Ning, Mengmeng; Chen, Xiaoyan; Zou, Qingan; Zhang, Liming; Feng, Ying; Zhang, Lina; Leng, Ying; Shen, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10475-10489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivs. as potent and orally efficacious TGR5 agonists are reported.  Several 4-phenoxynicotinamide derivs. were found to activate human and mouse TGR5 (hTGR5 and mTGR5) with EC50 values in the low nanomolar range.  Compd. I, with an EC50 value of 0.72 nM on hTGR5 and an EC50 value of 6.2 nM on mTGR5, was selected for further in vivo efficacy studies.  This compd. exhibited a significant dose-dependent glucagon-like peptide-1 (GLP-1) secretion effect.  A single oral dose of I (50 mg/kg) significantly reduced blood glucose levels in db/db mice and caused a 49% redn. in the area under the blood glucose curve (AUC)0-120 min following an oral glucose tolerance test (OGTT) in imprinting control region (ICR) mice.  However, the compd. I stimulated gallbladder filling, which might result in side effects to the gallbladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6wEfPKvXJbVg90H21EOLACvtfcHk0liKje2SG8VnDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfF&md5=2b031e54d7f089c039fcc8f87d42df4c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm301071h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301071h%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DH.%26aulast%3DNing%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antidiabetic%2520activity%2520of%25204-Phenoxynicotinamide%2520and%25204-Phenoxypyrimidine-5-carboxamide%2520derivatives%2520as%2520potent%2520and%2520orally%2520efficacious%2520TGR5%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10475%26epage%3D10489%26doi%3D10.1021%2Fjm301071h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nodop
Mazurek, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaude, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthukumarana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilpin, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinallo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzmich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harcken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerny, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modis, L. K.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Bile Acid Receptor 1 stimulation mediates arterial vasodilation through a KCa1.1 (BKCa)-dependent mechanism</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.210005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1124%2Fjpet.113.210005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=24399854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFajtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=421-431&author=R.+M.+Fryerauthor=K.+J.+Ngauthor=S.+G.+Nodop%0AMazurekauthor=L.+Patnaudeauthor=D.+J.+Skowauthor=A.+Muthukumaranaauthor=K.+E.+Gilpinauthor=R.+M.+Dinalloauthor=D.+Kuzmichauthor=J.+Lordauthor=S.+Sanyalauthor=H.+Yuauthor=C.+Harckenauthor=M.+A.+Cernyauthor=E.+R.+Hickeyauthor=L.+K.+Modis&title=G+Protein-Coupled+Bile+Acid+Receptor+1+stimulation+mediates+arterial+vasodilation+through+a+KCa1.1+%28BKCa%29-dependent+mechanism&doi=10.1124%2Fjpet.113.210005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled bile acid receptor 1 stimulation mediates arterial vasodilation through a KCa1.1 (BKCa)-dependent mechanism</span></div><div class="casAuthors">Fryer, Ryan M.; Ng, Khing Jow; Mazurek, Suzanne G. Nodop; Patnaude, Lori; Skow, Donna J.; Muthukumarana, Akalushi; Gilpin, Kyle E.; Dinallo, Roger M.; Kuzmich, Daniel; Lord, John; Sanyal, Sulagna; Yu, Hui; Harcken, Christian; Cerny, Matthew C.; Hickey, Eugene R.; Modis, Louise K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">421-431, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Bile acids (BAs) and BA receptors, including G protein-coupled bile acid receptor 1 (GPBAR1), represent novel targets for the treatment of metabolic and inflammatory disorders.  However, BAs elicit myriad effects on cardiovascular function, although this has not been specifically ascribed to GPBAR1.  This study was designed to test whether stimulation of GPBAR1 elicits effects on cardiovascular function that are mechanism based that can be identified in acute ex vivo and in vivo cardiovascular models, to delineate whether effects were due to pathways known to be modulated by BAs, and to establish whether a therapeutic window between in vivo cardiovascular liabilities and on-target efficacy could be defined.  The results demonstrated that the infusion of three structurally diverse and selective GPBAR1 agonists produced marked redns. in vascular tone and blood pressure in dog, but not in rat, as well as reflex tachycardia and a pos. inotropic response, effects that manifested in an enhanced cardiac output.  Changes in cardiovascular function were unrelated to modulation of the levothyroxine/thyroxine axis and were nitric oxide independent.  A direct effect on vascular tone was confirmed in dog isolated vascular rings, whereby concn.-dependent decreases in tension that were tightly correlated with redns. in vascular tone obsd. in vivo and were blocked by iberiotoxin.  Compd. concns. in which cardiovascular effects occurred, both ex vivo and in vivo, could not be sepd. from those necessary for modulation of GPBAR1-mediated efficacy, resulting in project termination.  These results are the first to clearly demonstrate direct and potent peripheral arterial vasodilation due to GPBAR1 stimulation in vivo through activation of large conductance Ca2+ activated potassium channel KCa1.1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbGVwYRqt84LVg90H21EOLACvtfcHk0lgsuxHW_eTFlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFajtL0%253D&md5=fe48570c7b439077da6787b5a292d369</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.210005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.210005%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DNg%26aufirst%3DK.%2BJ.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%2BG.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DSkow%26aufirst%3DD.%2BJ.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DGilpin%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DKuzmich%26aufirst%3DD.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DHarcken%26aufirst%3DC.%26aulast%3DCerny%26aufirst%3DM.%2BA.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DModis%26aufirst%3DL.%2BK.%26atitle%3DG%2520Protein-Coupled%2520Bile%2520Acid%2520Receptor%25201%2520stimulation%2520mediates%2520arterial%2520vasodilation%2520through%2520a%2520KCa1.1%2520%2528BKCa%2529-dependent%2520mechanism%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D421%26epage%3D431%26doi%3D10.1124%2Fjpet.113.210005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasalle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoguet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennuyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piveteau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belloy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lestavel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorchies, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulahjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herledan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tailleux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span> <span> </span><span class="NLM_article-title">Topical intestinal aminoimidazole agonists of G-Protein-Coupled Bile Acid Receptor 1 promote Glucagon Like Peptide-1 secretion and improve glucose tolerance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4185</span>– <span class="NLM_lpage">4211</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01873</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01873" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4185-4211&author=M.+Lasalleauthor=V.+Hoguetauthor=N.+Hennuyerauthor=F.+Lerouxauthor=C.+Piveteauauthor=L.+Belloyauthor=S.+Lestavelauthor=E.+Vallezauthor=E.+Dorchiesauthor=I.+Duplanauthor=E.+Sevinauthor=M.+Culotauthor=F.+Gosseletauthor=R.+Boulahjarauthor=A.+Herledanauthor=B.+Staelsauthor=B.+Deprezauthor=A.+Tailleuxauthor=J.+Charton&title=Topical+intestinal+aminoimidazole+agonists+of+G-Protein-Coupled+Bile+Acid+Receptor+1+promote+Glucagon+Like+Peptide-1+secretion+and+improve+glucose+tolerance&doi=10.1021%2Facs.jmedchem.6b01873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance</span></div><div class="casAuthors">Lasalle, Manuel; Hoguet, Vanessa; Hennuyer, Nathalie; Leroux, Florence; Piveteau, Catherine; Belloy, Loic; Lestavel, Sophie; Vallez, Emmanuelle; Dorchies, Emilie; Duplan, Isabelle; Sevin, Emmanuel; Culot, Maxime; Gosselet, Fabien; Boulahjar, Rajaa; Herledan, Adrien; Staels, Bart; Deprez, Benoit; Tailleux, Anne; Charton, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4185-4211</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The role of the G-Protein-coupled Bile Acid Receptor TGR5 in various organs, tissues and cell types, specifically in intestinal endocrine L-cells and brown adipose tissue, has made it a promising therapeutical target in several diseases, esp. type-2 diabetes and metabolic syndrome.  However, recent studies have shown deleterious on-target effects of systemic TGR5 agonists.  To avoid these systemic effects while stimulating Glucagon Like Peptide-1 (GLP-1) secreting enteroendocrine L-cells, the authors have designed TGR5 agonists with low intestinal permeability.  In this paper, the authors describe their synthesis, characterization, and biol. evaluation.  Amongst them, compd. I is a potent GLP-1 secretagogue, has low effect on gallbladder vol., and improves glucose homeostasis in a preclin. murine model of diet-induced obesity and insulin-resistance, making the proof of concept of the potential of topical intestinal TGR5 agonists as therapeutic agents in type-2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR4_PCsJZjAbVg90H21EOLACvtfcHk0lgsuxHW_eTFlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLY%253D&md5=717a5fdbb957d4f6949bf032d0eb6386</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01873%26sid%3Dliteratum%253Aachs%26aulast%3DLasalle%26aufirst%3DM.%26aulast%3DHoguet%26aufirst%3DV.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DBelloy%26aufirst%3DL.%26aulast%3DLestavel%26aufirst%3DS.%26aulast%3DVallez%26aufirst%3DE.%26aulast%3DDorchies%26aufirst%3DE.%26aulast%3DDuplan%26aufirst%3DI.%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DGosselet%26aufirst%3DF.%26aulast%3DBoulahjar%26aufirst%3DR.%26aulast%3DHerledan%26aufirst%3DA.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DTailleux%26aufirst%3DA.%26aulast%3DCharton%26aufirst%3DJ.%26atitle%3DTopical%2520intestinal%2520aminoimidazole%2520agonists%2520of%2520G-Protein-Coupled%2520Bile%2520Acid%2520Receptor%25201%2520promote%2520Glucagon%2520Like%2520Peptide-1%2520secretion%2520and%2520improve%2520glucose%2520tolerance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4185%26epage%3D4211%26doi%3D10.1021%2Facs.jmedchem.6b01873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span> <span> </span><span class="NLM_article-title">Bile Acid Reabsorption Inhibitors (BARI): novel hypolipidemic drugs</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.2174/092986706776361003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.2174%2F092986706776361003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=16611081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=997-1016&author=W.+Kramerauthor=H.+Glombik&title=Bile+Acid+Reabsorption+Inhibitors+%28BARI%29%3A+novel+hypolipidemic+drugs&doi=10.2174%2F092986706776361003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs</span></div><div class="casAuthors">Kramer, Werner; Glombik, Heiner</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">997-1016</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The enterohepatic circulation of bile acids is a major regulator of serum cholesterol homeostasis.  After biosynthesis from cholesterol in the liver, bile acids are secreted with bile into the lumen of the small intestine to aid in the digestion and absorption of fat and fat-sol. vitamins.  The bile acids are nearly quant. reabsorbed in the terminal ileum by a Na+-dependent transport system (IBAT) and are transported with portal blood to the liver and taken up by a second Na+-/bile acid cotransporter (LBAT) to be resecreted into bile.  In the liver bile acids inhibit the rate-limiting enzyme for the conversion of cholesterol into bile acid: cholesterol-7α-hydroxylase; interruption of the enterohepatic circulation of bile acids withdraws this feedback inhibition and leads to an upregulation of hepatic LDL-receptors with a concomitant decrease of serum LDL-levels.  Specific inhibitors of the ileal bile acid transporter belonging to different chemotypes have been developed in recent years for this purpose, some now entering clin. stage.  To exert a profound systemic effect these compds. do not need to be available systemically but can act from the luminal side of the small intestine, which offers the advantage to avoid the well-known adverse side effects of other hypolipidemic drugs like statins due to metab. and drug-drug interactions in the liver.  This implies several aspects in compd. optimization and drug development quite different from std. procedures, for example the concept of low absorption drugs was established to avoid systemic side effects.  This review article covers the mechanistic and therapeutic principles of the approach and presents an overview on the mol. target, the discovery of specific inhibitors and resp. optimization strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXNSDtAqiZbVg90H21EOLACvtfcHk0lj1QF4qd-0N_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D&md5=8411f5d6f3e3218ad5ba6cb8fe2075c4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F092986706776361003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361003%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DGlombik%26aufirst%3DH.%26atitle%3DBile%2520Acid%2520Reabsorption%2520Inhibitors%2520%2528BARI%2529%253A%2520novel%2520hypolipidemic%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D997%26epage%3D1016%26doi%3D10.2174%2F092986706776361003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charmot, D.</span></span> <span> </span><span class="NLM_article-title">Non-systemic drugs: a critical review</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1434</span>– <span class="NLM_lpage">1445</span>, <span class="refDoi"> DOI: 10.2174/138161212799504858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.2174%2F138161212799504858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=22300258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1434-1445&author=D.+Charmot&title=Non-systemic+drugs%3A+a+critical+review&doi=10.2174%2F138161212799504858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Non-systemic drugs: a critical review</span></div><div class="casAuthors">Charmot, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1434-1445</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Non-systemic drugs act within the intestinal lumen without reaching the systemic circulation.  The first generation included polymeric resins that sequester phosphate ions, potassium ions, or bile acids for the treatment of electrolyte imbalances or hypercholesteremia.  The field has evolved towards non-absorbable small mols. or peptides targeting luminal enzymes or transporters for the treatment of mineral metab. disorders, diabetes, gastrointestinal (GI) disorders, and enteric infections.  From a drug design and development perspective, non-systemic agents offer novel opportunities to address unmet medical needs while minimizing toxicity risks, but also present new challenges, including developing a better understanding and control of non-transcellular leakage pathways into the systemic circulation.  The pharmacokinetic-pharmacodynamic relationship of drugs acting in the GI tract can be complex due to the variability of intestinal transit, interaction with chyme, and the complex environment of the surface epithelia.  We review the main classes of nonabsorbable agents at various stages of development, and their therapeutic potential and limitations.  The rapid progress in the identification of intestinal receptors and transporters, their functional characterization and role in metabolic and inflammatory disorders, will undoubtedly renew interest in the development of novel, safe, non-systemic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdEQRhLF7irVg90H21EOLACvtfcHk0lj1QF4qd-0N_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKku7g%253D&md5=7a391aa741bb1a4bba9516b0f39acee1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F138161212799504858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799504858%26sid%3Dliteratum%253Aachs%26aulast%3DCharmot%26aufirst%3DD.%26atitle%3DNon-systemic%2520drugs%253A%2520a%2520critical%2520review%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1434%26epage%3D1445%26doi%3D10.2174%2F138161212799504858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasalle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulahjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoguet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Obbergen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span> <span> </span><span class="NLM_article-title">Access to newly functionalized imidazole derivatives: efficient synthesis of novel 5-amino-2-thioimidazoles using propylphosphonic anhydride (®T3P)</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2015.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.tetlet.2015.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFerug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=1011-1014&author=M.+Lasalleauthor=S.+Piconauthor=R.+Boulahjarauthor=V.+Hoguetauthor=J.+Van+Obbergenauthor=P.+Rousselauthor=B.+Deprezauthor=J.+Charton&title=Access+to+newly+functionalized+imidazole+derivatives%3A+efficient+synthesis+of+novel+5-amino-2-thioimidazoles+using+propylphosphonic+anhydride+%28%C2%AET3P%29&doi=10.1016%2Fj.tetlet.2015.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Access to newly functionalized imidazole derivatives: efficient synthesis of novel 5-amino-2-thioimidazoles using propylphosphonic anhydride (®T3P)</span></div><div class="casAuthors">Lasalle, Manuel; Picon, Sylvain; Boulahjar, Rajaa; Hoguet, Vanessa; Van Obbergen, Jolien; Roussel, Pascal; Deprez, Benoit; Charton, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1011-1014</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We describe here an efficient method to synthesize 5-amino-2-thioimidazole compds. by T3P-mediated cyclization of N-acetamidoisothiourea intermediates.  E.g., in presence of T3P, cyclization/cyclodehydration of N-acetamidoisothiourea intermediate (I) gave 58% imidazole deriv. (II).  The newly functionalized 5-amino-2-thioimidazole compds. are finally obtained in 5 steps from an amine as starting block.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDvXr2kChRcLVg90H21EOLACvtfcHk0lhhYAXsaiLzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFerug%253D%253D&md5=9bbd1dc423a88c19aea1808c85f3472b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DLasalle%26aufirst%3DM.%26aulast%3DPicon%26aufirst%3DS.%26aulast%3DBoulahjar%26aufirst%3DR.%26aulast%3DHoguet%26aufirst%3DV.%26aulast%3DVan%2BObbergen%26aufirst%3DJ.%26aulast%3DRoussel%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DCharton%26aufirst%3DJ.%26atitle%3DAccess%2520to%2520newly%2520functionalized%2520imidazole%2520derivatives%253A%2520efficient%2520synthesis%2520of%2520novel%25205-amino-2-thioimidazoles%2520using%2520propylphosphonic%2520anhydride%2520%2528%25C2%25AET3P%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D1011%26epage%3D1014%26doi%3D10.1016%2Fj.tetlet.2015.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versele, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselet, F.</span></span> <span> </span><span class="NLM_article-title">A miniaturized pump out method for characterizing molecule interaction with ABC transporters</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5529</span>, <span class="refDoi"> DOI: 10.3390/ijms20225529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.3390%2Fijms20225529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BB3cXptV2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=5529&author=E.+Sevinauthor=L.+Dehouckauthor=R.+Verseleauthor=M.+Culotauthor=F.+Gosselet&title=A+miniaturized+pump+out+method+for+characterizing+molecule+interaction+with+ABC+transporters&doi=10.3390%2Fijms20225529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A miniaturized pump out method for characterizing molecule interaction with ABC transporters</span></div><div class="casAuthors">Sevin, Emmanuel; Dehouck, Lucie; Versele, Romain; Culot, Maxime; Gosselet, Fabien</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5529</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Characterizing interaction of newly synthesized mols. with efflux pumps remains essential to improve their efficacy and safety.  Caco-2 cell line cultivated on inserts is widely used for measuring apparent permeability of drugs across biol. barriers, and for estg. their interaction with efflux pumps such as P-gp, BCRP and MRPs.  However, this method remains time consuming and expensive.  In addn., detection method is required for measuring mol. passage across cell monolayer and false results can be generated if drugs concns. used are too high as demonstrated with quinidine.  For this reason, we developed a new protocol based on the use of Caco-2 cell directly seeded on 96- or 384-well plates and the use of fluorescent substrates for efflux pumps.  We clearly obsd. that the new method reduces costs for mol. screening and leads to higher throughput compared to traditional use of Caco-2 cell model.  This accelerated model could provide quick feedback regarding the mol. design during the early stage of drug discovery and therefore reduce the no. of compds. to be further evaluated using the traditional Caco-2 insert method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpscFNnKALlMLVg90H21EOLACvtfcHk0lhhYAXsaiLzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXptV2qs7g%253D&md5=c2e1da8bb788bec0cfb4445753dcc5a0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fijms20225529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20225529%26sid%3Dliteratum%253Aachs%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DDehouck%26aufirst%3DL.%26aulast%3DVersele%26aufirst%3DR.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DGosselet%26aufirst%3DF.%26atitle%3DA%2520miniaturized%2520pump%2520out%2520method%2520for%2520characterizing%2520molecule%2520interaction%2520with%2520ABC%2520transporters%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D5529%26doi%3D10.3390%2Fijms20225529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brighton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rievaj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhre, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span> <span> </span><span class="NLM_article-title">Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">3961</span>– <span class="NLM_lpage">3970</span>, <span class="refDoi"> DOI: 10.1210/en.2015-1321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1210%2Fen.2015-1321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26280129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Ojur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=3961-3970&author=C.+A.+Brightonauthor=J.+Rievajauthor=R.+E.+Kuhreauthor=L.+L.+Glassauthor=K.+Schoonjansauthor=J.+J.+Holstauthor=F.+M.+Gribbleauthor=F.+Reimann&title=Bile+acids+trigger+GLP-1+release+predominantly+by+accessing+basolaterally+located+G+protein-coupled+bile+acid+receptors&doi=10.1210%2Fen.2015-1321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors</span></div><div class="casAuthors">Brighton, Cheryl A.; Rievaj, Juraj; Kuhre, Rune E.; Glass, Leslie L.; Schoonjans, Kristina; Holst, Jens J.; Gribble, Fiona M.; Reimann, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3961-3970</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Bile acids are well-recognized stimuli of glucagon-like peptide-1 (GLP-1) secretion.  This action has been attributed to activation of the G protein-coupled bile acid receptor GPBAR1(TGR5), although other potential bile acid sensors include the nuclear farnesoid receptor and the apical sodium coupled bile acid transporter ASBT.  The aim of this study was to identify pathways important for GLP-1 release and to det. whether bile acids target their receptors on GLP-1-secreting L-cells from the apical or basolateral compartment.  Using transgenic mice expressing fluorescent sensors specifically in L-cells, we obsd. that taurodeoxycholate (TDCA) and taurolithocholate (TLCA) increased intracellular cAMP and Ca2+.  In primary intestinal cultures, TDCA was a more potent GLP-1 secretagogue than taurocholate (TCA) and TLCA, correlating with a stronger Ca2+ response to TDCA.  Using small-vol. Ussing chambers optimized for measuring GLP-1 secretion, we found that both a GPBAR1 agonist and TDCA stimulated GLP-1 release better when applied from the basolateral than from the luminal direction and that luminal TDCA was ineffective when intestinal tissue was pretreated with an ASBT inhibitor.  ASBT inhibition had no significant effect in nonpolarized primary cultures.  Studies in the perfused rat gut confirmed that vascularly administered TDCA was more effective than luminal TDCA.  Intestinal primary cultures and Ussing chamber- mounted tissues from GPBAR1-knockout mice did not secrete GLP-1 in response to either TLCA or TDCA.  We conclude that the action of bile acids on GLP-1 secretion is predominantly mediated by GPBAR1 located on the basolateral L-cell membrane, suggesting that stimulation of gut hormone secretion may include postabsorptive mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopfu7ri_IsarVg90H21EOLACvtfcHk0lgygorjcU4WoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Ojur8%253D&md5=84e055a3542eaafd10875b3890e0eccc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1210%2Fen.2015-1321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2015-1321%26sid%3Dliteratum%253Aachs%26aulast%3DBrighton%26aufirst%3DC.%2BA.%26aulast%3DRievaj%26aufirst%3DJ.%26aulast%3DKuhre%26aufirst%3DR.%2BE.%26aulast%3DGlass%26aufirst%3DL.%2BL.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DReimann%26aufirst%3DF.%26atitle%3DBile%2520acids%2520trigger%2520GLP-1%2520release%2520predominantly%2520by%2520accessing%2520basolaterally%2520located%2520G%2520protein-coupled%2520bile%2520acid%2520receptors%26jtitle%3DEndocrinology%26date%3D2015%26volume%3D156%26spage%3D3961%26epage%3D3970%26doi%3D10.1210%2Fen.2015-1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedroso, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tellechea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidalgo-Carvalho, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span> <span> </span><span class="NLM_article-title">Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e16114</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0016114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1371%2Fjournal.pone.0016114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=21283630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Glsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=D.+C.+S.+Pedrosoauthor=A.+Tellecheaauthor=L.+Mouraauthor=I.+Fidalgo-Carvalhoauthor=J.+Duarteauthor=E.+Carvalhoauthor=L.+Ferreira&title=Improved+survival%2C+vascular+differentiation+and+wound+healing+potential+of+stem+cells+co-cultured+with+endothelial+cells&doi=10.1371%2Fjournal.pone.0016114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells</span></div><div class="casAuthors">Pedroso, Dora C. S.; Tellechea, Ana; Moura, Liane; Fidalgo-Carvalho, Isabel; Duarte, Joao; Carvalho, Eugenia; Ferreira, Lino</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e16114</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In this study, we developed a methodol. to improve the survival, vascular differentiation and regenerative potential of umbilical cord blood (UCB)-derived hematopoietic stem cells (CD34+ cells), by co-culturing the stem cells in a 3D fibrin gel with CD34+-derived endothelial cells (ECs).  ECs differentiated from CD34+ cells appear to have superior angiogenic properties to fully differentiated ECs, such as human umbilical vein endothelial cells (HUVECs).  Our results indicate that the pro-survival effect of CD34+-derived ECs on CD34+ cells is mediated, at least in part, by bioactive factors released from ECs.  This effect likely involves the secretion of novel cytokines, including interleukin-17 (IL-17) and interleukin-10 (IL-10), and the activation of the ERK 1/2 pathway in CD34+ cells.  We also show that the endothelial differentiation of CD34+ cells in co-culture with CD34+-derived ECs is mediated by a combination of sol. and insol. factors.  The regenerative potential of this co-culture system was demonstrated in a chronic wound diabetic animal model.  The co-transplantation of CD34+ cells with CD34+-derived ECs improved the wound healing relatively to controls, by decreasing the inflammatory reaction and increasing the neovascularization of the wound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqII4x8qj1KLVg90H21EOLACvtfcHk0lgygorjcU4WoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Glsro%253D&md5=2e2363c684f0324a388e2dc6149dd48a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0016114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0016114%26sid%3Dliteratum%253Aachs%26aulast%3DPedroso%26aufirst%3DD.%2BC.%2BS.%26aulast%3DTellechea%26aufirst%3DA.%26aulast%3DMoura%26aufirst%3DL.%26aulast%3DFidalgo-Carvalho%26aufirst%3DI.%26aulast%3DDuarte%26aufirst%3DJ.%26aulast%3DCarvalho%26aufirst%3DE.%26aulast%3DFerreira%26aufirst%3DL.%26atitle%3DImproved%2520survival%252C%2520vascular%2520differentiation%2520and%2520wound%2520healing%2520potential%2520of%2520stem%2520cells%2520co-cultured%2520with%2520endothelial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0016114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aday, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coisne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhardt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span> <span> </span><span class="NLM_article-title">A stable and reproducible human Blood-Brain Barrier model derived from hematopoietic stem cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e99733</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0099733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1371%2Fjournal.pone.0099733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=24936790" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=R.+Cecchelliauthor=S.+Adayauthor=E.+Sevinauthor=C.+Almeidaauthor=M.+Culotauthor=L.+Dehouckauthor=C.+Coisneauthor=B.+Engelhardtauthor=M.-P.+Dehouckauthor=L.+Ferreira&title=A+stable+and+reproducible+human+Blood-Brain+Barrier+model+derived+from+hematopoietic+stem+cells&doi=10.1371%2Fjournal.pone.0099733"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0099733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0099733%26sid%3Dliteratum%253Aachs%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DAday%26aufirst%3DS.%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DAlmeida%26aufirst%3DC.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DDehouck%26aufirst%3DL.%26aulast%3DCoisne%26aufirst%3DC.%26aulast%3DEngelhardt%26aufirst%3DB.%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DFerreira%26aufirst%3DL.%26atitle%3DA%2520stable%2520and%2520reproducible%2520human%2520Blood-Brain%2520Barrier%2520model%2520derived%2520from%2520hematopoietic%2520stem%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0099733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elhaik Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macheto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresler, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Oliveira, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liraz-Zaltsman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeri, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, I.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier cellular responses toward organophosphates: natural compensatory processes and exogenous interventions to rescue barrier properties</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">359</span>, <span class="refDoi"> DOI: 10.3389/fncel.2018.00359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.3389%2Ffncel.2018.00359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=30459557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFSmsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=359&author=O.+Ravidauthor=S.+Elhaik+Goldmanauthor=D.+Machetoauthor=Y.+Breslerauthor=R.+I.+De+Oliveiraauthor=S.+Liraz-Zaltsmanauthor=F.+Gosseletauthor=L.+Dehouckauthor=M.+S.+Beeriauthor=I.+Cooper&title=Blood-Brain+Barrier+cellular+responses+toward+organophosphates%3A+natural+compensatory+processes+and+exogenous+interventions+to+rescue+barrier+properties&doi=10.3389%2Ffncel.2018.00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier cellular responses toward organophosphates: natural compensatory processes and exogenous interventions to rescue barrier properties</span></div><div class="casAuthors">Ravid, Orly; Goldman, Shirin Elhaik; Macheto, David; Bresler, Yael; De Oliveira, Raquel Ines; Liraz-Zaltsman, Sigal; Gosselet, Fabien; Dehouck, Lucie; Beeri, Michal Schnaider; Cooper, Itzik</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">359</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The insecticide parathion) and as chem. warfare nerve agents.  Blood-brain barrier (BBB) leakage has been shown in rodents exposed to PX, which is an organophosphate oxon.  In this study, we investigated the cellular mechanisms involved in BBB reaction after acute exposure to PX in an established in vitro BBB system made of stem-cell derived, human brain-like endothelial cells (BLECs) together with brain pericytes that closely mimic the in vivo BBB.  Our results show that PX directly affects the BBB in vitro both at toxic and non-toxic concns. by attenuating tight junctional (TJ) protein expression and that only above a certain threshold the paracellular barrier integrity is compromised.  Below this threshold, BLECs exhibit a morphol. coping mechanism in which they enlarge their cell area thus preventing the formation of meaningful intercellular gaps and maintaining barrier integrity.  Importantly, we demonstrate that reversal of the apoptotic cell death induced by PX, by a pan-caspase-inhibitor ZVAD-FMK (ZVAD) can reduce PX-induced cell death and elevate cell area but do not prevent the induced BBB permeability, implying that TJ complex functionality is hindered.  This is corroborated by formation of ROS at all toxic concns. of PX and which are even higher with ZVAD.  We suggest that while lower levels of ROS can induce compensating mechanisms, higher PX-induced oxidative stress levels interfere with barrier integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0lO7kjzRm_bVg90H21EOLACvtfcHk0lgQi1AXVhQVKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFSmsLbE&md5=20a74a60cd795c721d6f358c1819b8fd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2018.00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2018.00359%26sid%3Dliteratum%253Aachs%26aulast%3DRavid%26aufirst%3DO.%26aulast%3DElhaik%2BGoldman%26aufirst%3DS.%26aulast%3DMacheto%26aufirst%3DD.%26aulast%3DBresler%26aufirst%3DY.%26aulast%3DDe%2BOliveira%26aufirst%3DR.%2BI.%26aulast%3DLiraz-Zaltsman%26aufirst%3DS.%26aulast%3DGosselet%26aufirst%3DF.%26aulast%3DDehouck%26aufirst%3DL.%26aulast%3DBeeri%26aufirst%3DM.%2BS.%26aulast%3DCooper%26aufirst%3DI.%26atitle%3DBlood-Brain%2520Barrier%2520cellular%2520responses%2520toward%2520organophosphates%253A%2520natural%2520compensatory%2520processes%2520and%2520exogenous%2520interventions%2520to%2520rescue%2520barrier%2520properties%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2018%26volume%3D12%26spage%3D359%26doi%3D10.3389%2Ffncel.2018.00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aday, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallier-Vanuxeem, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span> <span> </span><span class="NLM_article-title">Stem cell-based human blood-brain barrier models for drug discovery and delivery</span>. <i>Trends Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.tibtech.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1016%2Fj.tibtech.2016.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=26838094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVegtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=382-393&author=S.+Adayauthor=R.+Cecchelliauthor=D.+Hallier-Vanuxeemauthor=M.+P.+Dehouckauthor=L.+Ferreira&title=Stem+cell-based+human+blood-brain+barrier+models+for+drug+discovery+and+delivery&doi=10.1016%2Fj.tibtech.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery</span></div><div class="casAuthors">Aday, S.; Cecchelli, R.; Hallier-Vanuxeem, D.; Dehouck, M. P.; Ferreira, L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-393</span>CODEN:
                <span class="NLM_cas:coden">TRBIDM</span>;
        ISSN:<span class="NLM_cas:issn">0167-7799</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of novel neuropharmaceuticals requires the evaluation of blood-brain barrier (BBB) permeability and toxicity.  Recent studies have highlighted differences in the BBB among different species, with the most important differences involving the expression of P-glycoprotein (P-gp), multidrug resistance-assocd. proteins, transporters, and claudins.  In addn., functional studies have shown that brain pharmacokinetics of P-glycoprotein substrates are different in humans and rodents.  Therefore, human BBB models may be an important platform for initial drug screening before in vivo studies.  This strategy might help to reduce costs in drug development and failures in clin. studies.  We review the differences in the BBB among species, recent advances in the generation of human BBB models, and their applications in drug discovery and delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDN1Tf9LkGnLVg90H21EOLACvtfcHk0lhGN2xbeIGKsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVegtro%253D&md5=f6ef907b292f719a6dc945888c59f7c6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tibtech.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibtech.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DAday%26aufirst%3DS.%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DHallier-Vanuxeem%26aufirst%3DD.%26aulast%3DDehouck%26aufirst%3DM.%2BP.%26aulast%3DFerreira%26aufirst%3DL.%26atitle%3DStem%2520cell-based%2520human%2520blood-brain%2520barrier%2520models%2520for%2520drug%2520discovery%2520and%2520delivery%26jtitle%3DTrends%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D382%26epage%3D393%26doi%3D10.1016%2Fj.tibtech.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolliet-Riant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brée, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruchart, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillement, J. P.</span></span> <span> </span><span class="NLM_article-title">Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1790</span>– <span class="NLM_lpage">1797</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1992.tb10055.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=10.1111%2Fj.1471-4159.1992.tb10055.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1560234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;key=1%3ACAS%3A528%3ADyaK38Xit1Olsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1992&pages=1790-1797&author=M.-P.+Dehouckauthor=P.+Jolliet-Riantauthor=F.+Br%C3%A9eauthor=J.-C.+Fruchartauthor=R.+Cecchelliauthor=J.+P.+Tillement&title=Drug+transfer+across+the+blood-brain+barrier%3A+correlation+between+in+vitro+and+in+vivo+models&doi=10.1111%2Fj.1471-4159.1992.tb10055.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transfer across the blood-brain barrier:  correlation between in vitro and in vivo models</span></div><div class="casAuthors">Dehouck, Marie Pierre; Jolliet-Riant, Pascale; Bree, Francoise; Fruchart, Jean Charles; Cecchelli, Romeo; Tillement, Jean Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1790-7</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To assess the drug transport across the blood-brain barrier (BBB), the authors compared the maximal brain extn. values at time O [E(0) values] obtained using either in vitro or in vivo methods.  The in vitro BBB model consisted of a coculture of brain capillary endothelial cells growing on one side of a filter and astrocytes on the other.  The in vivo model used intracarotid injection in anesthetized rats.  Eleven compds. were tested.  They were selected because they exhibit quant. different brain extn. rates: very low for inulin and sucrose, low for oxicam-related nonsteroidal antiinflammatory drugs and diclofenac, and high for propranolol and diazepam.  As these compds. are apparently transferred by a passive diffusion mechanism, two others, glucose and leucine, were added that cross the BBB by a known carrier-mediated process.  The in vivo and in vitro E(0) values showed a strong correlation as indicated by the Spearman's correlation coeff. (r = 0.88, p <0.01).  The relative ease with which such cocultures can be produced in large quantities could facilitate the screening of new centrally acting drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBoWOtr2M6BbVg90H21EOLACvtfcHk0lhGN2xbeIGKsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xit1Olsb8%253D&md5=07e0a0cbf719c2b36d095027d0b440d1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1992.tb10055.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1992.tb10055.x%26sid%3Dliteratum%253Aachs%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DJolliet-Riant%26aufirst%3DP.%26aulast%3DBr%25C3%25A9e%26aufirst%3DF.%26aulast%3DFruchart%26aufirst%3DJ.-C.%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DTillement%26aufirst%3DJ.%2BP.%26atitle%3DDrug%2520transfer%2520across%2520the%2520blood-brain%2520barrier%253A%2520correlation%2520between%2520in%2520vitro%2520and%2520in%2520vivo%2520models%26jtitle%3DJ.%2520Neurochem.%26date%3D1992%26volume%3D58%26spage%3D1790%26epage%3D1797%26doi%3D10.1111%2Fj.1471-4159.1992.tb10055.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01774">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16580"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01774?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01774</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01774/suppl_file/jm0c01774_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01774/suppl_file/jm0c01774_si_001.csv">jm0c01774_si_001.csv (1.11 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01774&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01774%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01774" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b584fc383d06","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
